<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2025-11-17 09:20:08 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>122</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>69</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="CNS infection by HIV-1 contributes to neuroinflammation, cognitive impairments, and the establishment of viral reservoirs. Although HIV-1 is known to enter the brain early in infection via “Trojan horse” leukocytes, including infected monocytes and CD4⁺ T cells, the specific cellular phenotypes facilitating this process during acute infection remain incompletely characterized. This study aims to characterize the roles of brain lymphocytes during acute infection and primary CD4 + T cell phenotypes seeding the SIV to the CNS. scRNA-seq was performed on brain and blood cells of three acutely SIV-infected rhesus macaques. The transcriptomic data were analyzed using bioinformatics approaches and validated through in vitro co-culture assays and re-analysis of a publicly available scRNA-seq dataset. scRNA-seq of brain and blood immune cells from acutely SIV-infected rhesus macaques revealed an expansion of proliferating CD4⁺ cytotoxic T lymphocytes (CTLs) in the blood, characterized by high CD4, CCR5, and adhesion molecule expression, indicating strong potential for CNS infiltration. In the brain, CD4⁺ CTLs, tissue-resident memory cells, and a unique Myeloid–T cell cluster were enriched for SIV⁺ cells. Integration of brain and blood data revealed transcriptomic maturation of CD4⁺ CTLs upon brain entry. To validate the biological relevance of the Myeloid–T cluster, we used a macrophage–T cell co-culture system, which reproduced similar dual-marker expression and identified chemokines (e.g., CCL3, CCL4) as potential markers of T cell–myeloid cell interaction. Our findings suggest that CD4⁺ cytotoxic-like T cells represent a key lymphocyte subset responsible for initiating SIV entry into the brain and triggering neuroinflammatory processes. Furthermore, interactions between infiltrating lymphocytes and brain-resident myeloid cells, potentially through chemokine signaling, may facilitate viral propagation within the CNS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72fbfac68579326979ef04a1dc07549f993cb4aa" target='_blank'>
              T cell-mediated SIV dissemination into the CNS: a single-cell transcriptomic analysis
              </a>
            </td>
          <td>
            Xiaoke Xu, Meng Niu, Benjamin G. Lamberty, Kathleen M. Emanuel, L. D. Estrella, Howard S. Fox
          </td>
          <td>2025-10-08</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="The recent COVID-19 pandemic left behind the lingering question as whether new variants of concern might cause further waves of infection. Thus, it is important to investigate the long-term protection gained via vaccination or exposure to the SARS-CoV-2 virus. Here we compare the evolution of memory T-cell responses following primary infection with subsequent antigen exposures. Single-cell TCR analysis of three dominant SARS-CoV-2 spike-specific CD4+ T-cell responses identifies the dominant public TCRα clonotypes pairing with diverse TCRβ clonotypes that associated with mild disease at primary infection. These clonotypes are found at higher frequencies in pre-pandemic repertoires compared to other epitope-specific clonotypes. Longitudinal transcriptomics and TCR analysis, combined with functional evaluation, reveals that the clonotypes persisting 3–4 years post initial infection exhibit distinct functionality compared to those that were lost. Furthermore, spike-specific CD4+ T cells at this time point show decreased Th1 signatures and enhanced GZMA-driven cytotoxic transcriptomic profiles that were independent of TCR clonotype and associated with viral suppression. In summary, we identify common public TCRs used by immunodominant spike-specific memory CD4+ T-cells, associated with mild disease outcome, which likely play important protective roles to subsequent viral infection events. It is important to know how the recent COVID-19 pandemic shaped the immune memory against the causal SARS-CoV-2 virus. Here authors show that long years following mild disease at primary infection, SARSCoV-2 spike-specific CD4 + T cells with distinct phenotypes and T cell receptor clonotypes, associated with viral suppression persist.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1990a5c85f154fc42126796dea994523a0bcd1cc" target='_blank'>
              Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19
              </a>
            </td>
          <td>
            Guihai Liu, E. Antoun, A. Fries, Xuan Yao, Z. Yin, D. Dong, Wenbo Wang, P. Wing, Wanwisa Dejnirattisa, P. Supasa, Chang Liu, Timothy Rostron, C. Waugh, Kevin Clark, Paul Sopp, J. Fry, I. Vendrell, Jane A. McKeating, J. Mongkolsapaya, G. Screaton, Benedikt M. Kessler, R. Fisher, G. Ogg, A. Mentzer, J. Knight, Yanchun Peng, Tao Dong
          </td>
          <td>2025-10-01</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>68</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79890359565389b73c061b8b182c8a9f91a90fcd" target='_blank'>
              Mechanisms of sex differences in acute and long COVID sequelae in mice
              </a>
            </td>
          <td>
            Jennifer A. Liu, Sabal Chaulagain, Patrick S. Creisher, Weizhi Zhong, Tianle Zhang, Maraake Taddese, Karly Shi, Han-sol Park, Haley Hcnir, Arthur P. Arnold, Ralph S. Baric, Natasha B Barahona, Elizabeth Engler-Chiurazzi, Kevin J. Zwezdaryk, Chloe L. Thio, A. Balagopal, J.R. Harkema, Elizabeth A. Thompson, A. Pekosz, Andrea L Cox, S. Klein
          </td>
          <td>2025-10-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is an autoimmune and neuroinflammation disease characterized by axonal damage, inflammatory demyelination, and neurodegeneration. However, the precise mechanisms underlying MS pathogenesis remain largely unclear. Here, we identify ZNRF1, an E3 ubiquitin ligase, as a critical regulator of experimental autoimmune encephalomyelitis (EAE), a murine model that recapitulates the autoimmune demyelination features of MS. Mice lacking ZNRF1 exhibit increased susceptibility to EAE progression. Notably, ZNRF1 depletion in peripheral myeloid cells, but not in microglia, leads to enhanced immune cell infiltration into the central nervous system, resulting in demyelination and exacerbated disease severity. The heightened EAE severity in Znrf1-deficient mice is associated with increased polarization of Th1 and Th17 cells, elevated antigen-specific T helper cell proliferation, and amplified immune responses. Furthermore, following EAE induction, macrophages from Znrf1-deficient mice display elevated surface expression of MHC class II (MHC-II) molecules. Collectively, our findings suggest that ZNRF1 in peripheral myeloid cells plays a suppressive role in neuroinflammation by regulating MHC-II surface expression, thereby controlling antigen-specific T-cell proliferation and activation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f962a55325851d781ba99d1de0343d57aac16244" target='_blank'>
              Myeloid ZNRF1 suppresses autoimmune demyelination and neuroinflammation by regulating MHC-II-mediated T cell activation
              </a>
            </td>
          <td>
            Yung-Chi Chang, Ching-Chih Wu, Fu-Ting Hsiao, You-Sheng Lin, Ting-Yu Lai, Kang-Hsuan Huang, Shiue-Cheng Tang, Chih-Yuan Lee, Shen-Ju Chou, Li-Chung Hsu
          </td>
          <td>2025-10-22</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Aberrant and sustained activation of microglia is implicated in the progression and severity of multiple sclerosis (MS). However, whether intrinsic alterations in microglial function impact the pathogenesis of this disease remains unclear. We conducted transcriptomic and functional analyses of microglia-like cells (iMGLs) differentiated from induced pluripotent stem cells (iPSCs) from patients with MS (pwMS) to answer this question. We generated iPSCs from six pwMS showing increased microglial activity via translocator protein (TSPO)-PET imaging. We demonstrated that the differentiated iMGL transcriptional profile resembled the microglial signature found in MS lesions. Importantly, compared with healthy controls, MS iMGLs presented cell-autonomous differences in their regulation of inflammation, both in the basal state and following inflammatory lipopolysaccharide challenge. Through transcriptomic profiling, we showed that MS iMGLs display increased expression of genes known to be upregulated in MS microglia. Furthermore, upregulated genes in MS iMGLs were associated with immune receptor activation, antigen presentation, and the complement system, with known MS implications. Finally, functional analyses indicated that the transcriptional changes in MS iMGLs corresponded with alterations in the secretion of inflammatory cytokines and chemokines and increased phagocytosis. Together, our results provide evidence of putative cell-autonomous microglial activation in pwMS and identify transcriptomic and functional changes that recapitulate the phenotypes observed in vivo in microglia from pwMS. These findings indicate that MS disease-specific iPSCs are valuable tools for studying disease-specific microglial activation in vitro and highlight microglia as potential therapeutic targets in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce483627b1620ca8e2ea90bf499e8cad452ba523" target='_blank'>
              Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state
              </a>
            </td>
          <td>
            Tanja Hyvärinen, J. Lotila, Luca Giudice, Iisa Tujula, M. Nylund, S. Ohtonen, Flavia Scoyni, Henna Jäntti, Sara Pihlava, H. Skottman, Susanna Narkilahti, L. Airas, T. Malm, S. Hagman
          </td>
          <td>2024-12-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>2</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa0d09c722147bd759ef9cedc307b8c6a5fb7718" target='_blank'>
              Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Mohamed M. Shamseldin, Owen Whitham, Heba M Amer, Jeffery Atkinson, Asmaa Badr, Jesse Hall, Jihad Omran, Gauruv A. Gupta, Yara Hassan, Rabab Abdelaleem, Richard Perez, Sarah Faber, Maciej Pietrzak, Amy Webb, Xiaoli Zhang, A. Kenney, Destiny Bissel, Shady Z K Estfanous, Kylene P. Daily, Andrew Mcnamara, K. Mahesh, M. Peeples, Emily A. Hemann, Shahid M. Nimjee, E. Cormet-Boyaka, Jianrong Li, P. Boyaka, Jacob S. Yount, Benjamin M. Segal, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="In multiple sclerosis (MS), chronic compartmentalized inflammation is thought to drive relentless clinical deterioration. Here, we investigate the link between unresolved parenchymal inflammation and cellular senescence in MS progression. Single-cell transcriptomic analysis of human brain tissue reveals an accumulation of senescent-like glial cells in diseased white matter, especially in chronic active lesions, and to a lesser extent in the cortex. Spatial transcriptomics show gradients of senescence-like signatures extending from lesion cores to periplaque regions, alongside rewired cellular networks. Experimental induction of senescence in MS hiPSC-derived neural organoids demonstrates that microglia are especially vulnerable to inflammation-induced senescence, which can be partially rescued by CNS-penetrant anti-inflammatory drugs. At the patient level (n = 466), increased 3T MRI-estimated brain-age is observed, especially in individuals with more than four chronic active lesions. These findings suggest that chronic inflammation might accelerate senescence-like processes, potentially contributing to disease progression, and that its modulation might help limit further propagation. In multiple sclerosis, smoldering inflammation contributes to clinical progression. Using multi-omics data, here the authors link chronic inflammation to senescence-like processes and cellular network changes, suggesting a potential therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b77d9523c82f1187be87e3bd2154d78aa2798954" target='_blank'>
              Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids
              </a>
            </td>
          <td>
            Francesca Fagiani, Edoardo Pedrini, Maria Sofia Martire, Gaia Gastoldi, Colin Vanden Bulcke, Jing-Ping Lin, Dragan Maric, Elena Brambilla, F. Ruffini, Carolina Peri, P. Calabresi, Pietro Maggi, Paola Panina-Bordignon, Gianvito Martino, D. Reich, Martina Absinta
          </td>
          <td>2025-09-26</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1f062d3d912692ad94fd023b7389eaa8ae74fd9" target='_blank'>
              Temporal Dynamics of Antigen-Specific T Cell Expansion in Primary SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Andrew Pyo, Adlina Chan, J. Rosenheim, Clare Thakker, Lucy Bell, Gayathrie Nageswaran, Suzanne Byrne, Ben Killingley, David Scobie, M. Kalinova, A. Boyers, A. Catchpole, Alex J. Mann, Rik G. H. Lindeboom, Marko Z. Nikolić, Sarah A. Teichmann, H. Wagstaffe, M. Noursadeghi, Christopher Chiu, Curtis G. Callan, Andreas Tiffeau-Mayer, N. Wingreen, Benjamin M. Chain
          </td>
          <td>2025-11-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>80</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is characterized by invasion of the brain by effector memory T (TEM) lymphocytes that have been activated by repeated auto-antigen stimulation. Existing therapies target these and other autoreactive lymphocytes but their side effects include general immunosuppression and toxicity. Because the Kv1.3 potassium channel is highly expressed by chronically activated autoreactive TEMs, we investigated whether specific targeting of mitochondrial Kv1.3 using the pharmacological inhibitor PAPTP could selectively kill these TEMs in patients and mice with MS. 1 µM PAPTP targeted and reduced the number of autoreactive TEMs in blood samples from relapsing-remitting MS (RRMS) patients, leaving other T cell populations unaffected. Remarkably, pre-treatment of the entire T cell population with PAPTP during adoptive transfer of experimental autoimmune encephalomyelitis (EAE) killed TEMs and completely prevented disease onset in this mouse model. Moreover, PAPTP selectively eliminated activated TEMs and halted EAE progression when administered following disease onset. Our findings reveal the potential of PAPTP as an effective treatment for MS without adverse side effects. PAPTP mitigates multiple sclerosis (MS) progression by targeting mitoKv1.3 in effector memory T cells (TEMs), inducing ROS production and apoptosis. It prevents or halts MS-like disease in animal models and selectively eliminates TEMs from the peripheral blood of MS patients. MitoKv1.3 in TEMs was identified as the key target for PAPTP-mediated suppression of MS pathology. Increased ROS production and subsequent apoptosis were observed in TEMs treated with PAPTP. Selective elimination of peripheral TEMs halts MS-like disease progression in animal models. Therapeutic application of PAPTP curtails MS-like disease in experimental models and reduces TEMs in blood samples from MS patients. MitoKv1.3 in TEMs was identified as the key target for PAPTP-mediated suppression of MS pathology. Increased ROS production and subsequent apoptosis were observed in TEMs treated with PAPTP. Selective elimination of peripheral TEMs halts MS-like disease progression in animal models. Therapeutic application of PAPTP curtails MS-like disease in experimental models and reduces TEMs in blood samples from MS patients. PAPTP mitigates multiple sclerosis (MS) progression by targeting mitoKv1.3 in effector memory T cells (TEMs), inducing ROS production and apoptosis. It prevents or halts MS-like disease in animal models and selectively eliminates TEMs from the peripheral blood of MS patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bafd993e0b224c67ac0c7bb80c427491f7b31907" target='_blank'>
              Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo
              </a>
            </td>
          <td>
            Beatrice Angi, T. Varanita, M. Puthenparampil, Valentina Scattolini, M. Donadon, Mitra Tavakoli, Marta Favero, Maguie El Boustani, Matthias Soddemann, L. Biasutto, Diletta Arcidiacono, Alberto Ongaro, Andrea Mattarei, L. Trentin, Gregory C. Wilson, Erich Gulbins, Paolo Gallo, Ildiko Szabo
          </td>
          <td>2025-09-29</td>
          <td>EMBO Molecular Medicine</td>
          <td>1</td>
          <td>56</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d46811852497c54872a7282800dcab64fa68610f" target='_blank'>
              A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity
              </a>
            </td>
          <td>
            K. Slowikowski, P. Sen, C. Cosgriff, J. Tantivit, T. Eisenhaure, T. J. LaSalle, K. Manakongtreecheep, A. Tirard, B. Y. Arnold, A. Pacheco-Navarro, E. Y. Yang, M. Reyes, A. Gonye, I. Gushterova, B. Russo, M. Rojas-Lopez, N. Sharma, M. F. Thomas, T. Sharova, D. Frederick, K. Lavin-Parsons, B. Lilley, B. Mckaig, C. Lodenstein, H. Khanna, K. Kays, N. Charland, N. Smith, S. Ramesh, T. Delorey, D. Phillips, L. Amir-Zilberstein, E. M. Brown, M. Benson, S.-M. Park, B. Tusi, V. Pokatayev, C. Hecht, N. Pishesha, A. E. Woolley, L. Cosimi, Rozenblatt-Ro
          </td>
          <td>2025-09-21</td>
          <td>None</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d74835f8e845ea18beb20340e5bd3f281ac019ce" target='_blank'>
              Tonic type I interferon signaling optimizes the antiviral function of plasmacytoid dendritic cells
              </a>
            </td>
          <td>
            Joseph N. Pucella, Raul A Maqueda-Alfaro, Hai Ni, Fernando Bandeira Sulczewski, Anna Eichinger, E. Esteva, Ai C Ra, Annesa Das, Oriana A. Perez, Jue Feng, Marlon Stoeckius, Peter Smibert, Alireza Khodadadi-Jamayran, Igor Dolgalev, E. Ivanova, Stela Sota, Ken Cadwell, S. Koralov, Judy Zhong, Chetna Soni, Daniel B. Stetson, Stuart P Weisberg, Donna L. Farber, Juliana Idoyaga, Boris Reizis
          </td>
          <td>2025-10-14</td>
          <td>Nature Immunology</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Our understanding of the immune response in tuberculosis (TB) remains incomplete. This applies in particular to extrapulmonary TB (EPTB), a highly heterogeneous disease affecting up to 30% of patients in certain regions. Based on data-driven clustering of blood transcriptomes in an EPTB patient cohort, we define three highly distinct immunotypes. Combining bulk with single-cell RNA-sequencing delineates immunological trajectories characterized by dynamic IFN- and IL-1-mediated signalling in monocytes, alongside hyperactivation of T and NK cells, ultimately resulting in extensive immune dysregulation. Integrative analysis of multi-omics data provides deep insights into different layers of the anti-tuberculous immune response and the identification of immunotypes enabling stratification strategies for personalized host-directed treatments. In addition, our comprehensive approach helps to develop an accurate diagnostic gene expression signature for both EPTB and pulmonary TB highlighting the translational potential of our data. This work uses gene expression and single cell analyses to group extrapulmonary tuberculosis patients into three immune types, revealing immune pathways driving pathogenesis and markers that could improve diagnosis and guide tailored treatments.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/03cb07105c64f52d8dc00fc9152c22bdcb4ddb77" target='_blank'>
              Deep immune profiling delineates hallmarks of disease heterogeneity in extrapulmonary tuberculosis
              </a>
            </td>
          <td>
            Sebastian J. Theobald, Kilian Dahm, Dinah Lange, Jannis B. Spintge, S. Winter, Angela Klingmüller, L. Holsten, Alexander Simonis, Elena De Domenico, H. Walczak, Martina van Uelft, J. Schultze, M. Beyer, Thomas Ulas, Isabelle Suárez, J. Rybniker
          </td>
          <td>2025-11-10</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Lipid alterations in the brain have been implicated in many neurodegenerative diseases. To facilitate comparative lipidomic research across brain diseases, we establish a data common named the Neurolipid Atlas that we prepopulated with isogenic induced pluripotent stem cell (iPS cell)-derived lipidomics data for different brain diseases. Additionally, the resource contains lipidomics data of human and mouse brain tissue. Leveraging multiple datasets, we demonstrate that iPS cell-derived neurons, microglia and astrocytes exhibit distinct lipid profiles that recapitulate in vivo lipotypes. Notably, the Alzheimer disease (AD) risk gene ApoE4 drives cholesterol ester (CE) accumulation specifically in human astrocytes and we also observe CE accumulation in whole-brain lipidomics from persons with AD. Multiomics interrogation of iPS cell-derived astrocytes revealed that altered cholesterol metabolism has a major role in astrocyte immune pathways such as the immunoproteasome and major histocompatibility complex class I antigen presentation. Our data commons, available online (https://neurolipidatlas.com/), allows for data deposition by the community and provides a user-friendly tool and knowledge base for a better understanding of lipid dyshomeostasis in neurodegenerative diseases. The authors introduce the Neurolipid Atlas, a dynamic resource for the community to gain insight into lipid alterations in neurodegenerative disease, and they leverage the platform to show how cholesterol alterations in astrocytes can dysregulate neuroinflammatory pathways in Alzheimer disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d0eed80d4dd7f2f5820bc067e4d87483e9a7ca84" target='_blank'>
              The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases
              </a>
            </td>
          <td>
            Femke M. Feringa, Sascha J Koppes-den Hertog, Lian Y Wang, R. J. Derks, Iris Daphne Kruijff, Lena Erlebach, Jorin Heijneman, Ricardo Miramontes, Nadine Pömpner, N. Blomberg, D. Olivier-Jimenez, L. Johansen, Alexander J. Cammack, A. Giblin, C. Toomey, Indigo V. L. Rose, Hebao Yuan, Michael E Ward, Adrian M. Isaacs, Martin Kampmann, Deborah Kronenberg‐Versteeg, T. Lashley, Leslie M. Thompson, Alessandro Ori, Y. Mohammed, M. Giera, R. van der Kant
          </td>
          <td>2025-09-22</td>
          <td>Nature Metabolism</td>
          <td>2</td>
          <td>38</td>
        </tr>

        <tr id="The release of danger-associated molecular patterns (DAMPs) such as ATP from stressed or damaged cells is a key initiator of sterile inflammation. In autoimmune diseases, extracellular ATP acts as a potent pro-inflammatory signal by activating the purinergic receptor P2X7, which is expressed on both mononuclear phagocytes (MPs) and T cells—key drivers of pathological processes. While it is well established that P2X7 mediates ATP-dependent immune activation, its cell-specific contributions to innate versus adaptive immunity in autoimmune conditions remain unclear, especially in autoimmune uveitis. Here we used the experimental autoimmune uveoretinitis (EAU) mouse model to delineate the cellular mechanisms underlying P2X7’s role in autoimmune responses. Using a combination of multiple cell-specific conditional models and transcriptomic approaches, we showed a pivotal role forP2X7 expressed by MPs in orchestrating T-cell mediated autoimmune responses. P2X7 deficiency in MPs decreased disease severity. Additionally, cell-specific transcriptomic analyses, including single-cell analyses, revealed that P2X7 exerted distinct modulatory effects across monocyte-derived macrophages (MdM) versus microglia. In MdM, lack of P2X7 was associated with reduced expression of genes related to the inflammasome, phagocytosis pathways, and components of the complement system, leading to a marked decrease in pathogenic Th17 cell frequency in the retina. In microglia, P2X7 deficiency instead particularly impacted an IFN-responsive microglial subset that is normally characteristic of EAU. By specifically deleting P2X7 in microglia, we demonstrate its role in driving pathogenic processes in this cell population. These findings suggest that inhibition of P2X7 could be a promising therapeutic strategy in autoimmune neuroinflammatory disorders. P2X7 expressed on MPs, rather than on CD4+ T-cells, plays a primary role in the development of EAU. Lack of P2X7 expression by MPs not only down-regulated phagocytosis and inflammasome pathways but also complement components. P2X7 indirectly influences Th17 polarization through its expression in MPs. P2X7-deficiency in MPs reduced the frequency of the IFN-responsive microglial subset during EAU. P2X7 expression by microglia contributes to the development of EAU. P2X7 expressed on MPs, rather than on CD4+ T-cells, plays a primary role in the development of EAU. Lack of P2X7 expression by MPs not only down-regulated phagocytosis and inflammasome pathways but also complement components. P2X7 indirectly influences Th17 polarization through its expression in MPs. P2X7-deficiency in MPs reduced the frequency of the IFN-responsive microglial subset during EAU. P2X7 expression by microglia contributes to the development of EAU.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31d6dca4ac613c86885fb67afae84c460cb78a38" target='_blank'>
              Macrophage expression of P2X7 controls autoimmune uveitis
              </a>
            </td>
          <td>
            Paul-Alexandre Déchelle-Marquet, Yueshen Che, Camille Roux, Frédéric Blond, Kaitryn E. Ronning, S. Augustin, Pauline Lagouge-Roussey, C. Nous, Sara Touhami, Bahram Bodaghi, Jean Kanellopoulos, S. Adriouch, X. Guillonneau, Florian Sennlaub, Cécile Delarasse
          </td>
          <td>2025-09-25</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a progressive, chronic, and highly disabling neuroinflammatory disorder characterized by demyelination and T cell–driven inflammation. Pathogenic T cells play a central role in MS, but effective therapeutic targeting remains challenging. Here, we identified ankyrin repeat domain–containing protein 55 (ANKRD55) as a key regulator of T cell function by single-cell transcriptomic analysis of cerebrospinal fluid and blood from MS patients. ANKRD55 was predominantly expressed in CD4+ T cells in both compartments. Genetic ablation of Ankrd55 led to a robustly reduced disease severity and neuroinflammation in experimental autoimmune encephalomyelitis (EAE), a widely used animal model for MS. Furthermore, T cell–specific deficiency of Ankrd55 significantly impaired Th1 polarization and Th17 differentiation, reducing EAE pathogenicity. Mechanistically, we found that Ankrd55 deficiency disrupted T cell receptor (TCR) signaling integrity. We demonstrated that ANKRD55 regulates the formation of the immune synapse, an essential prerequisite for TCR activation, by interacting with subunits of the chaperonin-containing TCP1 (CCT) complex and modulating its activity, enhancing its assembly by competing with CCT5 for binding to TCP1, CCT3, and CCT6. This facilitates proper microtubule organization and TCR activation. These findings establish ANKRD55 as a critical regulator of TCR signaling and highlight its therapeutic potential in pathogenic T cell–driven autoimmune diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/865b26367cf4f5ce2ee12fb7cd224a9d528add57" target='_blank'>
              ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis
              </a>
            </td>
          <td>
            Chuyu Wu, Mei-Ling Jiang, Xue Yang, Yixuan Liu, Bin Huang, Yi Guo, Runjing Cao, Zhihui Cui, Guozhen Deng, Weiyan Wang, Mengdi Guo, Zhiyong Lin, Jiahui Fan, Lin-ming Zhang, Lorenzo Di Cesare Mannelli, Tao Pang, Chenhui Wang, Cun-Jin Zhang
          </td>
          <td>2025-10-15</td>
          <td>The Journal of Clinical Investigation</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a significant global health burden, characterized by complex host–pathogen interactions that drive heterogeneous clinical outcomes. While pulmonary epithelial cells are increasingly recognized as active participants in innate immunity during Mtb infection, how host defense are altered when the epithelial barrier is compromised remains unclear. In this study, we developed a murine model combining naphthalene-induced pulmonary epithelial injury with Mtb infection and mapped the pulmonary cells landscape through single-cell RNA sequencing (scRNA-seq), followed by in vitro stimulation assays to validate macrophage functional changes. Notably, we found a pronounced impairment in pulmonary bacterial clearance. Transcriptomic analysis revealed a widespread suppression of epithelial immune functions and showed that macrophages transitioned from an antimicrobial to an antigen-presenting phenotype, indicating waning pulmonary innate defenses and heightened adaptive immune activation. In vitro experiments further suggested that this macrophage transition may be linked to epithelial cell alterations. These findings indicate that pulmonary epithelial integrity may influence early host immune responses to Mycobacterium tuberculosis and provide a transcriptomic framework for exploring epithelial–immune crosstalk as a potential therapeutic target. Single-cell transcriptomics reveal epithelial–immune crosstalk remodeling during Mtb infection in mice. Pulmonary epithelial injury weakens mucosal defense and increases bacterial burden. Macrophages shift from innate immune defense to adaptive immune activation in response to Mtb challenge.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e41984afd63dd846e210a4451e9fc159cd48e46" target='_blank'>
              Lung epithelial injury impairs early host immune responses to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Xuan Miao, Xue Li, Zuokuan He, Guiying Xu, Yu Li, Youwei Wang, Junping Wu, Qi Wu, Huaiyong Chen
          </td>
          <td>2025-10-03</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7926169db8376b81cfe85e7301b1ef3978ec2753" target='_blank'>
              Innate immune responses to Plasmodium falciparum disrupt the blood-brain barrier
              </a>
            </td>
          <td>
            Alina Batzilla, Pia Dernick, Jon Bezney, A. Gschwind, Fumio Nakaki, Mireia Altadill, Hannah Fleckenstein, Livia Piatti, Silvia Sanz Sender, Manuel Fiegl, O. Oyerinde, Borja Lopez Gutierrez, M. López-Botet, James Sharpe, Lars M. Steinmetz, G. Moncunill, Maria Bernabeu
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Abstract Background Intracerebral haemorrhage (ICH) progresses rapidly with complex pathology and limited treatment options, making it a severe subtype of stroke. The extravasation of blood into the brain parenchyma triggers a cascade of inflammatory responses, contributing to secondary injury. Single‐nucleus RNA sequencing (snRNA‐seq) data have enabled more profound insights into the cellular heterogeneity and dynamic interactions within the haemorrhagic brain. Immune cells play a crucial role in shaping neuroinflammation. However, the lack of comprehensive longitudinal studies limits our understanding of the temporal evolution of these inflammatory processes, posing a challenge to the development of targeted therapeutic strategies. Methods We used snRNA‐seq in collagenase‐induced ICH mouse models at Days 1, 3, 7, 14 and 28 post‐injury, alongside naive controls, to profile the dynamics of gene expression over time. Results We obtained 281 577 high‐quality transcriptional profiles representing 21 distinct cell types. Co‐expression network analysis revealed a prominent ‘inflammation module’ that remained active throughout ICH. Integrative single‐cell transcriptomic and immunofluorescence staining suggested that the various Mif‐expressing cells may contribute to local inflammation, potentially engaging macrophages via receptor–ligand pairs such as Cd44 and Cd74. Over time, microglia appeared to serve as key recipients of pro‐inflammatory signals increasingly. During the resolution phase, oligodendrocytes exhibited transcriptional signatures consistent with enhanced maturation and remyelination, which T cell‐mediated interactions may have facilitated. Conclusions These findings offer a systems‐level perspective on cell‐type–specific responses and immune‐mediated interactions during ICH progression and resolution. Key points Establish intracerebral haemorrhage (ICH) mouse models at various time points (Days 1, 3, 7, 14, 28) and construct a high‐quality single‐nucleus RNA sequencing (snRNA‐seq) atlas. Computational analyses suggest that macrophage recruitment in the early stage of ICH potentially involves migration inhibitory factor (MIF) signalling pathways. T cells may interact with myelin‐forming oligodendrocytes during the resolution phase, potentially contributing to remyelination after ICH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/93fbc9517918c734a8d8739f3255c47b54244947" target='_blank'>
              Single‐nucleus transcriptomic profiling reveals temporal dynamics of neuroinflammation and myelin repair after intracerebral haemorrhage
              </a>
            </td>
          <td>
            Zhan Chen, Qinglin Wang, Rong Xiang, Ruoqi Ding, Jin Tao, Qinfeng Peng, Shao-Long Wang, Nannan Cheng, Mengke Zhao, Jiaxin Li, Qidi Xue, Chuanyu Liu, Xuemei Chen, Longqi Liu, Junmin Wang, Jian Wang, Mingyue Wang
          </td>
          <td>2025-09-28</td>
          <td>Clinical and Translational Medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a global health crisis, marked by high transmissibility and virulence. Despite widespread vaccination efforts, effective treatments for COVID-19, particularly for severe cases leading to Acute Respiratory Distress Syndrome (ARDS), remain limited. This study investigates the efficacy of KVX-053, a protein tyrosine phosphatase type IVA (PTP4A3) small molecule inhibitor, in modulating SARS-CoV-2-induced inflammation and lung injury using in vitro cell models and in vivo K18-hACE2 transgenic mice. KVX-053 reduced in vitro pro-inflammatory cytokine expression, including TNFα, CXCL10, and CXCL11, without impacting viral replication or cell viability. K18-hACE2 mice treated with KVX-053 demonstrated marked improvement in clinical scores and reduced histological evidence of lung injury compared to untreated SARS-CoV-2-infected controls. KVX-053 mitigated the activation of key inflammatory mediators in the lung, including NLRP3 inflammasomes, IL-6, and phosphorylated STAT3, effectively curbing the “cytokine storm” associated with severe COVID-19. Importantly, treatment preserved lung parenchymal integrity, reduced edema, and minimized macrophage infiltration. Our findings highlight PTP4A3 as a potential critical regulator of the inflammatory response during SARS-CoV-2 infection. KVX-053, a potent and selective PTP4A3 inhibitor, emerges as a promising host-directed therapeutic strategy for mitigating ARDS and inflammation-driven lung injury in SARS-CoV-2 and potentially other respiratory viral infections. Future studies are required to optimize dosing strategies, elucidate precise molecular mechanisms, and validate these findings in clinical settings.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/20ae8d61209d49d0e74feaa9c96947aababae586" target='_blank'>
              The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice
              </a>
            </td>
          <td>
            Ruben M. L. Colunga-Biancatelli, P. Solopov, Caitlin M Woodson, I. Allen, I. Akhrymuk, Maryna Akhrymuk, Brittany N. Heath, Hannah M. Ivester, T. Day, Dan E. Austin, K. Kehn-Hall, John S. Lazo, E. Sharlow, J. Catravas
          </td>
          <td>2025-10-28</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Guillain-Barré syndrome (GBS) is an autoimmune disorder that causes weakness, sensory loss, autonomic dysfunction, and chronic neuropathic pain. The mediators responsible for driving early autoimmune injury in the most common GBS variant, acute inflammatory demyelinating polyradiculoneuropathy (AIDP), remain incompletely understood. We performed bulk and single-cell RNA sequencing on peripheral blood mononuclear cells collected from early untreated AIDP-variant GBS patients and healthy controls to comprehensively deduce leukocyte transcriptome alterations and predict disease-driving interactions between pathogenic leukocytes and peripheral nervous system cells. Bulk transcriptomics showed interferon- and JAK/STAT-driven proinflammatory signatures in myeloid cells. CD8+ T-cells were highly proliferative and expressed axon guidance genes. Single-cell transcriptomics revealed dysregulation of CD4+FOXP3+ regulatory and CD4+ effector memory T-cells indicative of poorly controlled type 1 and type 17 immune responses. Highly activated intermediate monocytes upregulated genes related to angiogenesis and oncostatin M. Interactome analysis between GBS leukocytes, Schwann cells, and sensory neurons predicted increased engagement of ligand-receptor pairs with nerve integrity and pain functions, including epiregulin, interferon-beta, adrenomedullin, clusterin, IL-6, IL-15, and CCL4. Functional validation demonstrated that CCL4 sensitizes human sensory neurons in vitro. These results unearth molecular interactions by which specific leukocyte populations in AIDP-variant GBS may induce peripheral nerve injury and drive neuropathic pain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f32750fba6dd394e7dec1bcd5d3da578effc6cef" target='_blank'>
              Peripheral nerve-targeting and pain-promoting transcriptomic signatures in early Guillain-Barré syndrome
              </a>
            </td>
          <td>
            Jayden A O'Brien, Joseph B. Lesnak, Ishwarya Sankaranarayanan, A. Arendt-Tranholm, Nikhil N. Inturi, Spoorthi Sadasivuni, Hemanth Mydugolam, Katelyn E. Sadler, Theodore J. Price, E. Ubogu
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Immune mechanisms contribute to the neuropathology of Alzheimer’s disease (AD) but the role of adaptive immune cells is unclear. Here we show that the brain CD8+ T cell compartment is dysregulated in AD patients and in the 3xTg-AD mouse model, accumulating activated CD103– tissue-resident memory T cells that produce large amounts of granzyme K (GrK). These CD103–CD8+ T cells originate from the circulation and migrate into the brain using LFA-1 integrin. Ablation of brain CD103–CD8+ T cells in 3xTg-AD mice ameliorates cognitive decline and reduces neuropathology. GrK induces neuronal dysfunction and tau hyperphosphorylation in human and mouse cells via protease-activated receptor-1 (PAR-1), which is expressed at higher levels in the AD brain, revealing a key immune-mediated neurotoxic axis. We conclude that communication between CD8+ T cells and the nervous system is altered in AD, paving the way for therapies targeting T cell-dependent neurotoxic inflammation. Neuroimmune communication in Alzheimer’s disease (AD) is poorly understood. Here, the authors show that CD103–CD8+ resident memory T cells induce neurotoxicity and neuroinflammation in AD via the granzyme K–PAR-1 axis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c24140f7a28c20dee970a76d1c7b38f4dde8a42" target='_blank'>
              CD103–CD8+ T cells promote neurotoxic inflammation in Alzheimer’s disease via granzyme K–PAR-1 signaling
              </a>
            </td>
          <td>
            Eleonora Terrabuio, E. Pietronigro, A. Bani, Vittorina Della Bianca, C. Laudanna, Barbara Rossi, Giulia Finotti, Bruno Santos-Lima, Elena Zenaro, Ermanna Turano, Gabriele Tosadori, M. Calgaro, Nicola Vitulo, Monica Castellucci, Daniela Cecconi, J. Brandi, Nikolaos Vareltzakis, Fabiana Mainieri, Antonella Calore, G. Angelini, Bruno Bonetti, Gabriela Constantin
          </td>
          <td>2025-09-24</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="A growing body of evidence implicates inflammation as a key hallmark in the pathophysiology of Parkinson’s disease (PD), with microglia playing a central role in mediating neuroinflammatory signaling in the brain. However, the molecular mechanisms linking microglial activation to dopaminergic neuron degeneration remain poorly understood. In this study, we investigated the contribution of the PD-associated LRRK2-G2019S mutation to microglial neurotoxicity using patient-derived induced pluripotent stem cell (iPSC) models. We found that LRRK2-G2019S mutant microglia exhibited elevated activation markers, enhanced phagocytic capacity, and increased secretion of pro-inflammatory cytokines such as TNF-α. These changes were associated with metabolic dysregulation, including upregulated glycolysis and impaired serine biosynthesis. In 3D midbrain organoids, these overactivated microglia resulted in dopaminergic neuron degeneration. Notably, treating LRRK2-G2019S microglia with oxamic acid, a glycolysis inhibitor, attenuated microglial inflammation and reduced neuronal loss. Our findings underscore the link between metabolic targeting in microglia and dopaminergic neuronal loss in LRRK2-G2019S mutation, and highlight a potential strategy that warrants further preclinical evaluation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a8e14aa86bc78d1db27bcda8e7aad65c9a7807db" target='_blank'>
              The Parkinson’s disease-associated LRRK2-G2019S variant restricts serine metabolism, leading to microglial inflammation and dopaminergic neuron degeneration
              </a>
            </td>
          <td>
            Henry Kurniawan, Sarah L Nickels, Alise Zagare, Elisa Zuccoli, Isabel Rosety, Gemma Gomez-Giro, Enrico Glaab, J. Schwamborn
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) is the leading cause of dementia globally. The accumulation of amyloid and tau proteins, neuronal cell death and neuroinflammation are seen with AD progression, resulting in memory and cognitive impairment. Microglia are crucial for AD progression as they engage with neural cells and protein aggregates to regulate amyloid pathology and neuroinflammation. Recent studies indicate that microglia contribute to the propagation of amyloid beta (Aβ) via their immunomodulatory functions including Aβ phagocytosis and inflammatory cytokine production. Three-dimensional cell culture techniques provide the opportunity to study pathophysiological changes in AD in human-derived samples that are difficult to recapitulate in animal models (e.g., transgenic mice). However, these models often lack immune cells such as microglia, which play a critical role in AD pathophysiology. In this study, we developed a neuroimmune assembloid model by integrating cerebral organoids (COs) with induced microglia-like cells (iMGs) derived from human induced pluripotent stem cells from familial AD patient with PSEN2 mutation. After 120 days in culture, we found that iMGs were successfully integrated within the COs. Interestingly, our assembloids displayed histological, functional and transcriptional features of the pro-inflammatory environment seen in AD, including amyloid plaque-like and neurofibrillary tangle-like structures, reduced microglial phagocytic capability, and enhanced neuroinflammatory and apoptotic gene expression. In conclusion, our neuroimmune assembloid model effectively replicates the inflammatory phenotype and amyloid pathology seen in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ba2bac36842c4690c8354cfc8e3da0fb0dfc219" target='_blank'>
              A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer’s disease
              </a>
            </td>
          <td>
            Andrea Becerra-Calixto, Anik Banerjee, Huihui Fan, Chunfeng Tan, E. Lee, Louise D. McCullough, Juneyoung Lee
          </td>
          <td>2025-10-08</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="SARS-CoV-2 variants have demonstrated distinct epidemiological patterns and clinical presentations throughout the COVID-19 pandemic. Understanding variant-specific differences at the respiratory epithelium is crucial for understanding their pathogenesis. Here, we utilized human nasal organoid air–liquid interface (HNO-ALI) cell cultures to compare the viral replication kinetics, innate immune response, and epithelial damage of six different strains of SARS-CoV-2 (B.1.2, WA, Alpha, Beta, Delta, and Omicron). All variants replicated efficiently in HNO-ALIs, but with distinct replication kinetic patterns. The Delta variant exhibited delayed replication kinetics, achieving a steady state at 6 days post-infection compared to 3 days for other variants. Cytokine analysis revealed robust pro-inflammatory and chemoattractant responses (IL-6, IL-8, IP-10, CXCL9, and CXCL11) in WA1, Alpha, Beta, and Omicron infections, while Delta significantly dampened the innate immune response, with no significant induction of IL-6, IP-10, CXCL9, or CXCL11. Immunofluorescence and H&E analysis showed that all variants caused significant ciliary damage, though WA1 and Delta demonstrated less destruction at early time points (3 days post-infection). Together, these data show that, in our HNO-ALI model, the Delta variant employs a distinct “stealth” strategy characterized by delayed replication kinetics and epithelial cell innate immune evasion when compared to other variants of SARS-CoV-2, potentially explaining a mechanism that the Delta variant can use for its enhanced transmissibility and virulence observed clinically. Our findings demonstrate that variant-specific differences at the respiratory epithelium could explain some of the distinct clinical presentations and highlight the utility of the HNO-ALI system for the rapid assessment of emerging variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2a66e6213ba7653ae3a1d826608bc43258345cb7" target='_blank'>
              Strain-Specific Variability in Viral Kinetics, Cytokine Response, and Cellular Damage in Air–Liquid Cultures of Human Nasal Organoids After Infection with SARS-CoV-2
              </a>
            </td>
          <td>
            G. Aloisio, Trevor McBride, Letisha Aideyan, Emily M. Schultz, Ashley M. Murray, Anubama Rajan, Erin G Nicholson, D. Henke, Laura Ferlic-Stark, Amal Kambal, Hannah L. Johnson, Elina A. Mosa, F. Stossi, S. Blutt, Pedro A. Piedra, V. Avadhanula
          </td>
          <td>2025-10-01</td>
          <td>Viruses</td>
          <td>1</td>
          <td>41</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb9bb43ca18bcdc65e766eeeb0e1676e8131ed1b" target='_blank'>
              Transcriptional regulation of disease-relevant microglial activation programs
              </a>
            </td>
          <td>
            Amanda McQuade, Reet Mishra, Venus Hagan, Weiwei Liang, Peter J. Colias, Vincent Cele Castillo, Justin P. Lubin, Verena C. Haage, Victoria Marshe, Masashi Fujita, Layla Gomes, Thomas Ta, Olivia M Teter, Sarah E. Chasins, Philip L. De Jager, James K. Nuñez, Martin Kampmann
          </td>
          <td>2025-10-27</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bf6a125bf5a20acd2dd923b3e2909d9abf0a8c6f" target='_blank'>
              Single-cell RNA profiling of blood CD4+ T cells identifies distinct helper and dysfunctional regulatory clusters in children with SLE
              </a>
            </td>
          <td>
            Preetha Balasubramanian, Uthra Balaji, M. Santos, Jeanine Baisch, Cynthia Smitherman, Lynnette Walters, Paola Sparagana, Lorien Nassi, Katie Stewart, Julie Fuller, Terry K. Means, Virginia Savova, Jacques Banchereau, Tracey Wright, Virginia Pascual, Jinghua Gu, S. Caielli
          </td>
          <td>2025-10-21</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>13</td>
        </tr>

        <tr id="The COVID-19 pandemic, caused by SARS-CoV-2, represents one of the most profound global public health challenges in modern history. While T cell immunity is crucial for viral clearance, the dynamics of the T cell receptor (TCR) repertoire during reinfection remain poorly understood. This study sought to characterize the TCR repertoire in peripheral blood T cells from healthy convalescent individuals (HC), patients with primary SARS-CoV-2 infection (PI), and reinfected individuals (RI), aiming to identify distinct TCR signatures linked to susceptibility or protection against reinfection. We enrolled 48 age- and sex-matched participants (18 PI, 18 RI, 12 HC), collecting blood samples during acute infection (PI/RI) or convalescence (HC). Deep TCRα/β sequencing was performed using the SMARTer Human TCR Profiling Kit with unique molecular identifiers (UMIs), followed by analysis of TCR repertoire diversity, clonal expansion, V(D)J gene usage, and CDR3 characteristics. Compared to HC, both PI and RI groups exhibited significantly reduced TCR diversity (p< 0.001), though no significant differences were observed between PI and RI. COVID-19 patients displayed skewed TCR repertoires dominated by expanded clones (>1%), whereas HC primarily harbored small clones (≤ 0.1%). RI patients demonstrated intermediate clonality, suggesting partial memory recall. Group-specific V(D)J pairings were identified, including TRAV27/TRAJ42 in RI, TRAV24/TRAJ42 in PI, and TRAV35/TRAJ42 in HC, while TRBV6-4/TRBD2/TRBJ2–3 was conserved across all groups. Additionally, HC-enriched and RI-exclusive CDR3 clusters were detected. Our findings indicate that SARS-CoV-2 reinfection is associated with impaired TCR diversity and distinct clonal expansion patterns, underscoring the role of T cell immunity in reinfection susceptibility. HC-enriched TCR clusters may represent protective memory responses, whereas RI-specific signatures suggest compromised immunity. These results offer valuable insights for vaccine design and risk stratification, though further functional validation of the identified TCRs is necessary.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d977242eab98e457279671a381065b9ee003f60" target='_blank'>
              Distinct characteristics of T cell receptor repertoire associated with the SARS-CoV-2 reinfection
              </a>
            </td>
          <td>
            Li Zeng, Li Liu, Baolin Ren, Bing Feng, Xudong Lai, Xunxi Lai, Zhimin Chen, Yihui Huang, Wenxin Hong
          </td>
          <td>2025-10-23</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b1d0d64915e039a05df492a9420be5b6930184b1" target='_blank'>
              Early cell autonomous and niche-mediated alveolar epithelial response to influenza infection in primary lung organoids
              </a>
            </td>
          <td>
            Amber Elitz, Sharlene Fernandes, K. Cook, H. Warheit-Niemi, Barbara Zhao, Andrea Toth, Amanda L. Zacharias, William J. Zacharias
          </td>
          <td>2025-10-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2affd9966e7d74eae7ebff40360fcc4663c6bf18" target='_blank'>
              Clonal expansion of cytotoxic CD8âº T cells in lecanemab-associated ARIA
              </a>
            </td>
          <td>
            Lance A. Johnson, Kai Saito, Akhil Pallerla, Jessica L Funnell, Ashley R. Ezzo, Chelsea L. Song, Douglas A Harrison, Noah J. Norton, Lauren C. Moore, L. Eldik, D. Fardo, Greg E. Cooper, Josh M Morganti
          </td>
          <td>2025-09-21</td>
          <td>None</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), is characterized by its high contagiousness. The COVID-19 pandemic has exerted profound impacts on human society. The persistent circulation of SARS-CoV-2 in human populations continues to pose re-exposure risks for both vaccinated individuals and those with prior natural infection. Against this epidemiological background, there is an urgent need to characterize the transmission dynamics of SARS-CoV-2 in the context of pre-existing immunity. Using a ferret infection model, this study systematically addresses critical scientific questions, including viral transmission efficiency, temporal patterns of transmissibility, and the ability of pre-existing immunity to mitigate reinfection and viral shedding. The findings provide robust experimental evidence for elucidating the transmission mechanisms of SARS-CoV-2 and offer scientific insights to inform the rational design of optimized antiviral strategies. IMPORTANCE In this study, a ferret infection model was used to systematically investigate SARS-CoV-2’s in vivo transmission dynamics and modes with pre-existing immunity. By characterizing viral transmission efficiency, temporal shedding patterns, and immunity’s role in mitigating re-infection severity and dissemination, it provides direct evidence for understanding SARS-CoV-2 spread in immune-exposed hosts. It quantifies how humoral immunity modulates viral load (primary/secondary infections) and ferret contact transmission. Findings establish a key SARS-CoV-2 transmission framework—pre-existing immunity shortens shedding, reduces secondary attack rates but retains residual transmissibility—fill knowledge gaps, guide vaccine/herd immunity/public health measures, and lay a foundation for predicting real-world transmission and antiviral policies via integrated endpoints. In this study, a ferret infection model was used to systematically investigate SARS-CoV-2’s in vivo transmission dynamics and modes with pre-existing immunity. By characterizing viral transmission efficiency, temporal shedding patterns, and immunity’s role in mitigating re-infection severity and dissemination, it provides direct evidence for understanding SARS-CoV-2 spread in immune-exposed hosts. It quantifies how humoral immunity modulates viral load (primary/secondary infections) and ferret contact transmission. Findings establish a key SARS-CoV-2 transmission framework—pre-existing immunity shortens shedding, reduces secondary attack rates but retains residual transmissibility—fill knowledge gaps, guide vaccine/herd immunity/public health measures, and lay a foundation for predicting real-world transmission and antiviral policies via integrated endpoints.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/28bd990eb8431c26b9877e0d5998540288695456" target='_blank'>
              Transmission of SARS-CoV-2 between ferrets in presence of pre-existing immunity
              </a>
            </td>
          <td>
            Chong Wang, Lei Shuai, Gongxun Zhong, Zhiyuan Wen, Renqiang Liu, Qilong Liu, Jinliang Wang, Jinying Ge, Xianfeng Zhang, Y. Guan, Xijun He, Z. Bu
          </td>
          <td>2025-11-04</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1adb144859e1add4bf4fcfba4fbb11e22fcf1d31" target='_blank'>
              SAMHD1 promotes SARS-CoV-2 infection by enhancing HNF1-dependent ACE2 expression in lung epithelial cells
              </a>
            </td>
          <td>
            Pak-Hin Hinson Cheung, Pearl Chan, Hua Yang, Shravya Honne, Baek Kim, Stanley Perlman, Li Wu
          </td>
          <td>2025-10-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="SARS-CoV-2 infection is associated with long-lasting neuropsychiatric and cognitive symptoms, collectively referred to as neuro-PASC. Emerging studies indicates that accelerate brain aging and cellular senescence in COVID brain could lead to altered neuroimmune responses and neurodegenerative outcomes. However, little is known about how cellular senescence is development in neuro-PASC. Here, we examined the role of spike protein subunit S1, a persistent viral antigen, in driving the development of cellular senescence in primary human astrocytes. We have demonstrated that S1 enters endolysosomes and induces endolysosome dysfunction and cellular senescence. Moreover, the multibasic motif is critical for such S1-induced damaging effects. Importantly, we identified Toll-like receptor 7 (TLR7), an endolysosome-resident pattern recognition receptor, as a critical mediator of S1-induced damaging effects. Mechanistically, S1 interacts with TLR7 at the site of the endolysosome lumen and activates p38 MAPK signaling of downstream of TLR7, which drive the development of cellular senescence. Together, these findings suggest that TLR7 mediates S1-induced endolysosome dysfunction and cellular senescence, and that TLR7 represents a therapeutic target for mitigating neuro-PASC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8ee07e08edc89cce8e4214928941b26b2316b896" target='_blank'>
              SARS-CoV-2 spike triggers TLR7-dependent endolysosome dysfunction and senescence in human astrocytes
              </a>
            </td>
          <td>
            Wendie A. Hasler, Emily McKay, Gaurav Datta, Samantha Johnson, Neda Rezagholizadeh, Xuesong Chen
          </td>
          <td>2025-10-31</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Human NK cells exhibit functional heterogeneity, yet the clinical conditions and cellular processes driving this diversity remain insufficiently understood. Here, we report that NK cell diversity emerges during peripheral development, influenced by the divergence of adaptive NK cells from various stages of canonical NK cell maturation during the resolution phase of severe COVID-19. Using scRNA-seq, we analyzed blood NK cells from patients with severe COVID-19 (acute phase and post-intensive care), individuals vaccinated with the SARS-CoV-2 mRNA vaccine (BNT162b2), and healthy donors. The frequencies of immature CD56bright and proliferating NK cells increased following BNT162b2 vaccination. In contrast, the frequency of adaptive CD56dim cells was markedly elevated in patients recovering from severe COVID-19, alongside clonal expansion and enhanced mitochondrial oxidative phosphorylation. Trajectory analysis revealed a bifurcation in peripheral NK cell development, with CD56bright cells diverging into canonical and adaptive CD56dim subsets during the course of severe COVID-19. Notably, adaptive NK differentiation exhibited transcriptional and signaling profiles analogous to those of T-cell activation. Thus, NK cell diversity is shaped by the induction of an intrinsic adaptive program. These findings uncover the mechanisms underlying NK cell heterogeneity and have implications for medical applications, including the development of immunotherapies that leverage adaptive NK cell functions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a0a71ca475b9bbf9d2f431483da1cc2babd0b42" target='_blank'>
              Mapping NK cell diversity in response to COVID-19 and mRNA vaccination
              </a>
            </td>
          <td>
            Yosuke Kishi, Yu-chen Liu, Masakazu Ishikawa, Maika Yamashita, Hisatake Matsumoto, Hiroshi Ogura, Shuhei Sakakibara, Daisuke Okuzaki
          </td>
          <td>2025-10-28</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Interferon alpha-inducible protein 27 like 2A (Ifi27l2a) was initially identified as an interferon-stimulated gene (Isg) involved in host-dependent mechanisms during viral invasion. We have recently shown that the Ifi27l2a protein also plays a critical role in microglia and the spreading of neuroinflammation. However, the detailed mechanisms of action of intracellular and extracellular Ifi27l2a in glial cells, particularly in inflammatory and neurodegenerative diseases, are not yet defined. We now report that systemic inflammation leads to an elevated level of circulating Ifi27l2a in the plasma of lipopolysaccharide (LPS)-treated mice, which is associated with elevated Il1b mRNA expression in the brain. Elevated IFI27L2 (human isoform) was also found in plasma of human stroke patients. To test whether extracellular (e.g. secreted) Ifi27l2a can contribute as an autocrine or paracrine inducer of microglial activation and inflammation, we treated microglial cells with recombinant Ifi27l2a (rIfi27l2a). Treatment with rIfi27l2a led to increased expression of proinflammatory cytokines and elevated reactive oxygen species (ROS) levels in microglial cells. These effects resulted from alterations in mitochondrial function and a metabolic shift from oxidative phosphorylation toward glycolysis for ATP synthesis. Additionally, Ifi27l2a led to increased caspase-1 activity, demonstrating that Ifi27l2a causes Nlrp3 inflammasome activation. RNA sequencing revealed that Ifi27l2a mediates transcriptional changes reflecting activated microglia. These data support an extracellular role of Ifi27l2a as a novel cytokine, in which it promotes a phenotypic shift in microglia toward a proinflammatory phenotype. Targeting Ifi27l2a may therefore provide an additional strategy to reduce microglia-mediated inflammation in the brain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd2010c6e0038f96da5055e23679983e49ae84e2" target='_blank'>
              Ifi27l2a acts as a cytokine that promotes a pro-inflammatory phenotype in microglia and enhances neuroinflammation
              </a>
            </td>
          <td>
            Sodam Kim, Haven Burrous, Elisabeth Harmon, Lauren Vance, Ting Wu, Alexander Andersohn, Andrea Doan, Darby Wolocko, Zachary Wise, Yuki Kitamura, Joo Eun Jung, G. Colpo, Lucy Couture, Frank Blixt, Louise McCullough, Sean P. Marrelli, G. Kim
          </td>
          <td>2025-09-24</td>
          <td>Research Square</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background COVID-19, including its post-acute sequelae (Long COVID), is increasingly recognized as involving persistent immune dysregulation and chronic inflammation. Severe and prolonged disease states are often accompanied by sustained cytokine release, immune cell exhaustion, and ongoing cell-cell communication that shapes the inflammatory milieu. Among immune subsets, CD8+ T cells play a central role in antiviral defense, yet the molecular mechanisms linking their dysfunction to prolonged inflammation remain incompletely understood. Methods We analyzed 73,110 peripheral blood mononuclear cells (PBMCs) from individuals across four disease states (Healthy, Exposed, Infected, and Hospitalized) using single-cell RNA sequencing. Immune cell subsets were annotated, and T cell heterogeneity was profiled. Cytokine and inflammatory scores were calculated to assess immune activation. Differentially expressed genes (DEGs) underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Cell-cell communication was evaluated to map ligand-receptor networks. Additionally, nine machine learning models were trained on a bulk RNA-seq cohort, and the SHapley Additive exPlanations (SHAP) framework was applied to interpret key predictive genes. Results Progressive disease severity was associated with a decline in T cell proportions, enrichment of pro-inflammatory myeloid cells, and elevated cytokine expression, particularly IL-32. Memory CD8+ T cells showed increased exhaustion and inflammatory scores while maintaining a central position in MHC-I-mediated communication networks. Persistent activation of immune and metabolic pathways, including antigen presentation and oxidative phosphorylation, was observed in prolonged disease states. Seven genes (RPS26, RPS29, RPL36, RPL39, RPS28, RPS21, and CD3E) were identified as strong predictors of chronic immune dysregulation, with the XGBoost model achieving the highest AUC. SHAP analysis confirmed their contributions to disease classification. Conclusion This study maps the immune landscape of COVID-19 and Long COVID at single-cell resolution, revealing that persistent immune cell communication, particularly involving memory CD8+ T cells, may sustain chronic inflammation beyond the acute phase. The identified molecular signatures offer potential biomarkers and therapeutic targets for mitigating post-viral inflammatory syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/536000d345ef1e6f7663efc28145b0e979e70e7b" target='_blank'>
              Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID
              </a>
            </td>
          <td>
            Hengrui Liu, Zewen Xu, Ilayda Karsidag, Panpan Wang, Jieling Weng
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="The blood–brain barrier (BBB) is critical for central nervous system homeostasis, yet it is highly vulnerable to viral insults. While acute coronavirus infections are known to impair BBB integrity, the long-term impact of persistent infection on brain endothelial cells remains poorly understood. Using an in vitro BBB model, we examined the effects of a 12-week infection with the neurotropic murine coronavirus MHV-JHM. Structural and functional changes were assessed via fluorescein isothiocyanate (FITC)-dextran permeability assay, confocal imaging of mitochondria, actin cytoskeleton, reactive oxygen species (ROS), scanning electron microscopy (SEM) and RT-qPCR for viral RNA level. Long-term infection induced progressive mitochondrial fragmentation and sustained ROS overproduction. Permeability to 70 kDa dextran increased significantly at 48 h post-infection and exceeded control levels threefold by 168 h. SEM revealed gradual endothelial surface roughening, blebbing, and eventual monolayer collapse with extensive intercellular gaps by week 12. Our study demonstrates that long-term MHV-JHM infection profoundly alters brain endothelial cell structure and function, triggering a cascade of changes that culminate in the disintegration of the BBB model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ab1a64108138024202350f1901cc8262b24aa07" target='_blank'>
              The Effect of Long-Term Betacoronavirus Infection on the Permeability of the Blood–Brain Barrier—In Vitro Model Studies
              </a>
            </td>
          <td>
            W. D. Krahel, Marcin Chodkowski, M. Bartak, Agnieszka Ostrowska, Michał M Godlewski, Maksymilian Adamczyk, Małgorzata Krzyżowska, Joanna Cymerys
          </td>
          <td>2025-09-24</td>
          <td>Cells</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Early fetal demise (EFD), defined as the absence of cardiac activity in a visible fetus, represents a severe form of pregnancy loss with incompletely understood mechanisms. While genetic factors constitute the primary etiology, emerging evidence implicates maternal immune dysregulation in EFD pathogenesis, though the specific cellular and molecular pathways remain undefined. We performed single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells (PBMCs) from a 20-subject cohort comprising EFD patients, healthy pregnant women, and non-pregnant controls. Parallel murine studies involved GFP-labeled monocyte transfer into E8.5 pregnant mice, with subsequent embryonic viability assessment. Human villous tissues from EFD and control pregnancies were analyzed alongside functional characterization using primary neonatal rat cardiomyocytes exposed to IFN-α1. ScRNA-seq revealed significant CD14+ monocyte accumulation in EFD patients versus controls. In murine models, adoptively transferred maternal monocytes breached the placental barrier, inducing 25.7% embryonic lethality. EFD villous tissues exhibited CD14+ monocyte infiltration with selective IFN-α1 elevation (absent in IFN-α2). Cardiomyocyte functional assays demonstrated IFN-α1-mediated contractile impairment through significant reduction in beating frequency. These findings establish maternal CD14+ monocytes as key mediators of EFD via IFN-α1-dependent cardiac dysfunction, revealing a targetable immune axis for pregnancy preservation. The study provides the first direct evidence linking monocyte trafficking with embryonic viability, offering new therapeutic paradigms for miscarriage prevention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/185ea4b0c6ba004d626d528a1bbb76348a0abedd" target='_blank'>
              Maternal monocyte-derived IFN-α1 triggers early fetal demise
              </a>
            </td>
          <td>
            Dandan Wang, Wu Li, Kai Jiang, Yue Xu, Ruhua Deng, Xingbo Yang, Huici Jiang, Jiayi Liang, Ke Wei, Jinlong Qin, Yaozu Xiang
          </td>
          <td>2025-10-14</td>
          <td>Journal of Translational Medicine</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Oligodendrocyte progenitor cells (OPCs) have the capacity to self-renew, differentiate into mature myelinating cells, and remyelinate the central nervous system in response to demyelination. Normal aging is associated with a reduction in the functional capacity of OPCs and induces distinct transcriptional signatures even in the absence of an autoimmune inflammatory demyelination insult. To determine how aging impacts the OPC response to an acute inflammatory insult comparable to a demyelinating event in multiple sclerosis (MS), we performed adoptive transfer of young myelin-reactive Th17 T cells into young and aged mice. Spinal cord OPC responses were quantified using lineage tracing and myelin sheath thickness was quantified using transmission electron microscopy. In the subacute phase 9–10 days after adoptive transfer, the density of both young and aged OPCs is enriched in spinal cord lesions compared to non-lesion white matter. After adoptive transfer, the density of aged OPCs is significantly higher than naïve/non-adoptive transfer aged spinal cord. Differentiated oligodendrocytes (OLs) are relatively preserved within lesions of aged and young animals despite an overall reduction in OL density after adoptive transfer. While lineage tracing identified newly formed oligodendrocytes after adoptive transfer in both young and aged lesions, less oligodendrocyte differentiation was observed in aged animals. Despite the reduction of OPC differentiation in aged animals, there was no significant difference in the extent of remyelination observed for young and aged lesions. Aged OPCs rise to the challenge in response to a strong auto-immune attack, suggesting that compensatory strategies allow both young and aged OPCs to survive and remyelinate in the inflammatory environment. Identifying pathways that promote resilience of young and aged OPCs in the face of an inflammatory challenge will facilitate the development of remyelinating therapies for the treatment of people with MS across the full spectrum of human aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bf4b00ae565dbe87b7018d6254bfde844cedab80" target='_blank'>
              Oligodendrocyte progenitor cell responses to inflammatory demyelination with aging
              </a>
            </td>
          <td>
            Emily E. Fresenko, Camilla N. Bahri, Noor F. Ahmed, Davin Packer, Benjamin J. Tabor, Wenjing Sun, Michelle A. Wedemeyer, Cole A. Harrington
          </td>
          <td>2025-09-23</td>
          <td>Research Square</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The central nervous system (CNS) represents a uniquely immune-privileged environment, with inflammatory responses involving several resident CNS-specific cell types. While stereotyped cellular and transcriptional responses recur across varied diseases, relevant signaling pathways and regulatory networks are not fully understood. Here, we investigate multi-modal inflammatory gene networks at large scale by developing a high-throughput RNA-seq screening and analysis workflow. As proof-of-concept, we investigate genetically heterogeneous mice from a large-scale chemical mutagenesis screen to identify novel functionally relevant variants in six genes previously linked to human CNS disorders: Nrros, Ctsd, Smpd1, Idua, Nlrp1a, and Inpp5d. We leverage the readily interpretable data from our large-scale study to demarcate distinct inflammatory states arising from each mutation. In all, our work provides a validated analysis framework for identifying discrete gene expression modules that are engaged divergently across disease contexts, which can be used to discover novel regulators of CNS neuroimmune homeostasis. Brain bulk-tissue RNA-seq database from a large-scale ENU-mutagenized mouse cohort. Variants in Nrros, Ctsd, Smpd1, Idua, Nlrp1a, and Inpp5d alter microglia homeostasis. An Nlrp1a gain-of-function mutation causes widespread astrocyte and microglia activation. Cross-comparison of six disease and inflammatory states facilitates interpretation of bulk tissue transcriptomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a51f54829abe0e8b61931cb5f83b202b5c060ee" target='_blank'>
              Modular inflammation network discovery from large-scale phenotypic screening in genetically heterogeneous mouse brains
              </a>
            </td>
          <td>
            Monica Xiong, L. Miosge, Carolina Correa-Ospina, Claudia M. Y. Yan, Tiffany Cripps, Stefan Bauernfried, Yuanyuan Wang, Maggie Crow, Lucy X Morris, T. D. Andrews, Andrew Trujillo, Mitchell G. Rezzonico, Yuxin Liang, Qixin Bei, Z. Modrusan, Kimberly L Stark, Tracy J Yuen, Brad A Friedman, Jesse E Hanson, Edward M Bertram, Christopher J Bohlen
          </td>
          <td>2025-09-29</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>95</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23d1526f5a77ff12eace732146acf8b49367f516" target='_blank'>
              Pigs lacking Natural Killer T cells have altered cellular responses to influenza
              </a>
            </td>
          <td>
            T. Kwon, Weihong Gu, Igor Morozov, Mariano Carossino, Eu-Lim Lyoo, Chester D. McDowell, Yonghai Li, U. Balasuriya, Yi Huang, Kiho Lee, Juergen A Richt, John P Driver
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Long COVID (LC), also known as post-acute sequelae of COVID-19 infection (PASC), is a heterogeneous and debilitating chronic disease that currently affects 10 to 20 million people in the U.S. and over 420 million people globally. With no approved treatments, the long-term global health and economic impact of chronic LC remains high and growing. LC affects children, adolescents, and healthy adults and is characterized by over 200 diverse symptoms that persist for months to years after the acute COVID-19 infection is resolved. These symptoms target twelve major organ systems, causing dyspnea, vascular damage, cognitive impairments (“brain fog”), physical and mental fatigue, anxiety, and depression. This heterogeneity of LC symptoms, along with the lack of specific biomarkers and diagnostic tests, presents a significant challenge to the development of LC treatments. While several biological abnormalities have emerged as potential drivers of LC, a causative factor in a large subset of patients with LC, involves reservoirs of virus and/or viral RNA (vRNA) that persist months to years in multiple organs driving chronic inflammation, respiratory, muscular, cognitive, and cardiovascular damages, and provide continuous viral antigenic stimuli that overstimulate and exhaust CD4+ and CD8+ T cells. In this review, we (i) shed light on persisting virus and vRNA reservoirs detected, either directly (from biopsy, blood, stool, and autopsy samples) or indirectly through virus-specific B and T cell responses, in patients with LC and their association with the chronic symptomatology of LC; (ii) explore potential mechanisms of inflammation, immune evasion, and immune overstimulation in LC; (iii) review animal models of virus reservoirs in LC; (iv) discuss potential T cell immunotherapeutic strategies to reduce or eliminate persistent virus reservoirs, which would mitigate chronic inflammation and alleviate symptom severity in patients with LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3796710d45738cf5a8e99e8ba1c550198cbdf88b" target='_blank'>
              Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID
              </a>
            </td>
          <td>
            Swayam Prakash, Sweta Karan, Yassir Lekbach, D. Tifrea, Cesar J. Figueroa, Jeffrey B. Ulmer, James F. Young, Greg Glenn, Daniel Gil, Trevor M. Jones, Robert R. Redfield, L. BenMohamed
          </td>
          <td>2025-09-27</td>
          <td>Viruses</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="ABSTRACT A limited number of studies on human subjects with type-A hepatitis have found a positive correlation between activated natural killer (NK) cell frequencies in blood and the severity of liver injury. However, without knowledge of differences in viral burdens, it remains unclear whether NK cells are elevated due to hepatitis A virus (HAV) replication and ongoing associated injury, or if NK cell responses directly cause pathogenesis. To gain insight into how NK cells respond during the early stages of hepatitis A virus infection, we generated mice that are permissive for HAV infection in the liver but are otherwise immunocompetent. HAV readily infected the liver of these hepatocyte-specific type-I interferon receptor knockout mice (Ifnar1ΔHep), resulting in fecal virus shedding, elevated serum alanine aminotransferase levels, and immune cell infiltrates in the liver. Single-cell RNA sequencing analyses of liver leukocytes from infected Ifnar1ΔHep mice revealed a rapid accumulation of activated NK cells in the liver within 2 days. HAV infection and liver inflammation were brief and substantially reduced in magnitude in these mice compared to global Ifnar1-/- knockout mice that failed to induce substantial antiviral NK cell responses. NK cells were the principal source of interferon (IFN)-γ in Ifnar1ΔHep mice. Ifnar1ΔHep mice that were experimentally depleted of NK cells or IFN-γ showed greatly increased viral replication and liver damage. Moreover, IFN-γ alone was sufficient to suppress HAV replication in primary mouse hepatocytes. Collectively, these findings establish a critical role for type-I IFN induction of NK cells, their expression of IFN-γ, and protection against hepatitis A. IMPORTANCE Hepatitis A virus remains a leading cause of foodborne illness among unvaccinated individuals. Infection can result in severe liver injury that can progress to fatal fulminant viral hepatitis. Despite its clinical significance, the molecular, genetic, and cellular factors influencing infection severity remain poorly understood. Previous studies of patient blood have suggested that natural killer (NK) cells cause liver injury during infection. In this study, we used mouse models of infection to characterize early cellular defenses to infection and identified a critical role for NK cells and interferon-γ in conferring rapid immune protection rather than pathogenesis. Hepatitis A virus remains a leading cause of foodborne illness among unvaccinated individuals. Infection can result in severe liver injury that can progress to fatal fulminant viral hepatitis. Despite its clinical significance, the molecular, genetic, and cellular factors influencing infection severity remain poorly understood. Previous studies of patient blood have suggested that natural killer (NK) cells cause liver injury during infection. In this study, we used mouse models of infection to characterize early cellular defenses to infection and identified a critical role for NK cells and interferon-γ in conferring rapid immune protection rather than pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1d931c631c3918d6d10533d13ffd0bbf83e1d0c" target='_blank'>
              Natural killer cells and IFN-γ protect against liver injury during HAV infection in mice
              </a>
            </td>
          <td>
            I. Misumi, You Li, Takayoshi Shirasaki, Lixin Yang, Maryna Kapustina, Stanley M. Lemon, J. Whitmire
          </td>
          <td>2025-09-19</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid plaques, tau tangles, and synaptic dysfunction. Despite decades of research, effective disease-modifying therapies remain elusive, highlighting the need for alternative therapeutic targets. While neurons have traditionally been the focus of AD studies, increasing evidence underscores critical roles for glial cells particularly microglia and astrocytes in disease progression. Mitochondrial calcium (mCa2+) dysregulation has emerged as a key contributor to neurodegeneration, yet how mCa2⁺ signaling varies across brain cell types and contributes to AD pathology remains poorly understood. We developed stable human SH-SY5Y (neuroblastoma-derived cells), HMC3 (microglial-like cells), and SVGp12 (astrocytic-like cells) immortalized cell lines expressing APP mutations (Swedish, Florida, and London; APPswe/F/L). We assessed mitochondrial calcium uniporter (mtCU) expression, mCa2+ flux using ratiometric calcium (Ca2+) indicators, and evaluated calcium retention capacity (mito-CRC) as a readout of mitochondrial permeability transition pore opening. Bioenergetic parameters including ATP, NADH, membrane potential, and oxygen consumption rate (OCR) were measured alongside structural mitochondrial changes, ROS levels, and cell death using imaging and biochemical assays. APPswe/F/L expression induced mitochondrial dysfunction across all brain immortalized cell types, with neuroblastoma-derived cells exhibiting the highest susceptibility to mCa2+ overload, energy failure, and cell death. Compared to neuroblastoma-derived cells, glial-like cells (astrocytic-like and microglial-like cells) showed higher expression of mtCU components, elevated mCa2+ uptake at high Ca²⁺ concentrations, and greater mito-CRC. Conversely, neuroblastoma-derived cells displayed faster mCa2+ uptake at low Ca2+ levels, indicating distinct regulatory thresholds. Glial-like cells exhibited more elaborate mitochondrial networks and enhanced metabolic capacity, yet all cell types showed impaired mitochondrial structure, reduced membrane potential and respiration, and increased ROS under mutant APP expression. This study reveals cell-type-specific differences in mCa2+ signaling and mitochondrial function in AD, uncovering unique vulnerabilities in neuroblastoma-derived and glial-like cells. These findings highlight the need for cell-targeted strategies to restore mCa2+ homeostasis and mitochondrial function in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2dce50c803ecee4352b0fe0c3ce47a5251a8177a" target='_blank'>
              Cell-type-specific dysregulation of mitochondrial calcium signaling in Alzheimer’s disease
              </a>
            </td>
          <td>
            Shatakshi Shukla, Ashlesha Kadam, Shanikumar Goyani, Natasha Jaiswal, Kunal Samantaray, Shiridhar Kashyap, D. Tomar, P. Jadiya
          </td>
          <td>2025-11-03</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="ABSTRACT Systemic spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to extrapulmonary tissues has been observed following acute infections. Autopsy studies further indicate tissue-specific virus diversity, including in immune-privileged sites. Questions remain on the viral dynamics leading to the tissue tropism of SARS-CoV-2, including evolutionary trajectories and functional adaptations that could impact persistence and transmission. In this study, we characterized SARS-CoV-2 genomes from 27 distinct tissues collected from an autopsy case where the patient had a primary immune deficiency. We identified tissue-specific virus genotypes, in some instances coexisting within the same sites, with mutations primarily in the receptor-binding domain of the spike protein. Protein simulations and isolation of infectious virus indicate combinations of spike substitutions that would lead to increased protein stability and stronger binding of the virus to host cells. This highlights the importance of studying patients with weakened immune responses where potential tissue reservoirs provide an environment permissive for SARS-CoV-2 evolution and diversification. IMPORTANCE Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunocompromised individuals are considered a potential source of new viral variants. Beyond the respiratory tract, the virus can spread within days to organs like the brain, heart, and kidneys, where distinct tissue microenvironments may further drive viral evolution and the emergence of new mutations. In this study, we compared the genetic diversity of SARS-CoV-2 genomic RNA isolated from 27 distinct tissue sites collected from an individual with a weakened immune system. By linking viral population dynamics across these tissue sites, we defined the extent of compartmentalization during multi-organ spread, highlighting how non-respiratory tissues can impact SARS-CoV-2 diversification. Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunocompromised individuals are considered a potential source of new viral variants. Beyond the respiratory tract, the virus can spread within days to organs like the brain, heart, and kidneys, where distinct tissue microenvironments may further drive viral evolution and the emergence of new mutations. In this study, we compared the genetic diversity of SARS-CoV-2 genomic RNA isolated from 27 distinct tissue sites collected from an individual with a weakened immune system. By linking viral population dynamics across these tissue sites, we defined the extent of compartmentalization during multi-organ spread, highlighting how non-respiratory tissues can impact SARS-CoV-2 diversification.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c62bea121f229e468290e53c083e5676919d763" target='_blank'>
              Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19
              </a>
            </td>
          <td>
            Katherine E E Johnson, Sydney R. Stein, Rita Afriyie Boateng, Shilpi Jain, Sabrina C. Ramelli, Trevor M Stantliff, Shelly Curran, M. Ramos-Benitez, Andrew P. Platt, S. Banakis, Wei Wang, Stephen M. Hewitt, C. Zerbe, Steven M. Holland, Elizabeth M. Kang, Manmeet Singh, E. de Wit, William A. Lauer, E. Rouchka, Melissa Smith, Mehul Suthar, Daniel Chertow, E. Ghedin
          </td>
          <td>2025-10-31</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>62</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0707cbba42fd6744337c2f942467653295cac42" target='_blank'>
              Pharmacologic NLRP3 Inhibition Modulates Parkinson’s Disease-Associated Microglial Transcriptomic Signatures and Mitigates α-Synuclein–Triggered Neurodegeneration
              </a>
            </td>
          <td>
            Maria Luque, Magdalena Matic, A. Heras-Garvin, Jesús Amo-Aparicio, Kelvin C. Luk, M. Haindl, M. Khalil, D. Skouras, Charles A Dinarello, N. Stefanova
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Abstract Expression of inhibitory Siglec receptors has been described on T cells of patients with viral infection and cancer. However, the exact function and their role in T-cell activation and control of infections have not been well investigated. Here, we show that Siglec-9 levels increase on T cells in patients with acute severe acute respiratory syndrome coronavirus 2 infection relative to levels on healthy controls. T cells of these patients are inhibited by Siglec-9, and specific blocking with antibodies released this inhibition. To further test the role of Siglec-9 in acute viral infections, we characterized a murine model with T-cell intrinsic Siglec-9 overexpression. We found that Siglec-9 restricted T-cell immunity after acute infection with lymphocytic choriomeningitis virus, thereby dampening T-cell-mediated immune pathology. These results show that inhibitory Siglec receptors including Siglec-9 T cell intrinsically modulate and fine-tune antiviral T-cell activation, proliferation, and effector function.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ed06e49b5229600881efcceffb165b8a257a0279" target='_blank'>
              Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infections
              </a>
            </td>
          <td>
            N. Rodrigues Mantuano, A. Bärenwaldt, Mirza Sarcevic, Isabelle V M Siqueira, A. Jauch, Manina Maja Etter, Matthias S Matter, Gregor Hutter, Mike Recher, H. Läubli
          </td>
          <td>2025-10-27</td>
          <td>PNAS Nexus</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/65799dca4a24e6fbcd774c66d4741d26a7a006c5" target='_blank'>
              Targeting a macrophage stemness factor to mitigate diseases post respiratory viral infection
              </a>
            </td>
          <td>
            Mohd Arish, A. Chaudhuri, Janli Tang, H. Narasimhan, An Fang, Jinyi Tang, Xiaoqin Wei, Chaofan Li, I. Cheon, Wei Qian, Farha Naz, Gislane Almeida-Santos, Samuel Young, T. Parimon, Y. Shim, Robert Vassallo, Peter Chen, Jie Sun
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Background Acute rejection is a significant cause of impaired graft survival in the early post-transplantation period, and the early-stage immune cell dynamics with local intercellular communication during this process require further elucidation. Methods We performed single-cell RNA sequencing (scRNA-seq) on CD45+ immune cells isolated from rat renal allografts during the early phase of acute rejection (days 0, 1, 3, and 7). Using unsupervised clustering, functional enrichment analysis, cellular trajectory inference, and intercellular communication network mapping, we delineated the immune cell dynamics and local communication networks at single-cell resolution. Our findings were subsequently validated through multiplex immunofluorescence and therapeutic intervention experiments. Results Macrophages constituted the dominant immune population during acute rejection. Sub-clustering analysis revealed a rapid expansion of the Isg15+Mac subset by post-transplant day 1, which persisted at elevated levels thereafter. Functional enrichment and trajectory inference demonstrated the pro-inflammatory properties of Isg15+Mac, implicating this subset in acute rejection. Cell-cell communication analysis identified Ccl3-Ccr5 ligand-receptor interactions between Isg15+Mac and T cells. Multiplex immunofluorescence confirmed abundance of Isg15+Mac within the allografts. Moreover, the acute rejection after kidney transplantation was alleviated by the FDA-approved Ccr5 blocker Maraviroc. Conclusions Our study establishes an in-depth, early-stage immune landscape of renal transplantation, revealed that the Isg15+Mac subset activates T cells via the Ccl3–Ccr5 axis and thereby serves as a critical driver of acute rejection. And indicating that Maraviroc may potentially be a therapeutic candidate for transplant rejection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e9d767fb56923b15a4ac52a99263c253eebc577" target='_blank'>
              Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target
              </a>
            </td>
          <td>
            Fanchao Wei, Zhaoxiang Wang, Ruochen Qi, Jingliang Zhang, Shichao Han, Changhong Shi, Tong Lu, Zhite Zhao, Zhengxuan Li, Lang Li, Weijun Qin, Shuaijun Ma, Lijun Yang
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Microglia have emerged as key regulators in Alzheimer’s disease (AD), yet the molecular factors driving their dysfunction remain unclear. Through integrative transcriptomic and proteomic analyses, we identified PLXDC2, a transmembrane receptor, as a protein consistently upregulated in the AD brain and cerebrospinal fluid. Single-nucleus RNA-seq confirmed its microglia-specific enrichment, particularly in lipid-processing, phagocytic, and inflammatory subclusters. Functional assays revealed that PLXDC2 overexpression in BV2 microglial cells impaired Aβ uptake and suppressed pro-inflammatory cytokines Il-6 and Il-1β, without altering lipid droplet formation. These findings indicate that PLXDC2 plays a regulatory role in critical microglial functions and may drive AD pathogenesis by disrupting phagocytic activity and immune responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd2e059e5a9336779ce01698e78cf73cb3fa681f" target='_blank'>
              Microglial PLXDC2 Modulates Aβ Phagocytosis and Inflammatory Responses
              </a>
            </td>
          <td>
            Yoonah R. Oh, Se Eun Park, Hee Kyung Kim, Hyungseok Seo, Min-Kyoo Shin
          </td>
          <td>2025-10-23</td>
          <td>Biomolecules & Therapeutics</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/929f5e64525cee92d0f3fab0ebf61c85bfdd0623" target='_blank'>
              The spatial landscape of infectious mononucleosis tonsils
              </a>
            </td>
          <td>
            Ciara I Leahy, Matthew Pugh, Aoife Hennessy, Nadezhda Nikulina, Stefan Dojcinov, Gerald Niedobitek, Graham S. Taylor, Paul G Murray, É. Fennell
          </td>
          <td>2025-10-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="ABSTRACT T and B lymphocytes protect against the foot and mouth disease virus (FMDV). They are essential for long-term immunity and viral clearance, but their immunological features in FMDV infection remain unknown. Here, we performed single-cell RNA sequencing (scRNA-seq) and conducted integrative analyses to determine cell composition, gene expression, cell-cell communication state, and regulatory network of T and B cells in the spleen of FMDV- and mock-infected mice. Our results revealed variational compositions of immune cells on the subsets level. Additionally, we determined the reshaping of several essential pathways in T and B cells, such as the inhibition of antigen-presentation capacity. Finally, the virus-induced shaping of immune patterns, including cell-cell communication and regulatory networks, was also characterized during FMDV infection. Overall, our research provides valuable insights and resources for understanding the adaptive immune response in FMD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/698358d8d22a4a91509237d6ab2642bf2067fff2" target='_blank'>
              Single-cell RNA sequencing reveals T and B cell-related immune features in foot and mouth disease virus-infected mice
              </a>
            </td>
          <td>
            Yang Wang, Lihong Zhang, Zhao Zhang, Zhihua Chen, Jingru Xu, Han Zhang, Haixue Zheng, Jingjing Pei
          </td>
          <td>2025-10-27</td>
          <td>Virulence</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Disease-associated glia represent plastic transcriptional cellular states observed across neurodegenerative diseases (NDDs). In particular, microglial states have been characterized in Alzheimer’s disease and mouse models of amyloidosis. Although single-cell transcriptomic technologies have increased the dimensionality of information available across cell states, few studies have systematically tested for changes in glial transcription across brain regions and disease states. Here, we report a statistical framework for glial annotation, disease association, and transcriptional profiling, which facilitate identification of generalizable glial states that are present across a spectrum of NDDs (Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis, and Frontotemporal dementia). We identify seven astrocyte substates, 14 microglia/myeloid substates, and five oligodendrocyte substates where transcriptional variability is attributable to region, disease, or batch effects. Regional heterogeneity of astrocytes masked disease associations, even within cortical astrocytes. We found only limited oligodendrocyte transcriptional heterogeneity, resulting in few substates for further interrogation. Notably, microglia showed the strongest evidence for disease association. We show, for the first time, that this association exists across the entire NDD spectrum. Using latent factor analysis, we created a consensus human neurodegenerative disease-associated microglia (hnDAM) signature, which we experimentally validated in 11 independent sample series. We demonstrate that the hnDAM signature is a statistically testable biomarker for conserved microglial activation in NDDs by: i) comparing to murine DAM-like signatures, ii) performing transcription factor analysis, and iii) modeling transcriptional reprogramming perturbations in iPSC-derived microglia. Taken together, this work broadens our understanding of glial activation across neuropathologies and reveals hnDAM as a putative therapeutic target that can be widely generalized to patients suffering from NDDs. Graphical Abstract">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/175ef2b9aa311e9d2d89b0363a0201a247e0fb72" target='_blank'>
              Integrative analysis reveals generalizable human neurodegenerative disease-associated glial states
              </a>
            </td>
          <td>
            Liam Horan-Portelance, Dominic J. Acri, Alexandra Mann, Janet Brooks, Hannah M. Bailey, J. R. Gibbs, Alex R. DeCasien, Mark R. Cookson
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>62</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0f99bb18019cd4b39bd05d6d11bec440e5d21593" target='_blank'>
              B cell transcriptomics reveals lasting dysregulation and rapid decline of protective immune memory after chronic hepatitis C cure
              </a>
            </td>
          <td>
            Fang Chen, E. Giang, Padmaja Natarajan, Tony S. Mondala, Steven R. Head, Sing Chau Lau, Aishwarya Sundaresan, Liudmila Kulakova, Xiaohe Lin, Jasneet Aneja, R. Andrabi, Yun Zhang, Richard H. Scheuermann, Eric A. Toth, Thomas R. Fuerst, Lia Lewis-Ximenez, Arthur Y Kim, Paul Pockros, Georg M Lauer, M. Law
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d02c6ef788d3f06d122c2a526528f66cd2e89e08" target='_blank'>
              Pre-Omicron Immunity Generates IgG⁺ but Not IgA⁺ Memory B Cells Reactive to Omicron Spike Protein
              </a>
            </td>
          <td>
            T. Tsoleridis, I. Singh, D. Onion, JG Chappell, A. Kelly, J. Nightingale, AM Valdes, B. Ollivere, Kenneth B. Hoehn, RA Urbanowicz, JK Ball
          </td>
          <td>2025-09-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="The COVID-19 pandemic, which began in 2019 due to SARS-CoV-2, remains a global health crisis, especially as new variants emerge that could trigger widespread outbreaks again. While various aspects of SARS-CoV-2 infection warrant attention, the antiviral innate immune response is a crucial area of focus. Understanding how viruses evade host defenses is vital for developing effective vaccines and therapies. SARS-CoV-2 targets key components of the innate immune system for its survival, and this interference with the host immune system is central to the virus's ability to cause disease. However, the specific mechanisms by which the innate immune response counteracts SARS-CoV-2 infection have not been fully clarified. This review examines key elements of the antiviral innate immune response to SARS-CoV-2 infection, concentrating on viral evasion strategies and potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2283fdb7927a9966d77a4f3f180d82163d69d72b" target='_blank'>
              Host’s innate immune response to SARS-CoV-2 infection—Current understanding and trends
              </a>
            </td>
          <td>
            Nitin Saksena
          </td>
          <td>2025-11-08</td>
          <td>Journal of Cellular and Molecular Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a34b6d929a049357f2964e23e7d33976a5ca654" target='_blank'>
              DYNAMICS OF RHINOVIRUS SARS-COV-2 COINFECTIONS AND SUPERINFECTIONS IN HUMAN AIRWAY CULTURES REVEAL TYPE-DEPENDENT VIRAL INTERFERENCE
              </a>
            </td>
          <td>
            Romain Volle
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Introduction In severe COVID-19, direct-acting antiviral drugs were not effective in hyperinflammatory stages and steroid treatment may weaken host immunity. The MEK inhibitor zapnometinib, as a host-targeting drug, has demonstrated promising efficacy against severe acute viral infections. Proof-of-concept for the innovative approach was presented in a clinical Phase 2 trial with hospitalized COVID-19 patients. Methods The antiviral and immunomodulatory potential of zapnometinib was investigated in samples obtained from COVID-19 patients enrolled in a Phase 2 clinical trial (RESPIRE), as well as in a SARS-CoV-2 Syrian hamster model, an acute lung injury mouse model, and in cell culture. The antiviral activity of zapnometinib was assessed using viral load reduction assays and RT-qPCR. Cytokines and chemokines were analyzed via ELISA and RT-qPCR. Alterations in T and B cells from COVID-19 patients were analyzed using flow cytometry. Biomarker analysis in hamster serum was conducted to monitor potential toxic effects. Results Zapnometinib reduced SARS-CoV-2 viral load in hospitalized COVID-19 patients, in the hamster model and in various highly pathogenic coronaviruses in vitro. Pro-inflammatory cytokines and chemokines decreased in COVID-19 patients, in a lung injury mouse model, and in vitro in primary human blood cells treated with zapnometinib. In the hamster model, zapnometinib alleviated SARS-CoV-2-mediated lung pathology. In patients with COVID-19, zapnometinib increased T and plasma B cells. Conclusion Unlike direct-acting antivirals, zapnometinib’s dual effect highlights its therapeutic potential in the treatment of severe acute viral infections, with favorable antiviral and immunomodulatory properties.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/663d1de063408dd2a575fb958f6e07a877642b1a" target='_blank'>
              Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients
              </a>
            </td>
          <td>
            Yvonne Füll, Lara M. Schüssele, Hazem Hamza, Helen Hoffmann, Martin Bauer, Stephan Stenglein, Oliver Pötz, Andreas Steinhilber, Viktoria Anselm, M. Delany, J. V. D. van den Brand, G. van Amerongen, Leon de Waal, S. Pleschka, Stephan Ludwig, Oliver Planz
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Immunology</td>
          <td>1</td>
          <td>49</td>
        </tr>

        <tr id="ABSTRACT Understanding the protective mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines against severe COVID is important for therapeutic development to mitigate disease-associated lung pathologies. Here, we investigated the association between vaccination and the disease severity with a particular emphasis on viral-induced pulmonary fibrin formation in 43 COVID individuals. While COVID vaccination reduced the disease severity in this cohort, their plasma coagulation indices, including prothrombin time (PT), partial thromboplastin time (PTT), and D-dimer concentrations, remain unchanged between the vaccinated and non-vaccinated individuals. In contrast, vaccination lowered pulmonary inflammatory and coagulation signatures, reduced fibrinogen concentrations, and prevented prothrombin activation in bronchoalveolar lavage fluid (BALF), such that no viral-induced fibrin was observed in the vaccinated BALF. The formation of viral-induced fibrin correlated with the disease severity and was observed in non-vaccinated BALF samples containing high concentrations of fibrinogen and prothrombin, suggesting vaccination protected against the viral-induced pulmonary fibrin formation. Our finding highlights the use of pulmonary rather than plasma fibrinogen levels as a risk indicator for severe COVID disease. IMPORTANCE Understanding the protective mechanism of COVID-19 vaccines against the severity of the disease is important for therapeutic development, and thus, subject to intense investigation. Here, we studied a cohort of 43 COVID patients based on their vaccination status. We showed that (i) COVID disease severity is associated with the formation of SARS-CoV-2-induced pulmonary fibrin, (ii) vaccination protected against severe COVID disease by reducing infiltration of coagulants, preventing prothrombin activation and fibrin deposition in infected lungs, and (iii) plasma coagulation indices are not useful indicators for fibrin deposition in infected lungs. Rather, the level of pulmonary fibrinogen provides an informative indicator for COVID-associated coagulation in lung. Understanding the protective mechanism of COVID-19 vaccines against the severity of the disease is important for therapeutic development, and thus, subject to intense investigation. Here, we studied a cohort of 43 COVID patients based on their vaccination status. We showed that (i) COVID disease severity is associated with the formation of SARS-CoV-2-induced pulmonary fibrin, (ii) vaccination protected against severe COVID disease by reducing infiltration of coagulants, preventing prothrombin activation and fibrin deposition in infected lungs, and (iii) plasma coagulation indices are not useful indicators for fibrin deposition in infected lungs. Rather, the level of pulmonary fibrinogen provides an informative indicator for COVID-associated coagulation in lung.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/27118e0d8c7e391446d9e4844b490cabe504b043" target='_blank'>
              Vaccination protects against COVID-associated pulmonary fibrin deposition
              </a>
            </td>
          <td>
            Joanna Ireland, David Myers, Chang Huang, Cameron Allen, Gwynne Roth, Zhongcheng Zou, Ming Zhao, Motoshi Suzuki, Lisa Olano, Joshua Tan, Shreya Kanth, J.A. Huapaya, Homer Twigg, A. Suffredini, Peter D Sun
          </td>
          <td>2025-11-06</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), uses the angiotensin-converting enzyme 2 (ACE2) receptor and transmembrane serine protease 2 (TMPRSS2) to enter host cells. Variability in gene expression of these entry factors has been hypothesized to influence susceptibility and disease severity. The present study aimed to evaluate the expression of ACE2 and TMPRSS2 in nasopharyngeal cells and their association with COVID-19 infection and clinical outcomes. Nasopharyngeal samples from 491 individuals (aged 18-80 years) treated in public hospitals in Brazil during 2020 were analyzed. Patients were categorized based on SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction (RT-qPCR) results and disease severity (including intensive care unit admission). Gene expression levels of ACE2 and TMPRSS2 were quantified using RT-qPCR, and statistical analyses assessed associations with infection status, age, sex, and disease severity. The findings revealed that infected individuals were significantly older (P=0.0010) and predominantly male (52.9%). ACE2 expression was significantly reduced in SARS-CoV-2-positive individuals compared with negative individuals (P<0.001), but no association with severity or sex was observed. By contrast, high ACE2 levels were found in moderately symptomatic SARS-CoV-2-negative individuals. TMPRSS2 expression did not significantly differ by infection status or disease severity. In summary, ACE2 downregulation appeared to be associated with SARS-CoV-2 infection, potentially reflecting viral evasion mechanisms. However, neither ACE2 nor TMPRSS2 gene expression in the nasopharynx served as a reliable biomarker for predicting COVID-19 severity. These findings underscore the need for multifactorial models integrating host, viral, and clinical factors to improve our understanding disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/601d43aad8b2e595606c7bb8e092bf4ba6f19a85" target='_blank'>
              Expression of ACE2 and TMPRSS2 and the severity of COVID-19.
              </a>
            </td>
          <td>
            Samantha Sanches De Carvalho, Anna Carolina Blanco Capassi Santos, Marcos Yuji Shiroma Graziano, Marina Cristina Peres, Renan Sousa Silva, Isabella Trufelli, Glaucia Luciano da Veiga, F. L. A. Fonseca, Beatriz da Costa Aguiar Alves
          </td>
          <td>2025-10-10</td>
          <td>Biomedical reports</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Severe influenza virus infection often triggers acute lung injury, and the efficacy of respiratory functional recovery critically depends on timely alveolar regeneration. However, the cellular dynamics and regulatory mechanisms underlying post-infectious alveolar repair remain incompletely understood. Utilizing Sftpc-CreER; Rosa26-mTmG lineage-tracing model, we determine the main stem cell population responsible for alveolar regeneration following influenza-induced injury. Through integrated single-cell RNA sequencing (scRNA-seq), immunofluorescence, and electron microscopy approaches, we mapped cellular transcriptional landscapes and spatial interactions. Key macrophage-epithelial crosstalk was further investigated via in vitro co-culture systems and in vivo conditional depletion models using diphtheria toxin receptor-transgenic mice. Putative regulatory factors were predicted through ligand-receptor interaction analysis and functionally validated in ex vivo organoid models. In this study, we revealed that the severely damaged alveolar barrier after influenza virus infection was rebuilt by the proliferation and differentiation of residual type II alveolar epithelial (AT2) cells in an inflammatory niche. In particular, monocyte-derived macrophage (Mo-Macs) expand, displaying intimate spatial proximity with AT2 cells. In addition, the cellular transcriptional status determined by scRNA-seq revealed that Mo-Macs regulate epithelial cell proliferation. Mo-Macs promoted the formation of AT2 spheres in vitro. Moreover, Mo-Mac depletion resulted in delayed repair of the alveolar epithelial structure in vivo. In addition, the mechanism by which Mo-Macs regulate alveolar epithelial repair involves the secretion of oncostatin M (OSM), which stimulates p-STAT3 activation and promotes AT2 cell proliferation. Our findings revealed that residual AT2 cells act as stem cells in the alveolus and are regulated by Mo-Macs through OSM secretion. These findings increase our understanding of the role of inflammatory signals in regulating tissue repair after severe injury, which may provide a potential avenue for therapeutic intervention in recovered patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c77e7cb9a0802132b1fb5c49fb2be2fef756fe89" target='_blank'>
              Monocyte-derived macrophages support alveolar regeneration via oncostatin M post-H1N1 infection during the recovery phase
              </a>
            </td>
          <td>
            Xiaoan Shang, J. Jia, Jiapei Yu, Shumei Zou, Zeyi Wang, Jiuyang Xu, Hui Li, Bin Cao
          </td>
          <td>2025-10-08</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Severe COVID‐19 is an immunological disorder characterized by a hyper‐inflammatory reaction of the immune system. SARS‐CoV‐2 anti‐spike antibodies of the IgG isotype are known to strongly contribute to this hyperinflammation by overactivation of alveolar macrophages. However, while the pathogenic function of IgG has been extensively studied, very little is known about the function of IgA, the most abundant immunoglobulin isotype in the airways. Although IgA is generally considered noninflammatory, in this study, we show that anti‐spike IgA induces pronounced proinflammatory responses. We demonstrate that stimulation of macrophages with anti‐spike IgA immune complexes in combination with a viral stimulus amplifies proinflammatory cytokine production. This IgA‐induced inflammation is particularly driven by IgA2, the IgA subclass that is increased in the plasma of severely ill COVID‐19 patients. We identified that IgA2‐induced inflammation is predominantly dependent on FcαRI‐Syk signaling. Mechanistically, IgA2‐induced inflammation is linked to enhanced glycolysis and altered mitochondrial function, indicating subclass‐specific immunometabolic reprogramming. Taken together, these data indicate a pathogenic role for IgA2 in severe COVID‐19 and highlight its signaling cascades and metabolic pathways as potential druggable targets to counteract hyperinflammation in severe coronavirus infections, such as COVID‐19, SARS, MERS, and potential future outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/108f6fbe490f0df81a3f8e4a427171366e4fce33" target='_blank'>
              Anti‐SARS‐CoV‐2 Spike IgA2 Induces Inflammation by Human Macrophages
              </a>
            </td>
          <td>
            Lynn Mes, Jennifer Veth, Julie Van Coillie, J. Keijser, Elise Mantel, R. van der Mast, Theo Rispens, G. Vidarsson, M. van Egmond, J. den Dunnen, Hung-Jen Chen
          </td>
          <td>2025-10-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="Host responses – autophagy, cell death, and inflammation – limit the growth of bacterial pathogens while minimizing tissue damage. During the early stages of infection, Mycobacterium tuberculosis (Mtb) thwarts these and other innate immune defense mechanisms in alveolar macrophages (AMs) derived from the yolk sac; in later stages, it circumvents defenses in recruited mononuclear cells (MNCs) and survives within them despite additional cytokine stimulation from recruited T cells. The mechanisms that drive variable rates of Mtb growth in different macrophage subtypes and how Mtb manipulates inflammatory responses to grow within innate immune cells remain obscure. Here we explored the role of the host factor, Tax-1 binding protein 1 (Tax1bp1), an autophagy receptor that targets pathogens for degradation through selective autophagy and terminates pro-inflammatory cytokine responses. Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to Mtb infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, Listeria monocytogenes, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. Contrary to our previous ex vivo findings in bone marrow-derived macrophages (BMDMs), in vivo growth of Mtb in AMs and a subset of recruited MNCs was more limited in mice lacking Tax1bp1 relative to wild-type mice. To better understand these differences, we performed global protein abundance measurements in mock- and Mtb-infected AM samples ex vivo from wild-type mice. These experiments revealed that Tax1bp1 protein abundance does not significantly change early after infection in AMs but does in BMDMs; moreover, early after infection, Tax1bp1-deficiency reduced necrotic-like cell death -- an outcome that favors Mtb replication -- in AMs but not BMDMs. Together, these results show that deficiency of Tax1bp1 plays a crucial, cell type-specific role in linking the regulation of autophagy, cell death, and anti-inflammatory host responses and overall reducing bacterial growth.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7346e21902a5204769fdc46d4603e81b0700379e" target='_blank'>
              Mycobacterium tuberculosis triggers reduced inflammatory cytokine responses and virulence in mice lacking Tax1bp1
              </a>
            </td>
          <td>
            Jeffrey Chin, Nalin Abeydeera, Teresa Repasy, Rafael Rivera-Lugo, Gabriel Mitchell, Vinh Q Nguyen, Weihao Zheng, Alicia L. Richards, Erica Stevenson, Danielle L. Swaney, N. Krogan, J. Ernst, Jeffery S. Cox, Jonathan M Budzik
          </td>
          <td>2025-10-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="ABSTRACT Down syndrome (DS) is associated with immune dysfunction, which led to higher hospitalization and mortality rates during the COVID-19 pandemic. We previously showed that antibody concentrations were lower in adults with DS after primary SARS-CoV-2 vaccination. However, knowledge on cellular vaccine-induced responses in DS is limited. Here, we investigated the T-cell response induced by SARS-CoV-2 vaccination in adults with DS. We included adults with DS and healthy controls (HC) between 18 and 64 years following primary (mRNA and vector) and booster (mRNA) SARS-CoV-2 vaccination. Using flow cytometry, SARS-CoV-2-specific T cells were analyzed after spike peptide re-stimulation. Additionally, interferon-gamma (IFNγ) production by SARS-CoV-2-specific T cells was measured with an IFNγ release assay (IGRA) after antigen stimulation. We observed major deficits in naive CD4+ and CD8+ T cells in adults with DS as previously described. However, overall there was no difference in the percentage of SARS-CoV-2-specific T cells or IFNγ production by these cells after primary vaccination, albeit with vaccine-specific differences. IFNγ concentrations measured by IGRA after primary vaccination were comparable between DS and HC. Booster vaccination increased SARS-CoV-2-specific T cells in HC but not in DS, while IFNγ release (IGRA) increased to similar concentrations. In conclusion, we show that while functional T-cell responses (IFNγ production) are comparable after primary and booster vaccination, the magnitude (percentage of SARS-CoV-2-specific T cells) may be lower after mRNA vaccination. We previously showed lower antibody concentrations and profound abnormalities in the naive T-cell compartment, warranting further investigation into T-cell-B-cell-interactions after vaccination in adults with DS. Clinical trial registration: NCT05145348 https://www.clinicaltrials.gov/study/NCT05145348?locStr=Netherlands&country=Netherlands&cond=Down%20Syndrome&term=SARS-CoV-2%20Vaccination&rank=1. Start date: 2021–02-03.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2448268bbfee83f7ff147f95f3dffc2e0f35b5a8" target='_blank'>
              T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome – a prospective cohort study
              </a>
            </td>
          <td>
            Lobke C M Hensen, Bianca M M Streng, F. van Wijk, S. Nierkens, Robert S. van Binnendijk, A. Buisman, Antonia M W Coppus, Corine H. Geurts van Kessel, Gert de Graaf, Fiona van der Klis, Regina Lamberts, G. Vidarsson, Tracy J Ruckwardt, Esther de Vries, R. D. de Vries, M. Weijerman, Daniel M Weinberger, J. Wildenbeest, Louis J. Bont, E. Delemarre
          </td>
          <td>2025-11-06</td>
          <td>Human Vaccines & Immunotherapeutics</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="Introduction In human neurocysticercosis (NCC), the cellular and molecular mechanisms of host-parasite interactions triggering brain inflammation and epileptic seizures in Sub-Saharan Africa are poorly understood. Emerging evidence indicates that the viability of the cyst of the pork tapeworm Taenia solium determines brain inflammation and, thus, symptom development and disease severity. We have previously shown that while viable cyst-released molecules promote immune regulation and often asymptomatic disease, the fluid from degenerating cysts causes inflammation in microglia and peripheral immune cells, potentially driving immune-mediated pathology. This study aims to elucidate the apoptotic signaling pathways underlying this process and their relevance for symptomatic disease in NCC patients. Materials and methods Human and porcine peripheral immune cells, as well as murine microglia, were exposed to T. solium cyst vesicular fluid (CVF). Apoptosis signaling pathways were analysed using flow cytometric FLICA (fluorochrome-labeled inhibitors of caspases) caspase 8 and 9 assays, while mitochondrial dysfunction was assessed via TMRE and MitoTracker Deep Red and Green fluorescent probes. Apoptosis-inducing CVF molecules were identified by differential mass spectrometry and functionally tested using specific inhibitors. Caspase activity and soluble mediators (FasL, ROS, TNFα) were measured in NCC asymptomatic and symptomatic patients’ sera, and inflammatory T cell infiltrates expressing caspases near viable and degenerating cysts in naturally infected pig brain slices were examined via immunohistology. Results We found that vesicular fluid derived from cysts primarily induced apoptosis and caspase 3 and 9 activity, and only minimal necrosis, in a dose-dependent manner across central and peripheral immune cells. This effect was prominent in CD16+ monocytes, microglia, and in CD3+ T cell-expressing caspase 3 near degenerating brain cysts. Apoptotic signaling was predominantly mediated by a dynamic remodeling of caspase 9 pathway, accompanied by a significant loss of mitochondrial potential and a sharp decrease in Bid and Bcl2 transcription, favoring the intrinsic over the FasL-dependent extrinsic pathway and mechanisms. This process is primarily mediated by small molecules (< 30 kDa), and remained unaffected by heat and proteinase treatment. Notably, symptomatic NCC patients exhibited elevated FasL levels correlating with increased caspase activity, underscoring the potential contribution of apoptosis to disease pathogenesis. Conclusions This study identifies caspase 9-mediated apoptosis as a mechanism of helminth-induced brain inflammation and implicates FasL in symptomatic disease progression. These insights enhance our understanding of NCC immunopathogenesis and may inform future therapeutic strategies targeting apoptotic pathways.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e6a1fef84d50d723dd9a0b4e1aa6dfcd7f5051b9" target='_blank'>
              Helminthic larval stage induces cellular apoptosis via caspase 9-mediated mitochondrial dysfunction
              </a>
            </td>
          <td>
            Leonardo Elias Sternkopf, Ulrich F Prodjinotho, Vitka Gres, Nikolaus Repgen, Katja Steiger, Julia Schluckebier, Chummy Sikasunge, Dominik Stelzle, C. Makasi, Andrea S Winkler, B. Ngowi, Nelly Villalobos, Friederike Ebner, Georg Häcker, Philipp Henneke, C. U. Prazeres da Costa
          </td>
          <td>2025-09-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8bf2e04bf6e2797aba3ea1f4f0aeb768b1def37b" target='_blank'>
              Memory Regulatory T Cells Reprogram into Protective Tfh-like Effectors in Recurrent Malaria
              </a>
            </td>
          <td>
            Nana Appiah Essel Charles-Chess, A. Ruberto, Carson Bowers, N. Obeng-Adjei, M. R. Hansen, Disha Bangalore Renuka Prasad, B. Traore, K. Klonowski, Peter D. Crompton, S. P. Kurup
          </td>
          <td>2025-10-15</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="COVID-19, caused by the SARS-CoV-2 virus, manifests with varying degrees of severity, affecting individuals worldwide. The spectrum of symptoms ranges from mild to severe, with respiratory failure being a leading cause of death. Immunological factors, particularly excessive cytokine production such as IL-18 and IL-1β, significantly contribute to disease severity. In this context, the NLRP3 inflammasome, a key component of the innate immune system, has influenced COVID-19 outcomes. This study investigated the association between single-nucleotide variants (SNVs) in the NLRP3 inflammasome and COVID-19 severity. A case-control study was conducted involving 800 adult participants infected with SARS-CoV-2, stratified into mild/moderate and severe/critical cases. Genetic associations were assessed through qPCR-based genotyping. While no association was found between SNVs in IL1B and CASP1 with COVID-19 severity, the multivariate analysis revealed that the gain-of-function SNV in the NLRP3 gene (rs35829419) was associated with a protective effect against COVID-19-related mortality. These findings suggest that genetic variations in the NLRP3 inflammasome may modulate the host response to SARS-CoV-2, highlighting potential biomarkers for disease prognosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c3bc942541c2b74961a12f103de05cc6065fe633" target='_blank'>
              An NLRP3 Variant Protects Against Severe COVID-19: An Unexpected Contribution of Inflammasome Genetics in SARS-CoV-2 Infection.
              </a>
            </td>
          <td>
            L. M. Paulino, V. N. C. Leal, W. M. D. S. Santiago, Débora de Fátima Almeida Donanzam, Célio Roberto Siqueira Ledesma, Maria Fernanda Silva Bertelli, W. S. Fava, A. Latini, Alessandra Pontillo, James Venturini
          </td>
          <td>2025-10-27</td>
          <td>International journal of immunogenetics</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Intoduction T lymphocytes, along with cytokines and chemokines-dependent pathways are primarily responsible for regulating the immune response, controlling inflammation and eliminating viral infections. However, excessive immune activity can lead to pathological effects such as cytokine storm, which may cause severe respiratory distress syndrome and multi-organ damage in COVID-19. The aim of this study was to identify potential biomarkers of SARS-CoV-2 infection that could predict the severity of COVID-19 progression. Methods The cohort in this study included 52 hospitalized adult patients with SARS-CoV-2 infection from Warsaw, Poland admitted to the hospital during COVID-19 pandemic (February to November 2021). Based on clinical symptoms, patients were divided into two groups: (i) mild/moderate symptoms (non-severe) – 44 patients and (ii) severe respiratory failure (severe) – 8 patients. The control group consisted of 26 individuals without COVID-19. All COVID-19 patients and healthy controls underwent immunophenotyping of peripheral blood to assess the abundance of T lymphocytes and regulatory T lymphocytes, as well as measurement of selected cytokine and chemokine concentrations in corresponding serum samples. Data analysis was performed using CytoFLEX Flow Cytometer. Results and discussion Decreased percentages of total lymphocytes and T lymphocytes in peripheral blood were observed across all COVID-19 patients, with varying degrees between the non-severe and severe groups. A significant reduction was also noted in double-positive lymphocytes (CD4+CD8+), regulatory T lymphocytes ( CD4+ CD25HiCD127Lo and CD4+CD25HiCD127LoFoxP3+), as well as CD4+CD25+/-, CD4+CD45RA+/-, and CD8+CD45RA+/- subsets. Elevated levels of IL-6, IL-10, IL-17A, IFN-g, CCL2, CXCL8, and CXCL10 were observed in the non-severe and/or severe groups compared to healthy controls. Most importantly, only CXCL10 was significantly elevated in the severe group at admission compared to the non-severe group. In this study, we identified the chemokine CXCL10 as a crucial marker for distinguishing the severe course of COVID-19 from non-severe form at the time of admission. It may serve as an early indicator of diseases progression during hospitalization, potentially allowing prediction of the disease course. Moreover, elevated CXCL10 levels, in combination with decreased total lymphocytes counts and increased levels of IL-6, IL10, IFNg, CCL2 and CXCL9, may represent a more comprehensive biomarker panel suitable for predicting the severity of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/befe135670515a1bc53405d52fd1e7cbd7111080" target='_blank'>
              Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland
              </a>
            </td>
          <td>
            Monika Leśniak, A. Borkowska, Krzysztof Kłos, K. Aleksandrowicz, K. Porębska, Dagmara Kobza, K. Piwowarek, K. Plewka-Barcik, Marcin Niemcewicz, Anna Lutyńska, Jacek Z. Kubiak, Andrzej Chciałowski, R. Zdanowski
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Aging is characterized by chronic low-grade neuroinflammation, which increases the risk of neurodegenerative disorders. Neuroinflammation, driven by the activation of astrocytes and microglia, underlies age-associated cognitive deficits. Amplified neuroinflammatory responses to immune challenges are attributed to microglial activation in the aged brain. Despite extensive clinical and experimental evidence linking neuroinflammation to aging, the molecular players that control age-associated neuroinflammatory responses in the brain are not fully understood. Genome-wide association studies (GWAS), proteomics, and transcriptomic datasets have revealed that Asrij/OCIAD1 is a novel aging and Alzheimer’s disease (AD)-associated factor. Asrij levels are increased in patients with AD and are known to promote amyloid-beta (Aβ) pathology and microglia-mediated neuroinflammation, which are associated with cognitive dysfunction in AD. Increased levels of Asrij are also reported in the brains of aged wild-type (WT) mice; however, whether this may promote neuroinflammation or be a protective response during aging is not known. To test this, we used young and aged WT and asrij KO mice and showed that normal aging is associated with increased microgliosis and astrocyte activation in WT mice. While young asrij KO mice do not display any differences in glial activation, aged KO mice have reduced microglial and astrocytic activation compared to aged WT mice. This is accompanied by reduced levels of pro-inflammatory mediators and downregulation of STAT3 and NF-κB signaling in the cortex and hippocampus of aged asrij KO mice. Additionally, asrij depletion inhibits LPS-induced microglial activation and neuroinflammation in aged mice. This indicates that Asrij is essential for the neuroinflammatory responses in the brains of aged mice. We propose that identifying pharmaceutical modulators of Asrij could provide novel means to control microglial activation and neuroinflammation during normal aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b05e7046c3b3a0c27c19a9838cb4c954fa499381" target='_blank'>
              Asrij/OCIAD1 contributes to age-associated microglial activation and neuroinflammation in mice
              </a>
            </td>
          <td>
            Prathamesh Dongre, Madhu Ramesh, T. Govindaraju, M. Inamdar
          </td>
          <td>2025-10-10</td>
          <td>Frontiers in Aging Neuroscience</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/61f2942696de914b8ddcd3d63d15f096d71ddb29" target='_blank'>
              Progenitor T cells drive chronic pulmonary type 2 inflammation
              </a>
            </td>
          <td>
            Radomir Kratchmarov, Xiaojiong Jia, Jun Nagai, Hiroaki Hayashi, Kinan Alhallak, Juying Lai, Chunli Feng, Jakob von Moltke, Joshua A. Boyce, Patrick J. Brennan
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Background Immune checkpoint inhibitor (ICI) therapies present a pillar of modern cancer therapy but can cause neurological immune-related adverse events (n-irAEs), of which up to 35% are severe or even fatal. However, the detailed immunological mechanisms and risk factors underlying n-irAEs remain largely unknown. Here, we leveraged single-cell genomics to dissect immune cell type, state, and clonal heterogeneity associated with n-irAEs. Methods We performed coupled single-cell RNA sequencing and T cell receptor (TCR) profiling on peripheral blood cells of 17 patients with cancer receiving ICI therapy, including 8 patients with acute neurotoxicity. This approach enabled integrated analyses of immune cell states and T cell clonality linked to ICI-induced n-irAEs. Results We profiled 186 435 immune cells and conducted pseudotime analyses, revealing that patients with n-irAEs, compared with controls, present with clonally expanded CD4+ cytotoxic T lymphocytes (CD4+ CTLs) with an n-irAE-specific effector gene expression profile. These T cells predominantly belong to a select set of expanded clonal families and express genes linked to antigen-induced activation, cell lysis, and neuroinflammation. Moreover, they highly express CXCR3 (FC=2.03 compared with control CD4+ CTLs, with a false discovery rate=7.7×10⁻⁴), encoding the chemokine receptor of CXCL10, previously nominated as a biomarker for severe ICI therapy-induced n-irAEs with concomitant multiple organ system toxicity. Conclusions Overall, our study highlights the expansion and activation of CD4+ CTLs in ICI-induced neurotoxicity, proposing these cells as potential targets for developing new biomarkers and therapeutic strategies to improve patient outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a4f4e0b8916eaa4261cd264db53571afd725a2f" target='_blank'>
              Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy
              </a>
            </td>
          <td>
            Ambre Giguelay, Patrick Maschmeyer, L. Müller-Jensen, Christian Schinke, Smilla K. Maierhof, Natasha Nambiar, Manpreet Meyer, Petra Huehnchen, Wolfgang Boehmerle, Matthias Endres, Samuel Knauss, L. S. Ludwig
          </td>
          <td>2025-10-01</td>
          <td>Journal for Immunotherapy of Cancer</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Immune checkpoint inhibitors (ICIs), targeting checkpoint receptors such as programmed cell death protein 1 (PD-1), are associated with increased risk of cardiovascular events, but the underlying mechanisms remain poorly understood. Here we show that PD-1+ T cells from murine atherosclerotic aortas mainly display a progenitor exhausted phenotype (PD-1intSlamf6+Tim3−), produce IFNγ in vivo, exhibit signs of recent proliferation and maintain polyfunctionality. PD-1 blockade induced marked changes in plaque immune phenotype, with increased PD-1high T cell accumulation, IFNγ production, formation of lymphocyte foci and neutrophil recruitment. Depletion of PD-1high T cells prior to PD-1 blockade did not impede T cell recruitment, suggesting a role for progenitor exhausted PD-1int T cells in ICI-driven T cell plaque accumulation. Human circulating PD-1+ T cells produced IFNγ and were associated with subclinical coronary atherosclerosis. Our studies highlight IFNγ-producing PD-1+ T cells as a potential key immune cell population mediating increased cardiovascular risk in patients with cancer receiving ICI. Mulholland et al. identify progenitor exhausted T cells, expressing intermediate levels of PD-1 (PD-1int), as a prominent source of pro-inflammatory cytokines in the murine atherosclerotic aorta and potential cellular targets driving checkpoint inhibition-elicited pro-atherosclerotic immune responses. They further demonstrate elevated levels of circulating PD-1-expressing T cells in individuals with subclinical cardiovascular disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a29caf4329bc4f3e79ec49abf0bdad10c56e11d" target='_blank'>
              Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis
              </a>
            </td>
          <td>
            Megan Mulholland, Anthi Chalou, Samuel H A Andersson, M. Depuydt, Yinda Yu, Shiying Lin, Klara Tallbäck, Astrid Ericsson, G. Jakobsson, J. de Mol, Dmytro Kryvokhyzha, A. Lichtman, A. Foks, A. Schiopu, Harry Björkbacka, B. Slütter, Anton Gisterå, D. Engelbertsen
          </td>
          <td>2025-10-01</td>
          <td>Nature Cardiovascular Research</td>
          <td>0</td>
          <td>65</td>
        </tr>

        <tr id="Despite advances in understanding systemic immune responses to Mycobacterium tuberculosis (Mtb), the localized immune dynamics within infected lymph nodes, particularly cell-type-specific transcriptional reprogramming and intercellular crosstalk, remain poorly defined, impeding targeted therapy development. By means of single-cell transcriptomics, the objective was to dissect the immune microenvironment and map intercellular crosstalk in Mtb-infected cervical lymph nodes, with the purpose of uncovering the mechanisms of localized immunity and immunopathology. Paired Mtb-positive cervical swollen lymph nodes (SLN) and adjacent Mtb-negative normal-appearing lymph nodes (NLN) from five cervical LNTB patients were analyzed using single-cell RNA sequencing (scRNA-seq). Computational network modeling (CellChat) and flow cytometry validation were employed to map immune cell heterogeneity and cell–cell communication. ScRNA-seq identified ten T cell subsets, ten B cell subsets, and six myeloid subsets, revealing conserved frequencies but substantial transcriptional reprogramming in SLN. The SLN exhibited extensive upregulation of pro-inflammatory pathways across T, B, and myeloid cells, accompanied by minimal alterations in subset frequencies. IL1B + macrophages in SLN showed an enrichment of genes associated with oxidative phosphorylation, antigen presentation, and inflammasome-related genes. The SLN demonstrated an increased cell–cell communication driven by the crosstalk between macrophage and CD8 + T/NKT cells. Validation through flow cytometry confirmed comparable proportions of immune subsets between the SLN and the NLN, which was consistent with the findings of scRNA-seq. This study delineates a spatially coordinated immune strategy in cervical LNTB. In this context, Mtb infection induces transcriptional and metabolic reprogramming rather than subset redistribution. The strengthened interaction between macrophages and T cells emphasizes that cellular immunity serves as the main impetus for bacterial containment. Nevertheless, there are trade-offs between inflammation and tissue integrity. These insights provide a framework for developing therapies that target intercellular networks to achieve a balance between immunity and pathology in LNTB.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/85f7d9d58e6ee25e924ad6baff06b4c1c3d3fa38" target='_blank'>
              Single-cell transcriptomics of cervical lymph node tuberculosis reveals cellular heterogeneity and enhanced cellular communication
              </a>
            </td>
          <td>
            Guohui Xiao, Haijiang Wang, Su Zhang, Xuefeng Zhou, M. Ou, Xiangmei Zhang, Guobao Li, Aimei Liu, Shimin Shuai, Guoliang Zhang
          </td>
          <td>2025-10-21</td>
          <td>BMC Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1cac498108b5305e7d2a1dde250a33c8a3e03b2" target='_blank'>
              Acute SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Amy C. Sherman, Glenda E Gray, Bin Cao, Kelvin K W To, Nadine G Rouphael, A. Henao-Restrepo, Anthony C Gordon, Lindsey Baden
          </td>
          <td>2025-10-24</td>
          <td>Nature Reviews Disease Primers</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Viral infections impose a substantial threat to human health, characterized by a wide range of pathogens, clinical manifestations, and complex immune responses. Single-cell multi-omics technologies have revolutionized the study of antiviral immunity by resolving cellular heterogeneity, transcriptional reprogramming, and clonal dynamics. However, no resource has yet comprehensively integrated such datasets in the context of viral infections. Here, we present scMOVIR, a single-cell multi-omics database for human viral infections and immune responses. The database systematically integrates transcriptomic, proteomic, and immune receptor repertoire profiles at single-cell resolution, compiling 8532 human samples across 114 viral species, subtypes, and strains. These datasets span 59 well-defined disease states, including acute and chronic infections, virus-associated malignancies, and immune-related disorders, and extend across >30 tissue types. In addition, these datasets incorporate vaccination cohorts, therapeutic interventions, and time-course models of infection. To ensure consistency and interoperability, all datasets undergo standardized preprocessing, including batch correction and unified cell-type annotation, with metadata harmonized using authoritative ontologies. scMOVIR provides user-friendly interfaces for dataset exploration and interactive visualization of cellular dynamics and molecular profiles, offering a high-resolution reference for investigating virus-host immune interactions and supporting antiviral research. The database is freely accessible at https://pgx.zju.edu.cn/scmovir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/130c5b82f9725db7d1697918120f36ba3e49fd02" target='_blank'>
              scMOVIR: a single-cell multi-omics database for human viral infections and immune responses.
              </a>
            </td>
          <td>
            Xue Zhang, Shounan Yang, Xiaobin Xu, Yitao Lin, Huaicheng Sun, Bangyu Zhu, Wenyi Zhao, Binbin Zhou, Yan Lou, Xinyu Wang, Shuqing Chen, Qiaojun He, Feng Zhu, Zhan Zhou
          </td>
          <td>2025-11-13</td>
          <td>Nucleic acids research</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68a61536fdb213f77defcf43b41942dda2c2a3d0" target='_blank'>
              SARS-CoV-2 Variant-Dependent Alterations in Nasopharyngeal Microbiota and Host Inflammatory Response
              </a>
            </td>
          <td>
            Mario Maulen, Ignacio Pezoa-Soto, Daniel León, Ela M. Dominguez, Alberto J. M. Martin, W. Díaz-Vásquez
          </td>
          <td>2025-10-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Bacterial infection is a key trigger of inflammatory pathways that damage the preterm brain, even without direct bacterial brain invasion. However, the mechanisms underlying the involvement of intracranial tissues and cells in early immune responses to acute systemic inflammation in preterm infants remain unknown. Lipopolysaccharide (LPS) was administered with a single intraperitoneal injection into postnatal day (P) 7 mice. Four hours later, the leptomeningeal macrophages initiated an intracranial reaction by producing IL-1β, which set the stage for the arachnoid, pial, and perivascular fibroblasts to act. These brain fibroblasts produced CCL2, which increased the number of brain parenchymal macrophages/microglia and led to their hypertrophy. The macrophages/microglia isolated from the brains of mice with systemic inflammation showed marked transcript expression of genes including Saa3, Irg1, Lcn2, and Cxcl9. The expression level of Saa3 reached its peak 4 and 12 h after LPS administration. Saa3 expression was upregulated in the macrophages in the leptomeninges, perivascular space, and cerebellar medulla, as well as in the fibroblasts of the leptomeninges, choroid plexus stroma, and perivascular space. The leptomeningeal macrophages expressing Saa3 continued their developmental migration from the leptomeninges to the brain parenchyma. The blood-brain barrier of pups remained intact up to 72 h after LPS administration at P7. The expression levels of Irg1, Lcn2, and Cxcl9 peaked 4 and 12 h after LPS administration. The cells that prominently expressed Irg1, Lcn2, and Cxcl9 were the leptomeningeal macrophages, perivascular fibroblasts and choroid plexus epithelial cells, and leptomeningeal fibroblasts, respectively. The early enhancement of Saa3 expression played a key role in priming inflammation initiated by macrophages and fibroblasts. Early enhancement of Irg1 expression was crucial for determining the direction of the inflammatory response. The increase of Lcn2 was vital, sequestering the iron siderophore to limit bacterial growth. It was interesting to observe how the early immune responses to systemic inflammation in the postnatal mouse brain were initiated by migrating macrophages and leptomeningeal fibroblasts, leading to immediate gene upregulation to protect immature brain tissue.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f0b35f26b99383b11b5240dc52d6f9e54408658a" target='_blank'>
              Early immune responses to systemic inflammation in the postnatal mouse brain initiated by migrating macrophages and leptomeningeal fibroblasts
              </a>
            </td>
          <td>
            Rei Settsu, Aki Obara, Takehiko Tarui, S. Hasegawa-Ishii, Atsuyoshi Shimada
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e819f35bfc49ec2545e41780dc01e007f076a26d" target='_blank'>
              Immune Cell Dysfunction of SARS-CoV-2: Mathematical Modeling of the Within-Host Immune Dynamics
              </a>
            </td>
          <td>
            Pagnapech Ngoun, Nicolas Alvarez, Ayesh Awad, Hwayeon Ryu
          </td>
          <td>2025-10-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Influenza A virus (IAV) induces ZBP1-mediated PANoptosis, a form of lytic inflammatory cell death characterized by concurrent activation of the pyroptosis, necroptosis and apoptosis pathways. Ninjurin-1 (NINJ1) is a recently identified mediator of plasma membrane rupture but functions diversely in different types of cell death. However, little is known about the role of NINJ1 in IAV-induced PANoptosis and viral pneumonia. Here, we report that IAV infection triggered an increase in the expression of NINJ1, which then oligomerized and mediated cell lysis in infected macrophages. The deficiency of NINJ1 prevented plasma membrane rupture and the release of DAMPs and IL-1β without affecting the progression of cell death. Activation of any single PANoptosis pathway was sufficient to trigger the oligomerization of NINJ1 and robust cell lysis. Accordingly, only when all PANoptosis pathways were concurrently blocked could the oligomerization of NINJ1, cell death, and cell rupture be prevented. Ablation of NINJ1 in vivo also alleviated IAV-induced lung injury and mortality. Furthermore, we revealed an association between NINJ1 upregulation and poor outcomes in patients with COVID-19. Collectively, our findings indicate a pivotal role of NINJ1 in the immunopathology of IAV infection and its potential as a bioindicator of disease severity and prognosis in viral pneumonia and viral sepsis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f0192bd0bcdfc2176df6642ca957782529e315b2" target='_blank'>
              Ninjurin-1 mediates cell lysis and detrimental inflammation of PANoptosis during influenza A virus infection
              </a>
            </td>
          <td>
            Yitian Xu, Ying Zheng, Yan Liu, Cheng Wei, Juan Ren, Wenting Zuo, Runqing Gu, Hongyu Liu, Xiaoyan Deng, Yaxue Liu, Xiao Shang, Weiwei Ge, Ziyao Li, Yijiao Huang, Di He, Xuhui Shen, Zeyi Wang, C. Lyu, Zai Wang, Yuxian Mu, Zihuan Zhang, Hongping Wu, Haibo Li, Bin Cao
          </td>
          <td>2025-09-23</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Elderly individuals represent a population at disproportionate risk for severe outcomes following SARS-CoV-2 infection. The humoral immune response critically controls viral replication and disease progression. However, the antibody responses and B-cell subsets to mutant strains of SARS-CoV-2 in elderly patients have not yet been fully elucidated. This study aims to elucidate the humoral immune response and B-cell subsets distribution in elderly patients infected with SARS-CoV-2 Omicron variant, thereby providing insights for identifying prognostic biomarkers and developing therapeutic strategies. Using enzyme-linked immunosorbent assays and pseudotyped virus neutralization assays, we determined plasma levels of RBD-specific IgA, IgM, IgG, and neutralizing antibodies from 46 elderly patients with SARS-CoV-2 Omicron variant infection within the first two weeks post-symptom onset (PSO). Using a multicolor flow cytometry approach, we analyze the frequencies of different B-cell subsets and assess the functional characterization of B-cells. In elderly non-severe patients, SARS-CoV-2 RBD-specific antibody levels (IgA, IgM, and IgG) increased progressively within the first two weeks post-symptom onset (PSO). In contrast, severe patients exhibited lower initial antibody levels during 0-3 days PSO but experienced a transient surge (11-fold for IgA, 12-fold for IgM, and 48-fold for IgG) during 4-7 days PSO, which was followed by a decline between 8-14 days. Despite this early elevated response in severe patients, both groups ultimately demonstrated generally weak neutralizing activity against the SARS-CoV-2 Omicron variant. Both elderly patient groups exhibited an higher proportion of plasmablasts (PB). Among these, class-switched IgM-IgG+ PB were significantly more abundant than IgM+IgG-PB. Notably, elderly severe patients showed a further lower in class-unswitched IgM+IgG-PB. Concurrently, IgA expression on PB was upregulated during early disease in all elderly patients. Beyond PB changes, IgG+double negative B (DNB) cells were higher than IgM+DNB cells in both groups. however, severe patients demonstrated a significant reduction in IgG+DNB cells frequencies. Furthermore, these elderly severe patients also exhibited a decline in co-stimulatory molecule expression (HLA-DR+CD80+) within both naive B (NB) and DNB cells, indicating a dysregulated humoral immune response. Elderly individuals generate RBD-specific and neutralizing antibody responses after SARS-CoV-2 Omicron variant infection, which correlate significantly with disease severity and infection duration. Clinically, these findings highlight the potential utility of antibody kinetics as prognostic biomarkers for stratifying elderly patients at high risk of severe outcomes, thereby informing tailored intervention strategies and vaccine booster optimization. Furthermore, SARS-CoV-2 Omicron variant infection affects the distribution of B-cell subsets, which may predict the long-term immune reconstitution capacity post-recovery. Notably, elderly patients exhibit pronounced PB expansion, a response pattern that facilitates antibody class-switching to enhance antiviral immunity. Such expansion represents a key immunologic feature in elderly patients with SARS-CoV-2 Omicron variant infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a46658b01f8e375d2ecb7d1a689cb7e49abb258f" target='_blank'>
              Differential immune profiles in elderly patients with non-severe versus severe SARS-CoV-2 omicron variant infection: dysregulation of antibody responses and B-cell subsets
              </a>
            </td>
          <td>
            Xue Li, Yuanyuan Li, Shiyang Liu, Juanjuan Zhou, Xinxin Yang, Junlian Yang, Wen Xu, Weiwei Chen
          </td>
          <td>2025-11-04</td>
          <td>Immunity & Ageing : I & A</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Introduction Balamuthia mandrillaris infection in humans is rare and usually fatal. It is well established that B. mandrillaris can cause granulomatous amebic encephalitis (GAE). However, little is known about the factors that determine B. mandrillaris pathogenicity and its host-specific interactions. Methods In this study, we conducted a cohort study of five patients with B. mandrillaris GAE and analyzed immune pathway alterations, differentially expressed genes (DEGs), and changes in immune cell composition to delineate the immune response in this rare infectious disease using bulk transcriptome analysis. Notably, we conducted bulk and single-cell transcriptome sequencing on paired cerebrospinal fluid (CSF) and blood samples from a single patient across three distinct stages of infection. Results Analysis of seven CSF specimens revealed a total of 5,177 DEGs as the infection progressed. The most enriched pathway among the upregulated DEGs was the “PI3K-Akt signaling pathway”. Moreover, its upstream pathways, the “Toll-like receptor (TLR) signaling pathway” and “JAK/STAT signaling pathway”, were also upregulated. Among these, TLR2, TLR9, and IFN-I/III-related genes played a crucial role in activating these pathways. The single-cell transcriptome results served to validate these findings. Disscusion Overall, our study aimed to elucidate the pathogenic mechanisms underlying B. mandrillaris GAE, providing novel insights into the associated immune responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d7019a6fdd2a06a1fda2257cd2d7dbf2a6e7bcaa" target='_blank'>
              Bulk and single-cell transcriptome profiling reveals the dynamic immune response in granulomatous amebic encephalitis caused by Balamuthia mandrillaris: a cohort study
              </a>
            </td>
          <td>
            Jingjia Zhang, Xinmiao Jia, Bin Yang, Ying Ge, Wei Jiang, Yang Cong, Huanwen Wu, Huifang Liu, Jingjing Tian, YingChun Xu, Qiwen Yang
          </td>
          <td>2025-10-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="As primary immune sentinels of the central nervous system (CNS), microglia respond rapidly to acute brain injury and engage in dynamic crosstalk with infiltrating peripheral immune cells. This interplay critically shapes the neuroinflammatory microenvironment—a key determinant of secondary brain injury (SBI) following intracerebral hemorrhage (ICH). Fatty acid-binding protein 4 (FABP4), an adipokine associated with metabolic disorders, is recognized as a pivotal modulator of inflammatory responses; however, its role in ICH-induced SBI remains undefined. To investigate the pathogenic functions of FABP4 in microglia after ICH, elucidate its molecular mechanisms, and develop targeted therapeutic strategies. Blood and brain tissue samples from ICH patients were analyzed to evaluate the relationships between FABP4 expression and prognosis. Behavioral tests, Nissl staining, and Golgi-Cox staining were used to quantify neuronal damage. Immunofluorescence and flow cytometry were used to assess microglial activation and immune cell infiltration. Transcriptomic, proteomic, co-immunoprecipitation, western blotting, and ChIP‒qPCR analyses were used to examine the FABP4 regulatory network. Brain-targeted nanoparticles were engineered to deliver FABP4-specific siRNA. Clinical analyses revealed microglia-specific FABP4 upregulation in ICH patients, correlating with poor neurological outcomes. Microglial Fabp4 knockout in mice attenuated neuronal loss, ameliorated cerebral edema, and enhanced functional recovery after ICH. Mechanistically, FABP4 promoted lipid droplet accumulation and inhibited the ubiquitin–proteasome-mediated degradation of S100A9 in microglia, synergistically amplifying neuroinflammation. Moreover, the activity of FABP4 in microglia facilitated neutrophil transendothelial migration into the brain parenchyma, exacerbating injury via the release of neutrophil extracellular traps (NETs). Finally, pharmacological FABP4 inhibition using brain-targeted nanoparticles conferred significant neuroprotective effects in ICH models. This study establishes that FABP4 acts as a novel orchestrator of post-ICH neuroinflammation through dual enzymatic and nonenzymatic pathways. We also demonstrate a targeted nanotherapeutic strategy to suppress FABP4 and improve neurological outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cbd6afea19f2780d62b43438f150276eb07542a8" target='_blank'>
              Fatty acid-binding protein 4 drives microglia-mediated neuroinflammation through promoting S100A9 expression and lipid droplet accumulation after intracerebral hemorrhage
              </a>
            </td>
          <td>
            Jiaqing He, Zijuan Qin, Haixiao Liu, Yaning Cai, Hao Wu, Tinghao Wang, Qing Hu, Yanni Xu, Pan Yang, Xun Wu, Yan Qu, Wei Guo
          </td>
          <td>2025-11-07</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Recent advances in single-cell transcriptomics have led to the identification of disease-associated microglia (DAM) as a distinct, conserved microglia state associated with mouse models of Alzheimer’s disease (AD) and amyotrophic lateral sclerosis, and with aging. DAM are characterized by downregulation of homeostatic genes and upregulation of lipid metabolism and phagocytosis genes, including key risk factors for AD in humans. Although characterized in models of AD, whether DAM acts as universal sensor across all neurodegenerative diseases remains unknown. This Essay discusses the dynamics, origins, and therapeutic potential of DAM in neurodegeneration, alongside evidence supporting a protective role for them in regulating disease processes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5bad4366689126c5807b6043f573a793e1757f43" target='_blank'>
              Disease-associated microglia in neurodegenerative diseases: Friend or foe?
              </a>
            </td>
          <td>
            Yi-Hsuan Cheng, Margaret S. Ho
          </td>
          <td>2025-10-01</td>
          <td>PLOS Biology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="COVID-19 has been a major public health concern for the past five years. While remarkable work has been done to develop therapies, there is still a need for more treatments to fight this disease. Recently, it was suggested that nisin, an FDA-approved antimicrobial compound, may interfere with SARS-CoV-2 entry into host cells. Here, we show that nisin does not inhibit SARS-CoV-2 replication in vitro. Surprisingly, nisin treatment leads to reduced host-cell death during infection in a dose-dependent manner, suggesting that nisin may mitigate SARS-CoV-2-induced pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7881f15a54d611593c884757932bc6e4b297393" target='_blank'>
              The antimicrobial peptide nisin promotes host cell survival during SARS-CoV-2 infection
              </a>
            </td>
          <td>
            B. English, A. Radaic, Ross Barrios-Medina, Kerui Lin, P. Kamarajan, Anita Sil, Yvonne L. Kapila
          </td>
          <td>2025-10-01</td>
          <td>Virology Journal</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Immunosuppressive therapies used in clinics to reduce the risk of rejection in transplanted patients unfortunately also decrease the response of the immune system to the pathogens. Previous data has shown that the most diffuse SARS-CoV-2 variants of concern between 2020 and 2021 showed a different modulation of the host immune response in healthy subjects, with the Delta B.1.617.2 variant leading to a failure in the activation of the adaptive immune response. In this study, the transcriptomic profiles of monocyte-derived macrophages (MDM), isolated from four immunosuppressed kidney transplant patients and exposed to SARS-CoV-2 VOCs, were analyzed and compared with previously published data gathered from immune-competent subjects. Human monocytes were isolated from peripheral blood mononuclear cells (PBMCs) of four kidney transplant patients admitted to the IRCCS Policlinico San Matteo of Pavia (Italy), differentiated into macrophages, and exposed to the active and the UV-inactivated particles of the different SARS-CoV-2 VOCs (D614G, Alpha B.1.1.7, Gamma P.1, Delta B.1.617.2 and Omicron BA.1). Bulk RNA-Seq was performed and significant transcripts were assessed based on Student’s t-test (p-value < 0.05) and Fold change > 2. RNA-Seq data analyses of immunosuppressed MDMs showed that SARS-CoV-2 VOCs, although transcriptionally active, did not induce strong alterations in the transcriptomic profiles of these cells, while a strong down-regulation of key genes involved in the innate immunity pathways was observed when comparing these data to the ones obtained from immunocompetent participants. Overall, this study suggests that patients under immunosuppressive therapies do have an altered macrophage response to SARS-CoV-2 viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/04f26f9af852ab5923f6e34e833030407d8ac128" target='_blank'>
              Attenuated Molecular Response to SARS-CoV-2 in MDMs Isolated from Immunosuppressed Transplanted Patients
              </a>
            </td>
          <td>
            Roberta Vazzana, J. Sammartino, N. Cuscino, Roberto Giambruno, C. Carcione, V. Miceli, Matteo Bulati, Valentina Agnese, D. Lilleri, P. Conaldi, Fausto Baldanti, I. Cassaniti, Alessia Gallo
          </td>
          <td>2025-10-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="Mpox virus (MPXV), a member of the Orthopoxvirus genus in the Poxviridae family, has long been endemic in Africa. The interaction between MPXV infection and peripheral immune responses is of great significance. However, the activation of signaling pathways and molecular changes in peripheral blood mononuclear cells (PBMCs) following MPXV infection remain poorly understood. This study evaluated the transcriptomic profiles of rabbit PBMCs during the mpox acute and recovery phases. The results showed that MPXV infection significantly altered the transcriptomic profiles of PBMCs. At 6 days post-infection, pathways related to pathogenic infection and IL-1 response were enriched, while at 14 days post-infection, the T cell receptor signaling pathway was enriched. During the mpox acute phase, inflammatory cytokines in serum such as IL-1α, IL-1β, IL-8, and IL-21 were upregulated, while MMP-9 and NCAM-1 were downregulated. In rabbits and rhesus monkeys, key genes upregulated in common during the mpox acute period were associated with the interferon pathway (e.g., the ISG15, OAS, and IFIT families), while downregulated genes were related to B-cell activation and differentiation (e.g., the MS4A1 and FCRL families). Additionally, rabbits developed protective immunity against reinfection, with neutralizing antibodies effectively activated. These findings provide insights into the molecular characteristics of PBMCs changes in in vivo models of MPXV infection, and offer references for the diagnosis, vaccine development, and therapeutic research of mpox.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a49c159e81a5446db89fd6f6f36a9c258007cfb" target='_blank'>
              Transcriptome Analysis Reveals Host Peripheral Blood Mononuclear Cells Response to Mpox Virus Infection
              </a>
            </td>
          <td>
            Chaode Gu, Caiyun Wang, Chenlu Zhang, Jie Ni, Yun Xia, Hongwei Wang
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="ABSTRACT Microglia, the brain's resident immune cells, are crucial for maintaining healthy brain homeostasis. However, as the brain ages, microglia can shift from a neuroprotective to a neurotoxic phenotype, contributing to chronic inflammation and promoting neurodegenerative processes. Despite the importance of understanding microglial aging, there are currently few human in vitro models to study these processes. To address this gap, we have developed a model in which human microglia undergo accelerated aging through inducible progerin expression. HMC3‐Progerin cells display key age‐related markers such as activation of the senescence‐associated secretory phenotype (SASP) as well as an increase in DNA damage. These prematurely aged HMC3 cells show a reduced response to LPS activation, exhibit impairments in essential microglial functions including decreased migration and phagocytosis as well as transcriptomic alterations including a shift observed in aging and neurodegeneration. Additionally, we observed an impaired stress response and a defect in nucleocytoplasmic transport, especially affecting the amyotrophic lateral sclerosis (ALS) associated protein FUS. This suggests that microglia play a contributory role in driving neurodegenerative processes in the aging brain. Our microglia aging model offers a valuable tool for exploring how aged microglia affect brain function, enhancing our understanding of their role in brain aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e3072179b677f46381c7a4cc1f169fadcbf7341d" target='_blank'>
              Prematurely Aged Human Microglia Exhibit Impaired Stress Response and Defective Nucleocytoplasmic Shuttling of ALS Associated FUS
              </a>
            </td>
          <td>
            Christiane Hartmann, Christina Haß, Muriel Knobloch, Israel Barrantes, Laura Fumagalli, Jessie Premereur, Franz Markert, Maite Peters, Georgia Koromila, Alexander Hartmann, Kathrin Jäger, Jette Abel, Renzo Mancuso, Alexander Storch, Michael Walter, Georg Fuellen, Andreas Hermann
          </td>
          <td>2025-09-19</td>
          <td>Aging Cell</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Understanding Alzheimer’s disease (AD) at the cellular level requires insights into how diverse cell types respond to hallmark pathologies, including amyloid plaques and tau aggregates. Although single-cell transcriptomic approaches have illuminated the trajectories of AD progression in both animal models and human brains, they often lack the spatial context necessary to fully comprehend cell–cell interactions and microenvironmental influences. In this review, we discuss recent advances in spatial transcriptomics—integrating both imaging- and sequencing-based methods—that map gene expression within intact brain tissues. We highlight how these technologies have revealed regional heterogeneity and functional diversity among microglia, and their dynamic interactions with astrocytes, neurons, and oligodendrocytes in both aging and AD. Emphasis is placed on the interactions of microglia within the amyloid plaque niche, their contribution to synaptic degeneration, and how aging accelerates microglial and glial activation. By synthesizing findings from AD mouse models and physiologically characterized human tissues, we provide a comprehensive view of the cellular interplay driving AD pathogenesis and offer insights into potential therapeutic avenues.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72aed1e9c6c402508fd3f06875f598180ad2a5a8" target='_blank'>
              Microglia networks within the tapestry of alzheimer’s disease through spatial transcriptomics
              </a>
            </td>
          <td>
            Yi Zhou, Christopher K. Glass
          </td>
          <td>2025-09-29</td>
          <td>Molecular Neurodegeneration</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6db7c438373e1be32f3e8f8962c7eb002d2e0ff" target='_blank'>
              Single-cell profiling reveals that dynamic lung immune responses distinguish protection from susceptibility to tuberculosis
              </a>
            </td>
          <td>
            Fergal J. Duffy, M. L. Neal, Courtney R. Plumlee, Sarah Cohen, B. Gern, A. Diercks, Michael Y Gerner, K. Urdahl, J. Aitchison
          </td>
          <td>2025-10-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="ABSTRACT Salmonella enterica serovar Typhi (S. Typhi) is a major bacteria responsible for foodborne illnesses. Understanding the temporal dynamics of the host immune response and associated metabolic reprogramming is crucial for identifying potential therapeutic targets. This study employed an integrated transcriptomic and metabolomic approach to investigate the response of macrophages infected with S. Typhi over a defined stage (0 h, 2 h, 4 h, 8 h, and 24 h). RNA sequencing (RNA-seq) was used to profile gene expression changes, while untargeted metabolomics characterized metabolic shifts. Gene set enrichment and pathway analyses were conducted to identify key immune and metabolic pathways. Additionally, Convergent Cross-Mapping (CCM) analysis was applied to uncover causal relationships between gene expression and metabolite fluctuations. Transcriptomic revealed distinct temporal phases of immune activation. Early responses were dominated by interferon signaling, cytokine production, and inflammatory responses, whereas later stages involved sustained immune signaling and metabolic adaptation. Key pathways, including NF-κB, TNF, and cytokine-cytokine receptor interactions, were significantly enriched. Metabolomic profiling demonstrated a transition from glycolysis and amino acid metabolism in early infection stages to fatty acid oxidation and mitochondrial function in later stages, with glutathione metabolism playing a central role in oxidative stress regulation. CCM analysis identified critical genes (e.g. RGS4, KIF18A, RSPO1) exhibiting strong causal relationships with metabolic alterations, underscoring the tight integration between immune and metabolic responses. This study provides a comprehensive, time-resolved view of S. Typhi infection, highlighting dynamic immune activation and metabolic reprogramming in macrophages. These findings advance our understanding of host-pathogen interactions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/26664a9ee0bf4865b5b007f8a9fececba555c250" target='_blank'>
              Temporal dynamics of macrophage activation during Salmonella enterica serovar Typhi infection: An integrated transcriptomic and metabolomic analysis
              </a>
            </td>
          <td>
            Fanfan Yang, Yuhui Liu, Ying Zhang, Dandan Wei, Zhongyi Xie
          </td>
          <td>2025-09-19</td>
          <td>Virulence</td>
          <td>1</td>
          <td>4</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) exhibits progressive cognitive decline and recent scientific studies hint to the peripheral immune system as a contributor. In this study, we isolated peripheral immune cells including CD4 + and CD8 + T cells, CD14 + monocytes and CD19 + B cells from AD patients and age-matched controls via fluorescence-activated cell sorting. Label-free LC–MS/MS-based proteomic expression analysis within each cell type, comparing AD and control groups independently, 387 significantly altered proteins were identified in CD4 + and 121 in CD8 + T cells. Bioinformatic analysis uncovered distinct, cell-type-specific signatures: CD4 + cells showed dysregulation in ribosomal and RNA-binding proteins linked to neurodegeneration and oxidative stress while CD8 + cells showed elevated glycolytic enzyme expression and hyperpolarized mitochondrial membrane potential. Furthermore, mitochondrial functional assays, JC-1 and MitoSOX Red, further supported cell-type-dependent differences in mitochondrial activity. These findings may suggest that peripheral T cells have unique proteomic and functional alterations in AD, implicating mitochondrial dysfunction as a potential contributor to disease pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6b4b7f807e9ebfedbb7659f0f9fe80a617bdd792" target='_blank'>
              Proteomic signatures and mitochondrial dysfunctions in peripheral T cells reveal novel ınsights into Alzheimer’s disease
              </a>
            </td>
          <td>
            Sebile Koca, I. Kiris, Şevki Şahin, S. Karşıdağ, N. Çınar, A. Baykal
          </td>
          <td>2025-11-06</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1185bf27cd38b33e534c27d9aa87381e2cd898fa" target='_blank'>
              Impaired IFNγ responsiveness of monocyte-derived lung cells limits immunity to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Weihao Zheng, J. Limberis, Zachary P. Howard, Alexander Mohapatra, Enzo Takagi, J. Ernst
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2fef0ecf5b990a10a1f0fae7554cfa28ceb163d2" target='_blank'>
              SARS-CoV-2-induced damage to rat cortical neuronal networks ex vivo is mediated by the pro-inflammatory activation of the cGAS-STING pathway.
              </a>
            </td>
          <td>
            Pamela Martinez-Orellana, Matteo Manzati, Diletta Pozzi, Yingying Xiao, Alessio Di Clemente, Marika Mearelli, Chiara Kalebić, Valentina Perrera, Denise Ferrarini, Tea Carletti, Carmen Falcone, Michele Giugliano, Alessandro Marcello
          </td>
          <td>2025-10-25</td>
          <td>Journal of neurovirology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7a8f96a2324d1327914a92bba9009e04dbf070e" target='_blank'>
              Persistent Activation of Monocytes/Macrophages and Cell Senescence in SIV-Infected Macaques on ART
              </a>
            </td>
          <td>
            Yilin Chen, Xiaofeng Ding, Sonalika Ray, Siva Thirugnanam, Robert V. Blair, Ahmad Saied, S. Sukhanov, J. Kolls, , Patrice Delafontaine, Jay Rappaport, Xuebin Qin, Namita Rout
          </td>
          <td>2025-11-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Background: The COVID-19 pandemic prompted investigation into the interaction between SARS-CoV-2 infection and immune checkpoint inhibitor (ICI) therapy in lung cancer patients. Understanding this interplay is crucial for optimizing cancer immunotherapy. Methods: A retrospective analysis was conducted on lung cancer patients, characterizing changes in peripheral immune cells and plasma cytokines (including IL-10 and IL-12p70) before, during, and after SARS-CoV-2 infection. Progression-free survival (PFS) was compared between ICI-treated patients with and without COVID-19. Cytokine dynamics were further analyzed in a non-infected cohort. Results: SARS-CoV-2 infection induced a prolonged systemic cytokine storm, with elevated IL-10 and IL-12p70 levels and reduced monocyte proportions lasting up to 10 weeks post-recovery. Despite this immune perturbation, COVID-19 did not impair long-term PFS; instead, a transient improvement in disease control was observed in infected patients. In non-infected patients, sustained or increased IL-10 and IL-12p70 levels during ICI therapy were associated with longer PFS (p < 0.05). Conclusions: SARS-CoV-2 infection transiently alters the immune landscape in lung cancer patients without compromising ICI efficacy. The sustained elevation of IL-10 and IL-12p70 may contribute to short-term clinical benefits. Monitoring cytokine dynamics could serve as a prognostic tool for predicting ICI response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/751116a96b162ead6a92605da6ef16112bc11bf9" target='_blank'>
              SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes
              </a>
            </td>
          <td>
            Yanjing Peng, Panjian Wei, Meng Gu, Guirong Wang, Teng Ma, Jinjing Tan
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Introduction Neuroinflammation is a critical factor contributing to secondary brain injury following traumatic brain injury (TBI). This process engages diverse cell types within the central nervous system (CNS), including significant infiltration of myeloid lineage cells–primarily neutrophils and macrophages–during the acute and subacute phases of TBI. These myeloid-derived cells represent a major population that critically influences the development and progression of neuroinflammation. Microglia and peripherally infiltrating macrophages exhibit polarization phenotypes that play a pivotal role in modulating inflammatory changes. Due to their functional and phenotypic similarities, their distinct contributions to the inflammatory response in TBI remain a subject of considerable debate. Lysozyme 2 (Lyz2) is a well-established marker for myeloid lineage cells (including monocytes, macrophages, and neutrophils) in mice, allowing specific targeting and depletion of these cells to dissect their functional roles in TBI. Methods In the present study, we investigated the trend of inflammatory factors during the early stage of TBI using Lyz2-IRES-DTREGFP transgenic mice, which specifically target and deplete Lyz2-positive myeloid cells. Tissue samples for RT-qPCR and flow cytometry were harvested from the perilesional cortex (within a 2-mm radius of the impact site) and the underlying hippocampus. Results and discussion Our findings revealed a considerable reduction in the expression of pro-inflammatory factors (e.g., IL-1β, iNOS, IL-6, IFN-γ) and an increase in the expression of anti-inflammatory factors (e.g., IL-4, IL-10, IL-13, Arg-1). Furthermore, we observed a shift in polarization phenotypes, characterized by a decreased proportion of M1 macrophages and an increased proportion of M2 macrophages. However, during the chronic phase, behavioral and histological analyses revealed worse outcomes. These findings demonstrate that targeted depletion of Lyz2-positive myeloid cells during acute TBI attenuates neuroinflammation. However, this early immunomodulatory shift correlates paradoxically with exacerbated chronic neurological deficits, suggesting that transient suppression of myeloid-driven inflammation may disrupt long-term reparative processes critical for functional recovery after TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2b62a25efa9a7379563b95a2c6aaa7cdabd0939" target='_blank'>
              Dual role of Lyz2-positive myeloid cells in traumatic brain injury: acute anti-inflammatory effects vs. chronic neurological deterioration
              </a>
            </td>
          <td>
            Hua-Zheng Yan, Yi-Wan Fang, Shi-Yu Zhou, Jian-Xiong Gao, Ming-ming Bian, Yao-Mei Xu, Lin Zhang, Nan Zhang, He-Zuo Lü
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Cellular Neuroscience</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/17651de6c46a00b78395437afc40e239fdbc6f6f" target='_blank'>
              Neonatal Microglia and Their Secretome as Mediators of Brain Repair
              </a>
            </td>
          <td>
            Gabriela Lyszczarz, Eydís Sigurðardóttir Schiöth, A. Benmamar-Badel, Dominika Rusin, David Ramonet, Marco Anzalone, Thalissa Caers, Lejla Vahl Becirovic, Kirstine Nolling Jensen, S. G. Verberk, Fleur Mingneau, Martyna Makowska, Kate Lykke Lambertsen, Amy F. Lloyd, Jerome J. A. Hendriks, Agnieszka Wlodarczyk
          </td>
          <td>2025-09-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Long COVID (LC) is characterized by a wide range of symptoms, the causes of which remain unclear. We investigated associations between inflammatory and coagulation factors, adaptive immune response to SARS-CoV-2, and LC. We enrolled 196 unvaccinated individuals with SARS-CoV-2 (March–June 2020). Blood samples were collected at three (T3M) and twelve (T12M) months post infection. Plasma concentrations of coagulation factors (D-Dimer, E-Selectin, ICAM-1, VCAM-1) and inflammatory markers (IL-6, IL-8, TNF-α, IL-1β) were measured by ELISA, and SARS-CoV-2-specific T-cell response was assessed by Elispot. LC occurred in 66/196 patients (34%); 77.8% had been hospitalized. Respiratory symptoms were present in 54%, fatigue in 30%, and neuropsychological symptoms in 14%. At T3M, hospitalized patients exhibited higher levels of ICAM-1, VCAM-1, and IL-6, along with increased immunoreactivity. LC patients exhibited elevated IL-8 and TNF-α and enhanced immunoreactivity at T3M, though these differences were not observed at T12M. Inflammatory and coagulation markers were altered at three months after acute infection, with some changes persisting at one year, suggesting a long-term immunological impact of SARS-CoV-2 on the inflammatory response. A SARS-CoV-2-specific T-cell response was still detectable at T12M, albeit at a lower level than at T3M, suggesting the persistence of protective memory T-cells beyond the acute phase.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/661662040cb49d22a81b08c21000921af6c27b9d" target='_blank'>
              Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects
              </a>
            </td>
          <td>
            E. Cimini, A. Vergori, C. Cimaglia, Eleonora Tartaglia, S. Notari, F. Colavita, G. Matusali, I. Mastrorosa, V. Mazzotta, P. Chinello, P. Mencarini, M. L. Giancola, A. Abdeddaim, R. Casetti, G. Grassi, Simona Gili, Flavia Cristofanelli, F. Maggi, P. Piselli, E. Girardi, A. Antinori, M. Camici
          </td>
          <td>2025-10-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="SARS-CoV-2, the virus behind the COVID-19 pandemic, is primarily a respiratory pathogen, with host entry mediated by the ACE2 receptor that determines viral tropism. Notably, in humans, ACE2 is highly expressed in the gastrointestinal (GI) tract, particularly the small intestine (SI), prompting us to examine GI infectivity of SARS-CoV-2 variants of concern (VOCs). We found that ACE2 expression in Syrian hamsters closely resembles humans, supporting their use in studying GI tropism. Using this model, we compared infection and pathology of the ancestral Wuhan-like strain (Hong Kong), Delta, and Omicron variants. Despite high ACE2 expression, GI infection and pathology were generally low relative to the respiratory tract. However, the Delta variant showed markedly enhanced GI infectivity and pathology, especially in the SI, and caused the greatest disruption of the gut microbiome. These findings link SARS-CoV-2 virulence with GI infection and microbiome disturbance, establishing Syrian hamsters as a relevant model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/77df6d4abd298647386ce524f503a92d8f222d56" target='_blank'>
              Gut infection and dysbiosis are hallmarks of severe SARS-CoV-2 variants
              </a>
            </td>
          <td>
            S. K. Nagaraj, Christy M. Joy, Rishad Shiraz, R. Narayan, Sumandeep Kaur, Oyahida Khatun, Sagar Dubey, James Ng, N. Mishra, Shashank Tripathi
          </td>
          <td>2025-10-24</td>
          <td>npj Viruses</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/313fedd146b7503db4be885b70aaa8b04e759604" target='_blank'>
              A data-driven model of macrophage polarization states reveals an IFN macrophage signature in active Crohn’s disease
              </a>
            </td>
          <td>
            Sarina C. Lowe, Madelaine Leitman, Noah Yan, Alexander Hoffmann
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="
 Background:
 SARS-CoV-2 and influenza infections are associated with an increased risk of cardiovascular events. While the underlying mechanisms remain incompletely defined, mounting evidence points towards endothelial dysfunction and thrombotic activation, caused either directly or indirectly by viral infection.


 Aims:
 We sought to characterise the temporal effects of mild SARS-CoV-2 and H3N2 influenza infection on plasma biomarkers of endothelial, thrombotic and renal function.


 Methods:
 Plasma samples were collected from healthy volunteers enrolled in SARS-CoV-2 (n=7-10) and H3N2 (n=7-11) human challenge studies. Samples were taken at baseline (day 0/–1) and at days 3, 7, 10, 14, and 28 post-inoculation. Commercial ELISAs/colorimetric assays were used to quantify endothelial dysfunction using biomarkers of endothelial-mediated vasomotor control (endothelin-1, nitrate/nitrite, prostacyclin, ADMA, arginine), thrombosis (sCD40L, P-selectin, PSGL-1, tPA, PAI-1, D-dimer, factor IX), and renal function (uromodulin, NGAL, cystatin C, TFF3, OPN). One-way ANOVA, or a mixed effects model, and Dunnet’s test to correct for multiple comparisons, were used to compare baseline biomarker levels with levels at subsequent timepoints.


 Results:
 Infection with SARS-CoV-2 significantly increased thrombosis biomarkers (Figs. 1&2): P-selectin (p=0.025), PSGL-1 (p=0.024), sCD40L (p=0.048), PAI-1 (p=0.008) and tPA (p=0.006&0.008) at days 7 to 14. In contrast, infection with H3N2 resulted in a significant increase in D-dimer levels at day 14 (p=0.025) and no changes in other biomarkers of thrombosis. No changes from baseline were detected in biomarkers of endothelial dysfunction in either group. Uromodulin levels declined by day 28 in the SARS-CoV-2 group (p=0.034), otherwise no changes in biomarkers of renal function were noted in either group.


 Conclusions:
 There are two striking results of this study. Firstly, that for both H3N2 and SARS-CoV-2 infection, it was markers of platelet activation/thrombosis, without changes in endothelial or renal function, that increased after infection. Secondly, that a broader spectrum of these markers was increased in volunteers infected with SARS-CoV-2. These findings suggest distinct thrombotic mechanisms are activated by SARS-CoV-2 and H3N2 and support further investigation of thrombotic profiles in patients infected with other respiratory viruses allowing for strategies to identify and mitigate associated cardiovascular events.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/107604fa6ee17ee4f404ea6d1e3e14fcc6268770" target='_blank'>
              Abstract 4367854: The impact of viral infection with SARS-CoV-2 and influenza on plasma endothelial, thrombotic and renal biomarkers
              </a>
            </td>
          <td>
            Ahmed Bakr, Helen Wagstaffe, L. Papargyris, R. Vaja, Christopher Chiu, N. Kirkby, Jane A Mitchell
          </td>
          <td>2025-11-04</td>
          <td>Circulation</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Introduction COVID-19 has caused over 7 million deaths worldwide since its onset in 2019, and the virus remains a significant health threat. Identifying sensitive and specific biomarkers, along with elucidating immune-mediated mechanisms, is essential for improving the diagnosis, treatment, and prevention of COVID-19. To predict key molecular markers of COVID-19 using an established multi-omics framework combined with machine learning models. Methods We conducted an integrated analysis of single-cell RNA sequencing (scRNA-seq), bulk RNA sequencing, and proteomics data to identify critical biomarkers associated with COVID-19. The multi-omics approach enabled the characterization of gene expression dynamics and alterations in immune cell subsets in COVID-19 patients. Machine learning techniques and molecular docking analyses were employed to identify biomarkers and therapeutic targets within the disease’s pathophysiological network. Results Principal component analysis effectively grouped samples based on clinical characteristics. Using random forest and SVM-RFE models, we identified clinical indicators capable of accurately distinguishing COVID-19 patients. Transcriptomic analysis, including scRNA-seq, highlighted the pivotal role of CD8+ T cells, and WGCNA identified related module genes. Proteomic analysis, integrated with machine learning, revealed 36 DEPs. Further investigation identified several genes associated with monocyte proportions. Correlation analysis showed that BTD, CFL1, PIGR, and SERPINA3 were strongly linked to CD8+ T cell abundance in COVID-19 patients. ROC curve analysis demonstrated that these genes could effectively distinguish between COVID-19 patients and healthy individuals. Concordant findings from both transcriptomic and proteomic levels support BTD, CFL1, PIGR, and SERPINA3 as potential auxiliary diagnostic markers. Finally, AlphaFold-based molecular docking analysis suggested these biomarkers may also serve as candidate therapeutic targets. Discussion Preliminary findings indicate that BTD, CFL1, PIGR, and SERPINA3 are vital molecular biomarkers related of CD8+ T cell, providing new insights into the molecular mechanisms and long-term prevention of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c267a410d7788bd337a76f2dc6c4f824689a5545" target='_blank'>
              Multi-omics and machine learning identify novel biomarkers and therapeutic targets of COVID-19
              </a>
            </td>
          <td>
            Yumei Zhou, Pengbei Fan, Haiyun Zhang, Shuai Han, Ming-hua Bai, Ji Wang, Qi Wang
          </td>
          <td>2025-10-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Adipocytes can be infected by SARS-CoV-2, potentially contributing to the obesity-associated severity of COVID-19. Circumstantial evidence points to angiotensin-converting enzyme 2 (ACE2) as the necessary receptor for adipocyte infection, but this has not been demonstrated experimentally. Using differentiated immortalized human preadipocyte lines that we developed, we found that visceral adipocytes express higher levels of ACE2 and are more susceptible to SARS-CoV-2 spike (S)-mediated luciferase-VSV infection than subcutaneous adipocytes. Overexpression of ACE2 significantly increased infection, whereas knockout of ACE2 significantly decreased S-mediated infection. Visceral adipocytes at baseline were susceptible to infection by SARS-CoV-2 (Delta variant); however, increased levels of viral transcript with time were not apparent. ACE2 knockout significantly decreased the susceptibility of visceral adipocytes to SARS-CoV-2, whereas overexpression of ACE2 resulted in increased SARS-CoV-2 infection and was associated with increased viral transcript levels with time, as well as induction of IL6, a marker of the proinflammatory response. Our results demonstrate that ACE2 confers susceptibility to SARS-CoV-2 infection of visceral adipocytes. Higher levels of ACE2 in these cells may play a role in establishment of infection and a proinflammatory response, potentially leading to pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/02642fcf5cb0da22d039410a9d363e14d3e80030" target='_blank'>
              ACE2-Mediated Infection of Immortalized Human Visceral Adipocytes by SARS-CoV-2
              </a>
            </td>
          <td>
            Francoise Gourronc, Megan I. Ahmann, Michael R. Rebagliati, Aloysious Klingelhutz
          </td>
          <td>2025-09-27</td>
          <td>Viruses</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="ABSTRACT In vitro studies have repeatedly showed that extracellular vimentin (eVIM) promotes the penetration of viruses by acting as an adhesion factor, suggesting that reducing eVIM density in the blood could be an effective approach to treat viral infections. However, despite solid evidence, it has not been previously investigated whether eVIM plays a pathogenic role during viral infections in vivo experiments. Here, we provide in vivo evidence that eVIM plays a critical role during viral infections. The severity of COVID-19 in Roborovski SH101 hamsters was positively correlated with blood concentrations of eVIM during the infection period. The reduction of blood eVIM in the SARS-CoV-2-infected Roborovski SH101 hamster through intravenous injection of hzVSF-v13, a humanized anti-eVIM monoclonal antibody, dramatically improved disease manifestations, such as body weight reduction, body temperature, death rate, and more. It also inhibited the formation of blood clots and systemic inflammation compared to remdesivir or a SARS-CoV-2 neutralizing antibody (6D11F2). Histological examination confirmed the significantly better therapeutic efficacy of anti-eVIM compared to remdesivir or the neutralizing antibody. Quantification of SARS-CoV-2 in the hamsters’ lungs revealed that the viral titer in the anti-eVIM-treated groups was 77% to 80% lower than that in the infection group, while remdesivir and the neutralizing antibody resulted in reductions of 41.9% and 34.7% to 44.1%, respectively. We believe that this work provides a foundation for the development of hzVSF-v13 as an antiviral drug for COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4aeac131b55b918a235c7cedc73efe1a44e4a271" target='_blank'>
              Reduction of extracellular vimentin in blood provides protection against SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Hae-Mi Kim, Mingda Wang, Chongkai Zhai, Sura Kim, Jungha Park, Seong-Tshool Hong
          </td>
          <td>2025-10-07</td>
          <td>Virulence</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e63b1279f51d73cda78726f8cc10b215549aa1ac" target='_blank'>
              NK cells undergo transcriptional and functional reprogramming following Streptococcus pneumoniae infection
              </a>
            </td>
          <td>
            Júlia Torné, Claudia Chica, Tiphaine Camarasa, Bernd Jagla, Matilde Diaz Enes, Aymeric Zellner, S. Mella, V. Libri, M. Hamon
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="A certain degree of self-repair is initiated following spinal cord injury (SCI). Although intraneuronal regeneration and a supportive growth environment are limited, they serve as the foundation for functional recovery after SCI. In this study, we conducted single-cell RNA sequencing combined with spatial transcriptomics and spatial metabolomics to reveal the spatial molecular characteristics of self-repair processes after SCI at single-cell resolution. We identified three cell subsets-Mic2 (a microglia subset), Mac4 (a macrophage subset), and Fib4 (a fibroblast subset)-that express markers associated with spinal cord repair. Mic2 and Mac4 exhibit clustered spatial distribution patterns, whereas Fib4 is predominantly located around the injured spinal cord. Additionally, Mic2 is predominantly distributed in the white matter, particularly in the dorsal region of the injured spinal cord, and exhibits high expression of taurine. Mac4 and Fib4 exhibit high expression of copalic acid and uridine, respectively. In this study, we have identified three distinct cell subsets that express markers associated with wound healing and may promote regenerative processes, and we have determined their spatial transcriptional and metabolic features enriched within these regions. Our dataset represents a valuable resource that offers novel mechanistic insights into the pathobiology of spinal cord injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac7f990261ab040d2dcb9732e55fa91a396956f2" target='_blank'>
              Integrating single-cell RNA sequencing and spatial multi-omics reveals the molecular signature of regeneration after spinal cord injury
              </a>
            </td>
          <td>
            Haoru Dong, Yuanqing Ding, Xingyu Chen, Xiao Xiao, Longnian Zhou, Haiyue Lin, Zezhen Zhang, Yiming Tao, Shiyi Cai, Jianlan Zhao, Xiaomu Li, Rong Xie
          </td>
          <td>2025-10-21</td>
          <td>Biomarker Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/42649e5799d217ae2a59e14c7eb9e6893e79caba" target='_blank'>
              Pathogenicity and Transcriptomic Profiling Revealed Activation of Apoptosis and Pyroptosis in Brain of Mice Infected with the Beta Variant of SARS-CoV-2.
              </a>
            </td>
          <td>
            Han Li, Bao-Ying Huang, Gao Qian Zhang, Fei Ye, Li Zhao, Weibang Huo, Zhong Xian Zhang, W. Wang, W. Wang, Xiao Ling Shen, C. Wu, Wen Jie Tan
          </td>
          <td>2025-09-20</td>
          <td>Biomedical and environmental sciences : BES</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Primary open-angle glaucoma (POAG), a leading cause of irreversible blindness, involves complex neurodegeneration in which the contribution of systemic immunity remains enigmatic. Here, we dissect the circulating immune landscape in POAG patients via high-resolution single-cell RNA sequencing of ~1.4 million peripheral blood mononuclear cells (PBMCs) from 110 patients and 110 controls of Chinese ancestry. We revealed significant immune remodeling in POAG, characterized by increased CD4+ T lymphocytes and myeloid cells and impaired cytolytic potential, as evidenced by reduced cell proportions of terminally differentiated CD8+ GZMK+ T cells and NK cells. Transcriptomic analysis revealed a sophisticated dual transcriptional landscape in which both proinflammatory and neuroprotective signaling pathways coexist across multiple immune cell lineages. While TNF and IFNG pathway genes were broadly downregulated, specific inflammatory activation components and neuroprotective genes were upregulated in distinct cell populations, suggesting that POAG represents a complex immunometabolic syndrome characterized by a dysregulated balance between inflammatory and neuroprotective signaling. Cell type-specific eQTL mapping and SMR analysis revealed that POAG genetic risk loci exert their effects through immune gene regulation in specific PBMC subsets. Functional validation using Ifng-/- and Tnf+/- mice in an LPS/NMDA-induced retinal injury model, which mirrored the immune alterations observed in human POAG, demonstrated that genetic deficiency in these pathways markedly exacerbated retinal ganglion cell loss and visual pathway deficits. Our study establishes a crucial link between systemic immune dysregulation—specifically the disrupted balance between inflammatory and neuroprotective signaling—and retinal health, highlighting the importance of restoring this balance for future POAG therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fae6abc08a14880e3feddb70f5fc769e7cfeff07" target='_blank'>
              Single-cell RNA-seq reveals cell type-specific molecular and genetic associations with primary open-angle glaucoma
              </a>
            </td>
          <td>
            Huaping Tian, Yuhong Chen, Tujing Zhao, Lin Ye, Hongjing Li, Zheng Li, Wenqiao Qiu, Wentao Wang, Runze Li, Fulin Liu, Haojue Xue, Ruilin Liao, Chao Qu, Jie Li, Liang Zou, Yi Shi, Zhenglin Yang, Lulin Huang
          </td>
          <td>2025-10-10</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Alveolar macrophages are well known as the first responders to pulmonary cryptococcosis; however, their dynamic molecular responses to Cryptococcus gattii infection in vivo remain limited. Here, we investigated the transcriptional profiles of lung alveolar macrophages purified from mice intranasally infected with C. gattii and compared them to those infected with C. neoformans using RNA sequencing analysis. Alveolar macrophages from C. gattii-infected mice exhibited distinct transcriptional alterations, particularly in genes associated with sterol biosynthesis, whereas those from C. neoformans-infected mice showed enrichment in interferon and cytokine signaling pathways. Treatment with the sterol biosynthesis inhibitor lovastatin significantly reduced cholesterol accumulation in C. gattii-infected RAW 264.7 cells. Furthermore, lovastatin treatment of C. gattii-infected RAW 264.7 and bone marrow-derived macrophages suppressed intracellular cryptococcal proliferation and augmented inflammatory response, as evidenced by increased expression of Nos2 and Il6. Lovastatin also potentiated the antifungal effect of fluconazole by promoting intracellular fungal clearance and increasing nitric oxide activity in macrophages. In C. gattii-infected mice, lovastatin treatment enhanced the efficacy of fluconazole, resulting in improved pulmonary fungal clearance, increased lung CD4 ⁺ T cell numbers, and elevated nitric oxide activity. Collectively, these findings reveal a unique macrophage response to C. gattii infection and highlight the role of sterol metabolism in modulating host defense, offering potential avenues for therapeutic intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/361ffc878c85e98584a1bba17834f9329df4592a" target='_blank'>
              Transcriptomic profiling of lung alveolar macrophages reveals distinct contribution of sterol metabolism in macrophage response to Cryptococcus gattii infection
              </a>
            </td>
          <td>
            Siranart Jeerawattanawart, Adithap Hansakon, Rudi Alberts, Yongliang Zhang, P. Angkasekwinai
          </td>
          <td>2025-09-30</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Cryptococcal meningitis is a fungal infection in patients with compromised CD4 T cell function. CD4 T cells provide killing signals to macrophages, principally IFNγ, to limit intracellular fungal replication. However, CD4 T cells may also drive inflammatory tissue damage. Yet, it is not fully understood how fungal-specific CD4 T cells infiltrate the brain and how they influence functional phenotypes of CNS-resident myeloid cells. In the current work, we develop a mouse model to track fungal-specific CD4 T cells and determine their influence on microglia. We found IFNγ+ fungal-specific CD4 T cells have limited TCR signalling and characterise a population of inflammatory microglia that upregulate MHCII and IFNγ-regulated genes during infection. Inflammatory microglia have poor fungicidal capacity and significantly expand during infection, a process that depends on CD4 T cell infiltration. Taken together, these data identify the early inflammatory consequences of fungal-specific CD4 T cell infiltration and identify proliferating microglia as important drivers of brain inflammation during infection. Cryptococcal meningitis is a common infection in patients with compromised CD4 T cell function. Using a CD4 T cell activation tracking mouse the authors show the localisation and activation of CD4 T cells in the brain after cryptococcus infection and how these cells interact with MHCII expressing microglia which may increase pathologic brain inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37f4633c141c3226368499b170bc53f8df43b779" target='_blank'>
              Brain-infiltrating CD4 T cells drive inflammatory microglia proliferation during cryptococcal meningitis in mice
              </a>
            </td>
          <td>
            Sofia Hain, Man Shun Fu, Lucy Wigg, Lorna S. George, D. Lecky, Alexander J Whitehead, Erin Clipston, Ko Sato, Masahiro Ono, Marcel Wuthrich, Bruce Klein, Kazuyoshi Kawakami, J. Rayes, D. Bending, Rebecca A. Drummond
          </td>
          <td>2025-10-09</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a562ae04ce5e7352d04c04260cd955aebf004a62" target='_blank'>
              Spatial transcriptomics reveals injury-responsive compartments and coordinated immune–fibrotic signaling in ANCA-associated renal vasculitis
              </a>
            </td>
          <td>
            Yucheng Tang, Chunhua Zhu, Shuang Chen, Huimei Chen, Hai Qian, Aihua Zhang, Enrico Petretto
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e514b4570bf137645b9a0af1b1358cbb52f025a0" target='_blank'>
              Microbiota-derived indole metabolites inhibit rotavirus infection in vitro and in vivo and in human infants
              </a>
            </td>
          <td>
            Nurul I. Wirusanti, Yannick van Schajik, Jongchan Kim, Josephine F. Frempong, Nagina Simkhada, Sydney Fisher, Nicholas Pucci, Gonçalo J. Piedade, C. C. Luchen, Mwelwa Chibuye, Michelo Simuyandi, C. Chisenga, Suwilanji Silwamba, Kennedy Chibesa, Bertha T. Nzangwa, Dhvani H. Kuntawala, S. Ramani, Daniel R. Mende, Megan T. Baldridge, Bruno Sovran, Vanessa C. Harris
          </td>
          <td>2025-10-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and immune dysregulation, including expansion of pro-inflammatory monocytes and effector T cells, alongside reduced regulatory T cells (Tregs). Bacillus subtilis natto, a spore-forming probiotic, has shown anti-atherosclerotic effects, though its systemic immunomodulatory mechanisms remain unclear. In this study, we employed an AAV-mPCSK9-induced murine atherosclerotic model to investigate the effects of daily B. subtilis natto NTU-18 administration over 16 weeks. High-dimensional flow cytometry using two 13-marker panels enabled longitudinal profiling of 18 peripheral immune cell subsets across lymphoid and myeloid compartments. While no significant changes in serum cholesterol and mild decrease of body weight were observed, B. subtilis natto NTU-18-treated mice presented a significant reduction in aortic lesion area compared to PBS-treated controls. Immune profiling revealed a transient expansion of peripheral myeloid cells and CD44⁺ trained CD8⁺ T cells, followed by increased frequencies of naïve CD8⁺ T cells and reduced central/effector memory subsets at longer time point treatment. In the CD4⁺ T cell compartment, a transient increase in trained cells was accompanied by a sustained enrichment of CD25⁺CD4⁺ Tregs throughout the daily B. subtilis natto NTU-18 treatment. In contrast, no significant differences were observed in Ly6C⁻ or Ly6C⁺ monocytes, neutrophils, or eosinophils. These findings suggest that B. subtilis natto NTU-18 attenuates atherosclerosis progression not through lipid lowering or broad myeloid modulation, but via targeted reprogramming of peripheral T cell responses. This work provides mechanistic insight into the immunotherapeutic potential of B. subtilis natto NTU-18 in atherosclerosis prevention and treatment. • B. subtilis natto NTU-18 significantly reduces aortic plaque burden in atherosclerotic mice without affecting serum cholesterol levels. • B. subtilis natto NTU-18 induces transient immune remodeling, marked by early expansion of trained CD8⁺ and CD4⁺ T cells, followed by increased naïve and regulatory T cells. • The atheroprotective effect is primarily mediated through adaptive immunity as myeloid subsets remain unchanged throughout B. subtilis natto NTU-18 treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/45dd339de260cb5a70cef21d3c450ab6682f7820" target='_blank'>
              Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations
              </a>
            </td>
          <td>
            Jian-Da Lin, Yu-Zhen Ye, Sin-Ren Wang, Wen-Yi Kao, Kung-Ta Lee
          </td>
          <td>2025-10-17</td>
          <td>Applied Microbiology and Biotechnology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Acute respiratory distress syndrome (ARDS) is a critical condition characterized by diffuse alveolar damage and intense inflammatory responses. During the COVID‐19 pandemic, its incidence and mortality have remained persistently high. Conventional approaches have struggled to uncover the complex cellular heterogeneity and dynamic inflammatory networks underlying ARDS. The advent of single‐cell sequencing technologies has revolutionized our ability to dissect the molecular mechanisms of ARDS. This review systematically summarizes recent advances in the application of single‐cell sequencing in studying pulmonary inflammation in ARDS, with a focus on its strengths in elucidating immune cell heterogeneity, reconstructing intercellular communication networks, and identifying potential therapeutic targets. Furthermore, we discuss current technical limitations and translational challenges, aiming to provide a theoretical foundation and future direction for translating mechanistic insights into precision medicine for ARDS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7061390b06d4776270be5e5161ae41668426e25" target='_blank'>
              Single‐Cell Sequencing Redefines Immune Heterogeneity and Communication Networks in ARDS: Toward Precision Therapeutics
              </a>
            </td>
          <td>
            Han-Bing Chen, Anmin Xu, H. Qiu, Jie Chao, Songyun Zhao
          </td>
          <td>2025-01-01</td>
          <td>International Journal of Genomics</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f1c595bb04b33b2110b0229671f4eef2af24032e" target='_blank'>
              Genome-wide screen in Mycobacterium tuberculosis infected macrophages reveals innate regulation of antibacterial mediators by IRF2
              </a>
            </td>
          <td>
            A. W. Roberts, Linda N. Del Cid, Nick E. Garelis, Jeffery S. Cox
          </td>
          <td>2025-09-29</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>7</td>
        </tr>

        <tr id="Inflammation and excess cytokine release are hallmarks of severe COVID-19. While programmed cell death is known to drive inflammation, its role in SARS-CoV-2 pathogenesis remains unclear. Using gene-targeted murine COVID-19 models, we here find that caspase-8 is critical for cytokine release and inflammation. Loss of caspase-8 reduces disease severity and viral load in mice, and this occurs independently of its apoptotic function. Instead, reduction in SARS-CoV-2 pathology is linked to decreased IL-1β levels and inflammation. Loss of pyroptosis and necroptosis mediators in gene-targeted animals provides no additional benefits in mitigating disease outcomes beyond that conferred by loss of caspase-8. Spatial transcriptomic and proteomic analyses of caspase-8-deficient mice confirm that improved outcomes are due to reduced pro-inflammatory responses, rather than changes in cell death signalling. Elevated expression of caspase-8 and cFLIP in infected lungs, alongside caspase-8-mediated cleavage of N4BP1, a suppressor of NF-kB signalling, indicates a role of this signalling axis in pathological inflammation. Collectively, these findings highlight non-apoptotic functions of caspase-8 as a driver of severe COVID-19 through modulation of inflammation, not through the induction of apoptosis. During SARS-CoV-2 infection caspase-8 fuels harmful inflammation independent of apoptosis. Genetic loss of caspase-8 reduces cytokine levels, lowers viral load and mitigates disease severity, revealing non-apoptotic caspase-8 as a key driver of severe COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5fdd57c7d51f242c164bb60fdb057ec943038a10" target='_blank'>
              Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Stefanie M. Bader, Lena Scherer, Reet Bhandari, Allan J. Motyer, James P. Cooney, Liana Mackiewicz, Merle Dayton, Dylan Sheerin, David V. L. Romero, Jan Schaefer, J. Pang, Siqi Chen, Kael Schoffer, Le Wang, Xinyi Jin, D. Batey, Raymond K. H. Yip, Ishrat Zaman, P. Rajasekhar, Matthew J. Gartner, Stephen Wilcox, Lachlan L Whitehead, S. R. Georgy, Ana Maluenda, Kathryn C. Davidson, C. Allison, R. Bowden, Kerstin Brinkmann, M.-L. Asselin-Labat, B. Phipson, Maria C. Tanzer, Marco J. Herold, A. Samson, J. Vince, Andreas Strasser, Marc Pellegrini, Marcel Doerflinger
          </td>
          <td>2025-11-13</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="ABSTRACT Human cytomegalovirus (HCMV) is a prolific human herpesvirus that infects most individuals by adulthood. While typically asymptomatic in adults, congenital infection can induce serious neurological symptoms, including hearing loss, visual deficits, cognitive impairment, and microcephaly in 10%–15% of cases. HCMV has been shown to infect most neural cells, with our group recently demonstrating this capacity in stem cell-derived forebrain neurons. Infection of neurons induces deleterious effects on calcium dynamics and electrophysiological function paired with gross restructuring of neuronal morphology. Here, we utilize an induced pluripotent stem cell-derived model of the human forebrain to demonstrate how HCMV infection induces syncytia, drives neurite retraction, and remodels microtubule networks to promote viral production and release. We establish that HCMV downregulates microtubule-associated proteins while largely sparing other cytoskeletal elements. Furthermore, we pharmacologically modulate microtubule dynamics using paclitaxel (stabilize) and colchicine (destabilize) to examine the effects on neurite structure, syncytial morphology, and viral release. With paclitaxel, we found improvement of neurite outgrowth, but neither paclitaxel nor colchicine impacted viral titers. Together, these data suggest that HCMV infection-induced disruption of microtubules in human cortical neurons can be partially mitigated with microtubule stabilization, suggesting a potential avenue for future neuroprotective strategies. IMPORTANCE Infection by human cytomegalovirus (HCMV) continues to cause significant damage to human health. In the absence of a vaccine, vertical transmission from mother to fetus can result in profound neurological damage impacting quality of life. These studies focus on understanding the impact of HCMV infection on forebrain cortical neurons derived from induced pluripotent stem cells (iPSCs). We show that infection results in loss of neurite extension accompanied by cell-to-cell fusion. These pathogenic changes involve HCMV infection-mediated disruption of the microtubule network in iPSCs from different patient backgrounds. The microtubule stabilization agent paclitaxel partially protected neurite length and altered syncytia morphology without impacting viral replication. This work is part of our continued efforts to define putative strategies to limit HCMV-induced neurological damage. Infection by human cytomegalovirus (HCMV) continues to cause significant damage to human health. In the absence of a vaccine, vertical transmission from mother to fetus can result in profound neurological damage impacting quality of life. These studies focus on understanding the impact of HCMV infection on forebrain cortical neurons derived from induced pluripotent stem cells (iPSCs). We show that infection results in loss of neurite extension accompanied by cell-to-cell fusion. These pathogenic changes involve HCMV infection-mediated disruption of the microtubule network in iPSCs from different patient backgrounds. The microtubule stabilization agent paclitaxel partially protected neurite length and altered syncytia morphology without impacting viral replication. This work is part of our continued efforts to define putative strategies to limit HCMV-induced neurological damage.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/43ff406a50f0e094bdc2efb44261948bcae00376" target='_blank'>
              HCMV infection of terminally differentiated neurons disrupts microtubule organization, resulting in neurite retraction
              </a>
            </td>
          <td>
            Jacob W. Adelman, Andrew T Sukowaty, Kaitlyn J Partridge, Jessica E. Gawrys, Allison Akins, S. Terhune, Allison D. Ebert
          </td>
          <td>2025-10-08</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d493562d9cbf669c771bb336ea8a59baf52c39a" target='_blank'>
              A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus
              </a>
            </td>
          <td>
            Eden G. TenBarge, Ashley D. Wise, Morgan L. Hetzel, Helene A. Hoover, Helia Esfandiari, Bailey E. Holder, Eva Belevska, Ellie C. Mennen, Sarah R. McDaniel, Nicole M. Vaccaro, Courtney C. Lucca, Jonathan M. Williams, Jennifer Ferris, Timothy E Sparer, Leslie J. Crofford, Jeffry D. Bieber, Andrew J. Monteith
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Parkinson’s disease (PD) is clinically characterized by motor dysfunction, and its pathology primarily involves the progressive loss of dopaminergic neurons. Despite extensive research, the precise etiological mechanisms remain elusive. Recent findings have revealed a significant role of astrocytes in PD onset and progression. However, fully elucidating their function has been challenging because of the heterogeneity of cells and the complexity of the disease progression. Here, we successfully used single-nuclear RNA sequencing to characterize diverse genes expressed by astrocytes and analyzed changes in biological processes in a PD mouse model. Pseudotime analysis (Monocle2) indicated that as PD progressed the status of astrocytes transitioned from immune activation states to neurotoxic subtypes, which correlates with marked upregulation of inflammation-related genes, including Nlrp3 and IL-1β. Furthermore, CellChat analysis demonstrated that BMP signaling exhibited significant specificity in PD, with Bmp6 as the primary ligand and astrocytes as crucial mediators and responders. Thus, we demonstrated that BMP signaling activation in astrocytes exacerbates dopamine neuronal death. Rather, inhibiting BMP signaling in astrocytes significantly improved motor dysfunction and reduced the loss of dopamine neurons in a PD mouse model. Mechanistically, we found that activation of the BMP signaling pathway promoted the release of Nlrp3, IL-1β, and TNF-α, suggesting that increased neuroinflammation aggravated dopaminergic neuronal death. Together, these findings highlight the crucial role of astrocytes in the pathogenesis of PD and reveal a novel cellular mechanism that offers potential therapeutic targets for PD intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb1218eb2ef206119c35fe143ddaae9d52da6a97" target='_blank'>
              Inhibition of astrocyte BMP signaling alleviates neuroinflammation in experimental models of Parkinson’s disease
              </a>
            </td>
          <td>
            Yibo Li, Jiaxin Hao, Wenyu Wang, Zhaowen Su, Xiaofeng Tian, Hongfang Wang, Qing Liu, Jiamin Gao, Dandan Geng, Lei Wang
          </td>
          <td>2025-11-10</td>
          <td>Cell Death Discovery</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c48ccb41d3f252f85b5277e853ac6cb2ae72c91e" target='_blank'>
              Human immune response to primary cryptosporidiosis parallels murine infection models
              </a>
            </td>
          <td>
            Dana M. Van Fossen, Haroldo J. Rodriguez, Farha Naz, Carol A. Gilchrist, Justin J. Taylor, W. A. Petri, Audrey C. Brown
          </td>
          <td>2025-10-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="The Coronavirus disease 2019 (COVID-19) pandemic had a profound global impact, yet children exhibited distinct clinical and epidemiological patterns compared to adults. Pediatric cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were generally characterized by milder disease, lower hospitalization rates, and few long-term sequelae. However, a subset of children developed severe complications such as multisystem inflammatory syndrome in children (MIS-C), highlighting the heterogeneity in disease presentation. Differences in immune system maturity and comorbidities likely contribute to the age-dependent manifestation of SARS-CoV-2 and other respiratory viruses. Persistent SARS-CoV-2 infection, particularly in immunocompromised individuals, has been implicated in the emergence of new viral variants with immune escape characteristics due to ongoing viral replication in the presence of selective pressure. While SARS-CoV-2 evolution in persistently infected adults has been well-documented, it is less clear how the virus evolves during persistent infection in the pediatric population. To address this question, we performed viral whole genome sequencing of longitudinal specimens collected from immunocompetent and immunocompromised pediatric COVID-19 patients. Similarly to what has been observed in adult cohorts, mutations associated with enhanced viral fitness and immune escape arose intra-host over time. Intra-host diversity accumulated at similar rates in immunocompetent and immunocompromised children, though more mutations overall were observed in the immunocompromised cohort due to the longer infection time courses. Overall, we identified similar viral evolutionary trends over the course of infection despite clinical differences in pediatric COVID-19 manifestation and severity. This similarity suggests that persistent infection in children may be an additional, but not unique, source of ongoing viral diversification.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ffe2a38114a8ac606db5b1f233ceadfdc7d62ca" target='_blank'>
              Intra-Host Evolution of SARS-CoV-2 During Persistent Infection of Pediatric COVID-19 Patients
              </a>
            </td>
          <td>
            Charlie R. Boyle, Tien Doan, Estefany Rios-Guzman, Jessica Maciuch, Lacy M. Simons, Dulce S. Garcia, David B. Williams, A. Alisoltani, E. Ozer, R. Lorenzo-Redondo, J. Hultquist
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Despite heavy exposure to Mycobacterium tuberculosis (Mtb), some individuals are resistant to TST and IGRA conversion (RSTRs). The functional and immunological mechanisms governing resistance are poorly understood. We hypothesized that RSTR and LTBI alveolar macrophages (AMs) respond differently to Mtb infection with transcriptional programs that are distinct from peripheral blood monocytes. We examined media and Mtb-infected AMs from bronchoalveolar lavage fluid collected from a RSTR cohort in Uganda with over 10 years of clinical follow-up. With transcriptional profiles of BAL cells analyzed immediately after collection, gene set enrichment analysis (GSEA) revealed 13 differentially expressed gene sets between RSTR (n = 19) and LTBI (n = 26) groups, including one (Hallmark E2F targets) which was positively enriched in the RSTR group (FDR < 0.3). In a subset of this cohort (n = 7 RSTR and 8 LTBI), AMs were examined with and without Mtb infection. When comparing the RSTR and LTBI groups, we identified 52 DEGs including 22 in the media condition, 15 with Mtb stimulation, and 11 with the interaction term (FDR < 0.2, Log 2-fold change > 1/<-1). Notably, RSTR AMs appear to upregulate inflammation more strongly than LTBI counterparts, including Hallmark inflammatory response (FDR < 0.2), IFNγ response (FDR < 0.1), and IFNα response (FDR < 0.1) while existing in a more non-inflammatory state at baseline (Hallmark TNF signaling via NF-kB (down, FDR < 0.1), inflammatory response (down, FDR < 0.1). In a comparison of peripheral blood monocyte gene expression profiles from the same cohort, there were both shared and AM-specific RSTR profiles detected. Together, these results suggest that RSTR and LTBI AMs have different basal and Mtb-induced transcriptional profiles, including some that differ from peripheral blood monocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/74f6f6a91106ca8fedadea27abfb904beaf5f882" target='_blank'>
              Alveolar macrophage transcriptional signatures associated with resistance to TST/IGRA conversion following Mycobacterium tuberculosis exposure
              </a>
            </td>
          <td>
            Austin M. Haynes, Cristian Ovadiuc, G. Peterson, William Worodria, Sophie Nalukwago, Timothy Muwanguzi, M. Nsereko, Catherine M. Stein, Kimberly A. Dill-McFarland, Harriet Mayanja-Kizza, W. H. Boom, R. M. Segnitz, T. Hawn
          </td>
          <td>2025-10-31</td>
          <td>BMC Genomics</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e4a5d524256ca24b7d9653ca688695b9cdf80bc2" target='_blank'>
              Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity.
              </a>
            </td>
          <td>
            A. Harrer, RF Radlberger, Beate Buchegger, Brooke Slade, Thomas Haybaeck, Hannes Oberkofler, Konstantin E Thiel, Ferdinand Otto, Tobias Moser, P. Wipfler
          </td>
          <td>2025-10-08</td>
          <td>Neurology and therapy</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49cdf4d2b06dc0c77173ce97caf0d6a3fa0e9a28" target='_blank'>
              Single-Cell Immune Profiling Reveals Non-classical Monocyte-Driven Immunodepression in Tuberculosis Treatment Non-Responders
              </a>
            </td>
          <td>
            Yang Che, Yiqun Xiong, Dongliang Zhang, Yahong Qu, Hao Shen, Weixin Wang, Junshun Gao, ZhenBo Wang, Yi Chen, Zhihong Shen
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Innate immunity is the first line of defense against infections, including the detection and response to SARS-CoV-2. Cells of the innate system are usually activated within hours after pathogen exposure and do not generate conventional immunological memory. In this review, the current knowledge of the innate immune cells and of pattern-recognition receptors in sensing and responding to SARS-CoV-2 to mount a protective response has been shortly reviewed. Subsequently, the evasion strategies of the virus, as the inhibition of IFN-I/III production and autophagic response, counteracting the innate cell activity (including NK cells), have been briefly outlined. In the course of the infection, these strategies are also capable of rendering dysfunctional most innate cells, thus deeply interfering with the onset and maintenance of adaptive immunity. Possible mechanism(s) for the maintenance of dysfunctional innate immune response are also discussed. In this context, the importance of a rapid and robust activation of innate immunity through toll-like receptor (TLR) 4 as a key paradigm central to host defense against COVID-19 pathogenesis is also illustrated. We also discuss how the viral excess plus inflammatory signals upregulating TLR4 on innate cells may initiate a vicious loop which maintains and improves hyperinflammation, leading to the most critical outcomes. Targeting the TLR4 or its signaling pathway may be a promising therapeutic strategy, offering the dual benefits of viral suppression and decreasing inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cf626753ecf348c0167bafcded213489d5356d66" target='_blank'>
              The innate immune response in SARS-CoV2 infection: focus on toll-like receptor 4 in severe disease outcomes
              </a>
            </td>
          <td>
            Enrico Maggi, Nadine Landolina, Francesca Romana Mariotti, E. Munari, N. Tumino, P. Vacca, B. Azzarone, Lorenzo Moretta
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3145b8048f1a33f4e0cf44307241622724c18a05" target='_blank'>
              Mapping CD4+ T Cell Landscapes in Glioblastoma Reveals Effectors and Bystanders
              </a>
            </td>
          <td>
            Cameron M. Hill, Anthony Z. Wang, Jose A. Maldonado, T. Johanns, Allegra A. Petti, Gavin P. Dunn
          </td>
          <td>2025-09-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eaf43845c509a3749cf591b678f0bedd9e366627" target='_blank'>
              Alzheimer’s disease causes bone marrow myelopoiesis dysfunction
              </a>
            </td>
          <td>
            M. A. Abellanas, Leyre Basurco, Maitreyee Purnapatre, Chiara Burgaletto, Giulia Castellani, Sarah Phoebeluc Colaiuta, Javier Maria Peralta-Ramos, Angham Ibraheem, Sama Murad, Paola Antonello, Mariángeles Kovacs, Yuliya Androsova, Bar Nathansohn, Hannah Partney, L. Cahalon, Rafael Valdes-Mas, Joseph M. Josephides, T. Salame, M. Espelosin, M. Cuadrado‐Tejedor, A. García-Osta, Aleksandra Deczkowska, Michal Schwartz
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Epigenetic scarring of terminally dysfunctional (TDysf) CD8+ T cells hinders long-term protection and response to immune checkpoint blockade during chronic infections and cancer. We developed a faithful in vitro model for CD8+ T cell terminal dysfunction as a platform to advance T cell immunotherapy. Using TCR-transgenic CD8+ T cells, we found that 1-week peptide stimulation, mimicking conditions in previous models, failed to induce a stable exhaustion program. In contrast, prolonged stimulation for 2–3 weeks induced T cell dysfunction but triggered activation-induced cell death, precluding long-term investigation of exhaustion programs. To better mimic in vivo exhaustion, we provided post-effector, chronic TGF-β1 signals, enabling survival of chronically stimulated CD8+ T cells for over 3 weeks. These conditions induced a state of terminal dysfunction, marked by a stable loss of effector, cytotoxicity, and memory programs, along with mitochondrial stress and impaired protein translation. Importantly, transcriptomic and epigenetic analyses verified the development of terminal exhaustion-specific signatures in TDysf cells. Adoptive transfer of TDysf cells revealed their inability to recall effector functions or proliferate after acute lymphocytic choriomeningitis virus rechallenge. This tractable model system enables investigation of molecular pathways driving T cell terminal dysfunction and discovery of therapeutic targets for cancer or chronic infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc4dbe9ec01dc079f493706a4c9a1123f839c591" target='_blank'>
              Faithful modeling of terminal CD8+T cell dysfunction and epigenetic stabilization in vitro
              </a>
            </td>
          <td>
            Amira Yousif, Abbey A. Saadey, Ava Lowin, Asmaa M. Yousif, Ankita Saini, Madeline R. Allison, Kelley Ptak, Eugene M Oltz, Hazem E. Ghoneim
          </td>
          <td>2025-10-08</td>
          <td>JCI Insight</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="A Proliferation-Inducing Ligand (APRIL) is a tumour necrosis factor superfamily member with multiple effector roles in the peripheral and central nervous system (CNS). In the CNS, APRIL helps maintain immune homeostasis and supports neuronal survival, yet whether it can therapeutically modulate acute neuro-inflammatory and neurodegenerative processes is unclear. To investigate this in a severe neuro-inflammatory context, we tested whether local APRIL delivery can influence microglial/astrocytic responses and demyelination in the cuprizone (CPZ) mouse model of neuro-inflammation and demyelination. We applied adeno-associated virus (AAV)–mediated gene transfer to drive APRIL expression by cortical neurons positioned directly above the splenium of the corpus callosum. Following CPZ intoxication, we evaluated microglial and astrocytic activation and myelin content by in vivo T2 and diffusion magnetic resonance imaging (MRI), and validated them by post-mortem quantitative immunohistochemistry (IHC) and bulk transcriptomic and proteomic profiling. T2 and diffusion MRI, corroborated by quantitative IHC, demonstrated that secretion of APRIL by cortical neurons attenuated CPZ-induced microglial recruitment and demyelination in the splenium, but not in the cortex. Integrated transcriptome-proteome analysis of splenium and cortex, further supported by IHC, highlighted astroglial lipid-metabolic circuitry - marked by the astrocytic fatty-acid-binding protein 7 (Fabp7) - as a candidate axis underlying APRIL’s effects to reduce inflammatory cell recruitment and myelin preservation. AAV-mediated expression of APRIL by cortical neuron counteracted microglial recruitment and demyelination in the splenium of CPZ-treated mice. Our multi-omics integration analysis nominated several pathways, including Fabp7-linked astrocytic lipid metabolism, to elucidate APRIL’s mechanism of action. Together, these findings provide a framework for the mechanistic dissection of APRIL’s therapeutic potential and further translational evaluation in CNS pathologies characterised by acute neuro-inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b73ba8336580ec9e7f5e7539d0fbcc48e4944d3b" target='_blank'>
              AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
              </a>
            </td>
          <td>
            Leonardo Ricciardi, Federica Di Marco, Marion Decrop, Julia Di Stefano, Tejaswini Kakunuri, Joëlle van Rijswijk, N. Vidas-Guscic, Yousra El Ouaamari, Alexandro A. Bufi, Ignace Van Spilbeeck, Johan Van Audekerke, Carole Faghel, Esther Bartholomeus, Eva Lion, Nathalie Cools, Steven Van Laere, I. Cicalini, Vincenzo de Laurenzi, Una Fitzgerald, D. Pieragostino, B. Huard, P. Del Boccio, Peter Ponsaerts, M. Verhoye
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dc9320984fb7ca80afa8b2d49d724dd86390a378" target='_blank'>
              Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy
              </a>
            </td>
          <td>
            Erika Ciervo, Francesco Ceccarelli, A. D. Di Giacomo, Piera Grisolia, A. Covre, Z. M. Besharat, Antonio De Falco, F. Caruso, Luigi Laezza, Luigi Ferraro, Gloria Mas Martin, M. F. Lofiego, Tommaso Sani, E. Ferretti, Yan Guo, Sean B. Holden, R. Mortarini, A. Anichini, M. Maio, T. Noviello, M. Ceccarelli
          </td>
          <td>2025-10-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>60</td>
        </tr>

        <tr id="Ferroptosis plays a key role in neuronal death and functional outcomes following traumatic brain injury (TBI). While TBI affects diverse cell types in injured brain regions, the sex- and cell type-specific responses to ferroptosis during the acute phase in the immature brain remain poorly understood. Dexmedetomidine (DEX), a selective alpha-2 adrenergic receptor agonist, has been shown to reduce inflammation and improve survival outcomes in TBI patients, but its sex- and cell type-specific effects on ferroptosis are unclear. This study investigated whether TBI induces sex- and cell type-specific ferroptotic responses and examined the effects of DEX during the acute post-injury phase in a juvenile mouse model. By concurrently isolating neurons and microglia from the same animals, we demonstrate that TBI prompts distinct sex- and cell type-specific ferroptosis responses, including differential regulation of genes involved in iron and lipid metabolism, oxidative stress, and proinflammatory pathways in neurons and microglia. DEX treatment significantly improved behavioral outcomes and reduced iron overload, lipid peroxidation, and neuroinflammation, thereby decreasing ferroptosis in both neurons and microglia. However, its effects were less prominent in neurons from female mice. Further analysis indicated that these sex- and cell type-specific responses to DEX may be partially due to differences in alpha-2 adrenergic receptor expression in neurons and microglia following TBI. Overall, our findings offer new insights into the mechanisms underlying sex- and cell type-specific responses to ferroptosis and DEX treatment, highlighting the broader implications for lipid metabolism, oxidative stress, and inflammation in the immature brain during the acute phase after TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a73bf058969e84b7af62fcf495bc38cca54174d0" target='_blank'>
              Sex- and cell type-specific effects of dexmedetomidine on ferroptosis in neurons and microglia following traumatic brain injury in juvenile mice
              </a>
            </td>
          <td>
            Jie Fan, Stefanie Tasevski, Yara Mashal, Tia Atoui, Zahrah Naseer, Zhi Zhang
          </td>
          <td>2025-11-06</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1381579458dad0f9eaa04f54a5f62506afb46bc5" target='_blank'>
              Neuroimmune crosstalk in Parkinson’s disease: the pivotal role of microglia and infiltrating T cells
              </a>
            </td>
          <td>
            Xinze Li, Wangjie Sun, Wenmo Chen, Naixuan Wang, Shaoxia Wang
          </td>
          <td>2025-09-26</td>
          <td>Molecular Biology Reports</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Degeneration of myelinating oligodendrocytes and the resulting breakdown of the myelin sheath are key drivers of neurodegeneration and disability across numerous central nervous system pathologies. Thus, a compelling strategy to preserve neuronal function is to promote endogenous myelin repair by oligodendrocyte precursor cells (OPCs). Extracellular vesicles (EVs) secreted by pro-regenerative microglia have been shown to enhance OPC maturation and remyelination across different experimental models. Yet, the mechanisms by which microglia-derived EVs exert their beneficial effects on OPCs are not fully understood. In this study, we performed transcriptomic profiling of primary murine OPCs treated during differentiation with EVs obtained from donor microglia following stimulation with pro-inflammatory cytokines (i-EVs), interleukin-4 (IL4-EVs), or mesenchymal stem cells in the presence of the inflammatory cocktail (MSC-EVs; GEO accession number: GSE304130). Compared to controls, IL4-EVs and MSC-EVs induced robust changes in gene expression, whereas i-EVs elicited far fewer alterations. Using bioinformatic analyses, we identified the molecular pathways significantly modulated by microglial EVs, revealing a large overlap between IL4-EV and MSC-EV targets. Notably, many of these shared pathways centered on mitochondrial function and bioenergetic metabolism. Upstream regulatory network inference further pinpointed candidate transcription factors and kinases that may drive EV-induced transcriptional reprogramming in OPCs. Hence, our findings indicate that rewiring mitochondria-associated pathways is a core mechanism underlying the pro-differentiation effects of microglial EVs on OPCs. Elucidating these intracellular circuits will open new avenues for developing EV-based or mitochondria-targeted remyelinating therapies. Transcriptional effects of microglia-derived extracellular vesicles on oligodendrocyte maturation. Transcriptomics profiling revealed that extracellular vesicles derived from pro-regenerative microglia (IL4-EVs and MSC-EVs) reprogram oligodendrocyte precursor cells (OPCs) by modulating mitochondrial and bioenergetic pathways, promoting their maturation. In contrast, pro-inflammatory i-EVs induce minimal transcriptional changes and have a limited impact on OPC differentiation Transcriptional effects of microglia-derived extracellular vesicles on oligodendrocyte maturation. Transcriptomics profiling revealed that extracellular vesicles derived from pro-regenerative microglia (IL4-EVs and MSC-EVs) reprogram oligodendrocyte precursor cells (OPCs) by modulating mitochondrial and bioenergetic pathways, promoting their maturation. In contrast, pro-inflammatory i-EVs induce minimal transcriptional changes and have a limited impact on OPC differentiation">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1b95243ad26d133386a4eadb6ee422c452782bc0" target='_blank'>
              Microglia-Derived Extracellular Vesicles Enhance Oligodendrocyte Maturation by Transcriptionally Regulating Mitochondrial Molecular Pathways
              </a>
            </td>
          <td>
            S. Raffaele, Marta Lombardi, Davide Marangon, M. Abbracchio, D. Lecca, C. Verderio, Marta Fumagalli
          </td>
          <td>2025-10-21</td>
          <td>Cellular and Molecular Neurobiology</td>
          <td>0</td>
          <td>66</td>
        </tr>

        <tr id="Sepsis, due to dysregulated host responses to infection, demands early intervention. Nevertheless, it is challenging to identify immune changes in the transition from high-risk states to sepsis, which remains unclear. Here, we profiled the single-cell transcriptome of peripheral blood immune cells in healthy controls, high-risk individuals, and clinical sepsis patients to characterize the transcriptomic reprogramming featured by the monocyte and platelet activation across sepsis progression. Particularly, a core gene set (S100A8, S100A9, IFITM2, IFITM3) showed significant upregulation in monocytes in both the high-risk stage and clinical sepsis. Moreover, platelets also exhibited early activation of coagulation and inflammatory pathways, notably sharing this core gene set upregulation. We further analyzed Single-cell RNA Sequencing (scRNA-seq) data from independent cohorts of very preterm infants with sepsis and elderly patients with diabetes. The consistent, early, and persistent upregulation of the S100A8/A9 and IFITM2/3 monocyte signature was strikingly observed across these diverse, high-risk populations. This study provides novel single-cell insights into immune dysregulation during sepsis onset, pinpointing specific transcriptomic signatures in monocytes and platelets emerging during the high-risk phase.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/762ecf8be789dd05f23d4604ee048954d159d87d" target='_blank'>
              Single-Cell transcriptomic profiles of peripheral blood immune cells reveal early monocyte and platelet activation in the transition from high-risk states to clinical sepsis
              </a>
            </td>
          <td>
            Lanlan Sun, Peng Zhang, Haikun Zhang, Hailang Fan, Yansheng Li, Yaqian Zhao, Mengtong Wang, Yingdi Huang, Mingyang Liu, Dake Zhang, Xin Zhang
          </td>
          <td>2025-09-25</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/183f309102020194c23f7f4fa2e0b4a0bcc44a55" target='_blank'>
              Whole-genome DNA methylation profiling in COVID-19 positive patients reveals alterations in pathways linked to neurological dysfunction
              </a>
            </td>
          <td>
            S. Zameer, Ehraz Anis, Qiang Sha, Martha L. Escobar Galvis, Sanam Khan, Jennifer A. Steiner, M. Milčiūtė, Ieva Kerševičiūtė, Migle Gabrielaite, Juozas Gordevičius, Andrew Pospisilik, Nazia Saiyed, Stewart F. Graham, Patrik Brundin, L. Brundin
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Introduction Despite SARS-CoV-2 pandemic has subsided, vaccine response profiling in patients with cancer remains critical. Methods We longitudinally assessed humoral and cellular immunity in adults with solid tumours treated with chemotherapy (ChT) or non-ChT regimens after two mRNA vaccine doses plus booster, compared with vaccinated cancer-free controls, naturally infected (convalescent) subjects including both patients with cancer and cancer-free individuals, and unvaccinated/uninfected individuals with or without cancer as a baseline reference. Results Anti-Spike IgG titres matched cancer-free controls, but anti-RBD titres and neutralising activity were consistently lower in cancer post-vaccination, most markedly with ChT, and declined faster over 4-6 months. Boosters restored IgG, yet gains were smaller in ChT recipients. Cellular analyses revealed sustained and booster-enhanced Spike-specific B cells in all groups; however, ChT exposure was associated with reduced CD27 expression on these cells, suggesting impaired activation and memory maturation. Discussion These findings support tailored immune monitoring and vaccination strategies in oncology and identify CD27 downregulation as a novel B-cell dysfunction detected by high-dimensional immunophenotyping.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ece73c2c90429ae4c877fe3e324050afd6b55d35" target='_blank'>
              Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors
              </a>
            </td>
          <td>
            Andrea Favalli, Giorgio Patelli, P. Gruarin, A. Gobbini, E. Pesce, Sara Mariano, M. Bombaci, Francesca Vincenti, L. Donnici, Silvia Marchese, D. Piscazzi, A. Amatu, F. Tosi, Silvia Ghezzi, Arianna Pani, Silvia Principato, Andrea Lombardi, Alessandra Bandera, S. Abrignani, S. Siena, A. Sartore-Bianchi, Renata Grifantini, Kristin Renkema, Huang Huang, P. Favalli, Grifantini. This
          </td>
          <td>2025-09-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>66</td>
        </tr>

        <tr id="BACKGROUND
The COVID-19 pandemic, caused by SARS-CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they induce protective antiviral immunity. Acute myopericarditis (AMP) development after vaccination has repeatedly been reported; however, the pathogenesis of this complication remains elusive.


METHODS
In-depth phenotyping of peripheral blood T cells was undertaken in cohorts of patients who developed AMP after mRNA vaccination, patients hospitalized for severe COVID-19, and healthy subjects with no cardiac side effects after mRNA vaccine. Validation studies were carried out using an experimental model of cardiac inflammation, in which a shared epitope elicits functional responses in patients and mice and induces AMP.


RESULTS
We show that T cells from patients with AMP recognize vaccine-encoded Spike epitopes homologous to those of cardiac self-proteins. One of these epitopes, mimicking an amino acid sequence from a cardiomyocyte-expressed K+ channel, induced AMP in mice. When functional responses to the Kv2 were analyzed, patients with AMP after mRNA vaccination, but not patients with COVID-19, displayed an expanded pattern of cytokine production similar to that observed in AMP mice and in autoimmune myocarditis. Crucially, T-cell autoimmunity segregates to cardiotropic cMet (c-mesenchymal epithelial transition factor)-expressing T cells and is prevented by cMet inhibition, suggesting that heart homing imprinting, permitted by the unique mRNA vaccine biodistribution, is required for AMP development.


CONCLUSIONS
AMP development after mRNA vaccines is mediated by distinct immune components, including molecular mimicry, T-cell receptor affinity, and, importantly, homing imprinting.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7a2c7768da7a26c5948ed8c2a53768a7ad48ff71" target='_blank'>
              Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination.
              </a>
            </td>
          <td>
            Silvia Fanti, Carlene Dyer, I. J. Ingimarsdóttir, Daniel Harding, Guosu Wang, Antonio d'Amati, Eriomina Shahaj, Aðalbjörg Ýr Sigurbergsdóttir, Helga Thorsdottir, Oddný Brattberg Gunnarsdóttir, S. Kanoni, Paul Wright, John Martin, J. Chorlton, Zoe Hollowood, S. F. Brynjólfsson, Bjorn Rúnar Lúdvíksson, Egle Solito, Serena Bert, Jack M. Keane, S. Mohiddin, M. Longhi, F. Marelli-Berg
          </td>
          <td>2025-10-30</td>
          <td>Circulation</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="Uropathogenic Escherichia coli (UPEC) typically trigger rapid and robust innate immune responses in the bladder. In order to identify the key facets of the host response that influence pathogen clearance and tissue damage, single-cell RNA sequencing was used to investigate the transcriptomic changes of immune cells in mouse bladder after UPEC infection. Single-cell analysis revealed significant elevated CD137L expression in macrophages and dendritic cells in bladder after UPEC infection. CD137L defines a macrophage population in bladder that is important for the host response to UPEC infection. Deletion of CD137L in macrophages resulted in severe bacterial burden and bladder inflammation during the acute stage of UPEC infection. Further study demonstrated that the crucial role of CD137L+ macrophages in protecting against UPEC infection might be mediated by Tregs, which express high levels of CD137 (the receptor for CD137L). Deletion of CD137L+ macrophages decreased Treg cells and led to a reduction in inhibitory factors such as CTLA-4 and PD-1 on Tregs. Deletion of Tregs using Foxp3DTR mice also aggravated inflammatory reactions, bacterial load, and urothelial destruction during the acute phase of UPEC infection. Similarly, the deletion of CD137 in Tregs resulted in a decrease in these inhibitory factors on Tregs, causing more severe bladder inflammation during UPEC infection. These results illuminate the immune landscape of the bladder infected by UPEC and highlight the crucial role of CD137L+ macrophages during UPEC infection in bladder. CD137L+ macrophages might prevent excessive inflammatory response during the host response to UPEC infection by regulating Tregs.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7954121d279c90d1325ddfc45384733f19ba8846" target='_blank'>
              Single-cell analysis reveals an important role of CD137L+ macrophages in the host response to uropathogenic Escherichia coli infection in the bladder
              </a>
            </td>
          <td>
            Yaxiao Liu, Zizhuo Yang, Yinrui Xiang, Guangzhou Cheng, Lipeng Chen, Shuai Wang, Maolin Zang, Nan Zhou, Xiaoyi Zhang, Rui Chen, Benkang Shi, Yan Li
          </td>
          <td>2025-10-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/688de0b03999304bfc55a9981de1437a71ee2384" target='_blank'>
              UBA1 Mutations Drive RIPK1-Mediated Cell Death and Monocyte Dysfunction in VEXAS Syndrome
              </a>
            </td>
          <td>
            P. Breillat, Samuel J. Magaziner, Stéphane Camus, L. Dionet, Benjamin de Valence, P. Sohier, Amine Majdi, Quentin Delcros, Federica Pallotti, N. Rivet, Kevin Chevalier, Margot Poux, P. Tharaux, Olivia Lenoir, Abdelrahim Zoued, Olivier Kosmider, David B Beck, Benjamin Terrier
          </td>
          <td>2025-10-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>53</td>
        </tr>

        <tr id="As the pediatric COVID-19 landscape evolves, it is essential to evaluate whether SARS-CoV-2 infection predisposes children to allergic disorders. This narrative review synthesizes current epidemiological and immunological evidence linking pediatric COVID-19 with new-onset atopy. Epidemiological data remain heterogeneous: large Korean and multinational cohorts report increased risks of asthma and allergic rhinitis following COVID-19, whereas U.S. cohorts show neutral or protective associations, highlighting geographic and methodological variability. Mechanistic insights provide biological plausibility: epithelial injury and the release of alarmin cytokines (IL-33, IL-25, TSLP) promote Th2 polarization and ILC2 expansion, while epigenetic “scars” (e.g., LMAN2 methylation changes) and hematopoietic stem cell reprogramming may sustain long-term Th2 bias. Cytokine memory involving IL-7 and IL-15 contributes to altered T- and B-cell homeostasis, whereas disrupted regulatory T-cell function may reduce tolerance thresholds. Paradoxical trade-offs exist, such as ACE2 downregulation in allergic airways, which may lower viral entry but simultaneously amplify type-2 inflammation. Together, these processes suggest that SARS-CoV-2 infection could foster a pro-allergic milieu in susceptible children. Although current evidence is inconclusive, integrating epidemiological surveillance with mechanistic studies is crucial for predicting and alleviating post-COVID allergic outcomes. Longitudinal pediatric cohorts and interventions targeting epithelial alarmins or microbiome restoration may hold promise for prevention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/915e70de93eed337c1055b8bcb1c32ceec3aa48b" target='_blank'>
              Immunological Mechanisms Underlying Allergy Predisposition After SARS-CoV-2 Infection in Children
              </a>
            </td>
          <td>
            Filippos Filippatos, Dimitra-Ifigeneia Matara, Athanasios Michos, K. Kakleas
          </td>
          <td>2025-09-28</td>
          <td>Cells</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="

 Helminth infections are widespread in resource-limited settings, and modulate host immune responses, with potential implications for viral coinfections. Intestinal helminths can alter susceptibility to respiratory viruses, but the mechanisms influencing SARS-CoV-2 infection outcomes remain poorly understood.




 Using the Syrian hamster model, we investigated the impact of prior infection with the human hookworm
 Ancylostoma ceylanicum
 on host responses to SARS-CoV-2. Tissue-specific transcriptional responses were compared among four groups: naive, hookworm-only, SARS-CoV-2-only, and coinfected with both pathogens, 3 and 6 days post-viral infection. Viral titers and weight loss were assessed, and RNA-seq transcriptome profiles from lung and intestinal tissues were interrogated to identify differentially expressed genes and cellular pathways.





 Prior hookworm infection did not significantly alter viral titers or weight loss compared to SARS-CoV-2 infection alone, but distinct transcriptional signatures compared were identified compared to either single infection. Coinfection uniquely differentially regulated hematopoiesis and B cell-associated genes (e.g.,
 ATF5
 ,
 IGHM
 ,
 JCHAIN
 ) in the lungs, and immune and stress response pathways and inflammation-associated genes (e.g.
 FOLR2
 ,
 PLA2GF
 ,
 FABP3
 ) in the intestine. Genes and pathways differentially regulated by SARS-CoV-2 alone, but with attenuated transcriptional responses in the lungs of coinfected hamsters were observed, including the loss of upregulation of toll-like receptor signaling and previously proposed host biomarkers for COVID-19 severity (
 CHI3L1
 ,
 HMOX1
 ), Long COVID (
 FCG4
 /
 FCGR3A
 and
 FST
 ) and mortality (
 FST
 ). In the intestine, hookworm-associated suppression of type I interferon-related genes (
 TAP1
 ,
 IRF7
 ) was reversed with SARS-CoV-2 coinfection, highlighting pathogen-specific modulation of innate antiviral signaling. Genes and pathways consistently differentially regulated by with SARS-CoV-2 were consistent with expectations, and many hemoglobin pathways were differentially regulated with hookworm in the intestine. CIBERSORT analysis was estimated relative leukocyte abundances in each sample cohort.





 Our findings demonstrate that
 A. ceylanicum
 infection reshapes host transcriptional responses to SARS-CoV-2 in a tissue-specific manner, enhancing B cell immunity in the lung while driving intestinal inflammation. Hookworm-induced immune modulation attenuated key SARS-CoV-2-responsive genes and pathways, suggesting potential mechanisms for reduced disease severity observed in helminth-endemic regions. These findings establish a molecular framework to better understand helminth, SARS-CoV-2 and host immune interactions, with relevance for other respiratory viral infections.

">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1f50e16e55b6e57865962ad4879c8c3713d8086" target='_blank'>
              Hookworm infection modulates lung and intestinal transcriptomic responses to SARS-CoV-2 in Syrian hamsters
              </a>
            </td>
          <td>
            B. Rosa, Mahdiyeh Bigham, T. Darling, Ashutosh Arun, Kumar Sachin Singh, John Martin, A. C. Boon, M. Mitreva
          </td>
          <td>2025-11-05</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>58</td>
        </tr>

        <tr id="Pulmonary TB that develops in immunocompetent adult humans is responsible for approximately 85% of the disease burden and is central for Mtb transmission. Most humans contain Mtb infection within primary granulomatous lesions, but in certain immunocompetent humans, containment fails, leading to hematogenous spread and active pulmonary disease with the formation of cavities that enable Mtb transmission via aerosols. To reveal lung-specific microenvironments conducive for Mtb survival and replication despite systemic immunity, we use fluorescence multiplex immunohistochemistry and spatial transcriptomic analyses of heterogenous TB lesions that uniquely form in the lungs of immunocompetent but TB-susceptible B6.Sst1S mice after hematogenous spread from the primary lesion. Initially, these secondary lung lesions manifested local adoptive immunity featuring tertiary lymphoid follicles similar to resistant B6 mice and contained primarily non- replicating bacilli. Following these early events, however, the B6.Sst1S mice uniquely demonstrate expansion of myeloid cell populations with the appearance of alternatively activated macrophages, dissolution of lymphoid follicles, and the accumulation of de- differentiated lung epithelial cells. These processes led to bronchogenic expansion, broncho- occlusion, and necrosuppurative pneumonia closely resembling advanced pulmonary tuberculosis in humans. To determine whether lung parenchymal cells or lung oxygenation were necessary for the pulmonary TB progression, we implanted lung and spleen fragments subcutaneously prior to the infection. The lung implants uniquely displayed the formation of the characteristic organized granulomas with necrosis and Mtb replication that paralleled TB progression in native lungs, demonstrating that the cellular composition of inflamed lung tissue, not oxygenation, is a critical determinant of pulmonary TB progression. Our data demonstrate that deleterious bi-directional interactions of aberrantly activated macrophages with the inflammation-injured lung resident cells determine lung vulnerability to virulent Mtb in immunocompetent hosts. Because these mechanisms enable Mtb transmission among humans via aerosols, they are likely evolutionary conserved and, therefore, represent appealing targets for host-directed TB therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/35f6eb839e16d01a9865bac244ecffb0c7c4d177" target='_blank'>
              Dysplastic lung repair fosters a tuberculosis-promoting microenvironment through maladaptive macrophage polarization
              </a>
            </td>
          <td>
            Shivraj M. Yabaji, Suruchi Lata, Anna E. Tseng, Prasanna Babu Araveti, Ming Lo, Igor Gavrish, A. O’Connell, H. Gertje, Anna C. Belkina, Colleen E. Thurman, Hirofumi Kiyokawa, Darrell Kotton, Shumin Tan, Janice J Endsley, William R. Bishai, Nicholas A. Crossland, L. Kobzik, Igor Kramnik
          </td>
          <td>2025-10-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19) patients have a 1.7-fold higher arrhythmia risk with rates of cardiac complications ranging from 2% non-ICU patients to 59% in non-survivors. Atrial fibrillation (AF), the most common arrhythmia, is a frequent complication of acute and long COVID-19. The high expression of ACE2 in the heart suggested that infectious virus may underlie cardiac complications. However, we recently reported in human cardiac tissue from fatal COVID-19 cases perivascular spike protein, elevated pro-inflammatory cytokines, vascular damage, and cardiac remodeling without evidence for direct infection of cardiac cells by SARS-CoV2. Mislocalization of intercalated disc (ID) components, connexin-43 (Cx43) gap junctions and NaV1.5 sodium channels, was also evident in patients’ hearts, recapitulating structural remodeling we previously identified as providing a substrate for atrial arrhythmias following an acute inflammatory insult. Therefore, we hypothesized that the inflammatory response elicited by SARS-CoV2 spike protein is sufficient to provoke atrial arrhythmias. Structural and functional assessments of WT murine hearts were performed five days following a single bolus intravenous injection of the viral spike protein. In vivo ECGs demonstrated increased atrial arrhythmia burden in spike-injected mice vs. control. Immunohistochemistry studies revealed elevated expression of inflammatory markers and evidence of vascular damage in these mice. Additionally, we observed disruption of ID ultrastructure and mislocalization of Cx43 and NaV1.5 in the atria of spike protein-injected mice. Our results suggest that vascular-leak inducing inflammatory insult from viral spike protein, and not direct infection by SARS-CoV2 results in the pathophysiology of cardiac dysfunction in fatal COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c153f00606118d9f8c8e5f0644e86dd859e1dd6c" target='_blank'>
              SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19
              </a>
            </td>
          <td>
            Louisa Mezache, Andrew M. Soltisz, Esmerina Tili, Gerard J. Nuovo, R. Veeraraghavan
          </td>
          <td>2025-09-30</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) is a complex neurodegenerative condition linked to chronic neuroinflammation. This study investigates the cytokine gene expression profile in cortical tissue samples from elderly individuals with and without AD to identify potential biomarkers and enhance our understanding of disease pathogenesis. Utilizing high-depth RNA sequencing data, we identified a set of cytokines whose expression significantly associated with different aspects of the AD phenotype, including measures of neurofibrillary tangles, amyloid-β deposition, and a person-specific rate of cognitive decline. Single-nucleus transcriptomics data facilitated the identification of specific cell types, such as microglia and astrocytes, that significantly contribute to the inflammatory response in AD. Additionally, we observed a correlation between the expression of certain cytokines and genetic risk for the disease. Our findings indicate that cytokine-mediated neuroinflammation may play an important role in neurodegeneration and that modulating the immune response may offer a promising strategy for developing new therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/55f9275bb4433a571ad2ccb247185bf067482f8e" target='_blank'>
              Cytokine expression profile in the human brain of older adults
              </a>
            </td>
          <td>
            Juliana Beker Godoy, R. Vialle, Loren dos Santos, R. T. Raittz, Yanling Wang, Vilas Menon, P. D. De Jager, Julie A. Schneider, S. Tasaki, David A. Bennett, Dieval Guizelini, Katia de Paiva Lopes
          </td>
          <td>2025-10-03</td>
          <td>Journal of Neuroinflammation</td>
          <td>1</td>
          <td>68</td>
        </tr>

        <tr id="Since its emergence, the coronavirus (SARS-CoV-2) outbreak has been a pandemic responsible for about 7 million deaths worldwide. Numerous studies have been conducted to determine the virus’s multiorgan system involvement, particularly its relation to cancer biology. Spontaneous regression of cancer has been observed in some patients with the coronavirus, which may be attributed to the virus’s ability to trigger specific immune responses that can be oncolytic and help reduce and eliminate oncogenic cells. This study aims to explore the paradoxical effects of COVID-19 in inducing cancer regression. The paradoxical effect of SARS-CoV-2 infection has been attributed to the possibility of a heightened immune activation possibly triggered by the virus, and some of these include increased levels of cytokines such as interferon and tumor necrosis factor-alpha (TNF-α), as well as the activation of T cells and natural killer (NK) cells. COVID-19-induced cancer regression presents new perspectives on the relationship between viral infections and the immune system’s antitumor capabilities. This would help foster future research investigating specific immune pathways activated during SARS-CoV-2 and discover how these can be therapeutically harnessed to aid cancer regression. Not applicable.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b70234ee10e35d21e82680c57b0003d8503d4e0" target='_blank'>
              COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon
              </a>
            </td>
          <td>
            I. Ogieuhi, V. Ajekiigbe, C. Agbo, Chidera Stanley Anthony, Adegbesan Abiodun Christopher, Jennifer Chinaecherem Onyehalu, M. C. Agu, Sylvia Mmesomachi Mbaji, Adewunmi Akingbola, Bisharat Ahmed, Owa Ogieuhi, O. Akinmeji
          </td>
          <td>2025-10-23</td>
          <td>Infectious Agents and Cancer</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Recurrent pregnancy loss (RPL) profoundly impacts not only the physical health but also the psychological well-being of women. Despite its profound effects, the underlying pathophysiological mechanisms of RPL remain largely elusive, with few discernible warning signs. Lymphocyte activation gene-3 (LAG-3) is a crucial immune checkpoint that modulates immune responses during infection and tumor. In the present study, we examined the expression of LAG-3 on CD4+T cells during pregnancy via cytometry by time-of-flight and flow cytometry. Our findings revealed a higher frequency of LAG-3+ decidual CD4+T (dCD4+T) cells in response to trophoblasts during normal pregnancy. This specific LAG-3+ subset of dCD4+T cells was found to produce a greater number of anti-inflammatory cytokines. Notably, blocking LAG-3 was highly effective in inhibiting the production of anti-inflammatory cytokines, which is detrimental to the maintenance of pregnancy. A decrease in the number of LAG-3+dCD4+T cells was correlated with miscarriage. Interestingly, the RNA level of LAG-3 (data analyzed from the two published single-cell databases) remained stable in RPL. Palmitoylation might play a role in regulating LAG-3 expression during RPL, as the palmitoylation of LAG-3+dCD4+T cells was increased in RPL. Additionally, the general palmitoylation inhibitor 2-bromopalmitate was found to upregulate LAG-3 expression on dCD4+T cells both in vitro and in vivo. Collectively, these findings highlighted the significant roles of LAG-3 in regulating the function of dCD4+T cell and maintaining normal pregnancy. Furthermore, they suggested that lower LAG-3 expression on dCD4+T cells could serve as a potential biomarker for diagnosis of RPL.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fffd707a87006ae812efe04e7e914df2c52cf9ee" target='_blank'>
              LAG-3 palmitoylation-inducing dysfunction of decidual CD4+T cells is associated with recurrent pregnancy loss
              </a>
            </td>
          <td>
            L. Cui, Fengrun Sun, Xinhang Meng, Yujie Luo, Jinfeng Qian, Songcun Wang
          </td>
          <td>2025-09-29</td>
          <td>Molecular Medicine</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/10d55887dd7d12323eb386296c4572af9c380d12" target='_blank'>
              The nuclear receptor NR4A1 serves as a neutrophil-intrinsic regulator mitigating stroke severity
              </a>
            </td>
          <td>
            Jan-Kolja Strecker, Yannick Schmidt, M. Liebmann, Carolin Walter, Stefan Roth, Hanna Aleth, Anna-Lena Börsch, Antje Schmidt-Pogoda, Carolin Beuker, Ayan Mohamud Yusuf, Julian Revenstorff, Collins Osei-Sarpong, Lisa Krafft, Anna-Sophie Schwarze, M. Heming, Mathis Richter, Tanja Kuhlmann, S. Hucke, Jan-Niklas Heming, Uwe Hansen, Nina Hagemann, A. Bader, Jincheng Gao, Barbara Walzog, Daniela Maier-Begandt, Raphael Chevre, E. Hanschmann, Martin Lücke, Clemens Sommer, Dirk M. Hermann, Johannes Roth, Christian Thomas, G. Meyer zu Hörste, Matthias Gunzer, Thomas Vogl, Alexander Zarbock, Frank Rosenbauer, Carlos Silvestre-Roig, Oliver Söhnlein, L. Klotz, J. Minnerup
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Ending of COVID-19 pandemic does not exclude subsequent breakthrough infections caused by SARS-CoV-2 mutant strains. The rate of SARS-CoV-2 mutations increased with emerging omicron strain and exceeds those of the influenza virus. It remains unclear what IgG antibody levels are able to protect against new mutant SARS-CoV-2 strains, and how long the immune protection will last. The objective of this study was to monitor the maintenance of humoral and cellular immunity to SARS-CoV-2 viral antigens over 4 years after the infection. Thirty-two adult reconvalescents after COVID-19 were annually examined for humoral and cellular immunity markers to the SARS-CoV-2 S protein. Humoral immunity was assessed by ELISA; cellular immunity was evaluated by expression of CD107a on CD8hi lymphocytes after recognition of S protein antigens. A four-year observation of a group of patients who recovered from COVID-19 in 2020 (SARS-CoV-2, Wuhan strain) and were in contact with a novel, freely circulating mutant VoCs showed that, 1 year later, all subjects retained the IgG antibodies to S protein, mainly the IgG1 subclass, but the antibody avidity index barely exceeded 50%. After a breakthrough infection caused by the omicron strain, the level of IgG antibodies to S protein increased significantly, along with sufficient increase of antibody avidity. The IgG2, IgG3, and IgG4 antibodies to S protein occured in the spectrum of subclasses. The level of specific IgA decreased 1 year after the disease against their level after the primary disease. However, it was significantly increased to 4-5 PR after breakthrough infections. Cellular immunity to the SARS-CoV-2 S protein was detected in all subjects at 1 year after the primary disease. After repeated infection with the omicron strain, it increased significantly and remained at this level for the next year. By 4 years, it decreased to the level that was a year after the disease. Hence, humoral and cellular immunity to S protein does not fade away, but continues to persist, maturate, being maintained at a sufficient level. Upon exposure to a new VoC, it allows to endure such a meeting either asymptomatically, or as a mild clinical infection. In view of frequent mutations in the S protein, the role of T-cell responses in anti-infectious protection seems to increase significantly. When developing new vaccines, one should rely on development of cellular immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e639b1e50968635421ab873cef8a370649bdc963" target='_blank'>
              Immunological memory to SARS-CoV-2 S protein persists 4 years after the disease
              </a>
            </td>
          <td>
            Z. Afridonova, A. Toptygina, E. Semikina
          </td>
          <td>2025-09-28</td>
          <td>Russian Journal of Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Early studies on the evolution of SARS-CoV-2 revealed mutations that favored host transmission of the virus and more efficient viral entry. However, cell-free virus spread is vulnerable to host-neutralizing antibodies. As population immunity developed, mutations that confer escape from neutralization were selected. Notably, cell syncytia formation wherein an infected cell fuses with a noninfected cell is a more efficient route of transmission that bypasses humoral immunity. Cell syncytia formation has been implicated in the pathogenicity of SARS-CoV-2 infection whilst compromising host transmission due to impaired whole virion release. Therefore, understanding the mechanisms of virus-mediated cell–cell fusion will aid in identifying and targeting more pathogenic strains of SARS-CoV-2. Whilst the general kinetics of cell–cell fusion have been known for decades, the specific mechanisms by which SARS-CoV-2 induces fusion are beginning to be elucidated. This is partially due to emergence of more reliable, high throughput methods of quantifying and comparing fusion efficiency in experimental models. Moreover, the ongoing inflammatory response and emerging health burden of long COVID may point to cell–cell fusion in the pathogenesis. In this review, we synthesize current understanding of SARS-CoV-2-mediated cell–cell fusion and its consequences on immune escape, viral persistence, and the innate immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4f095dbd1f23fd0e176cf55b71219bd14507420b" target='_blank'>
              Mechanisms of Cell–Cell Fusion in SARS-CoV-2: An Evolving Strategy for Transmission and Immune Evasion
              </a>
            </td>
          <td>
            Kate Chander Chiang, Cheng En Nicole Chiu, Mazharul Altaf, M. Cheng, Ravindra K. Gupta
          </td>
          <td>2025-10-22</td>
          <td>Viruses</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/36e9b1a92955cd9fb81f83d2cc7d3196d038b91a" target='_blank'>
              Comparative analysis of T-cell signatures and astroglial reactivity in Parkinson’s pathology across animal models with distinct regenerative capacities
              </a>
            </td>
          <td>
            Simona Intonti, Volker Enzmann, Amalia Perna, Ferdinando Spagnolo, Claudia Curcio, F. M. Conedera
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Abstract The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the virus's remarkable ability to evolve and adapt in diverse hosts. Despite the observation of recurrent mutations and convergent evolution in the viral genome, the mechanisms driving these processes remain poorly understood, particularly in the context of diverse host environments and limited genomic surveillance. We established a rigorously controlled in vitro cellular system within a Biosafety Level 3 Laboratory, ensuring strict adherence to biosafety protocols while passaging the virus in seven cell lines derived from four tissues across five mammalian species. High-throughput sequencing revealed consistent positive selection on the Spike (S) protein, highlighting its adaptability in the absence of adaptive immune responses or therapeutic pressures. Type I interferons (IFN-I) and APOBEC-mediated editing may emerge as key modulators of viral evolution. Notably, IFN-I activation is inversely correlated with the accumulation of S protein mutations (E484D, P812R/L, L1186R). Our findings uncover host-specific selective forces in shaping SARS-CoV-2 evolution and highlight the need for systematic approaches to mitigate viral transmission and emerging variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/461722f90e682345662c6276a91b4383ad6356c7" target='_blank'>
              Convergent Evolution and Host-Limiting Impacts of SARS-CoV-2 Revealed by Cellular Experiments
              </a>
            </td>
          <td>
            Ting Zhang, Ren-Rong Tian, Fengyi Li, Xiaolu Tang, Wenbin He, Zhen-Ping Hao, Lin Zhuo, Jian Lu, Xuemei Lu, Yong-Tang Zheng
          </td>
          <td>2025-10-28</td>
          <td>Molecular Biology and Evolution</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Severe acute pancreatitis (SAP) is characterized by biphasic systemic inflammation, progressing from initial pro-inflammatory systemic inflammatory response syndrome (SIRS) to subsequent immunosuppressive compensatory anti-inflammatory response syndrome (CARS), which increases infection risks and predicts poor prognosis. Using a pancreatic duct ligation and caerulein-induced SAP murine model, we demonstrate that macrophage extracellular traps (METs) play a pivotal role in immune regulation. Mechanistically, acinar cell activation of the cGAS-STING pathway triggers pyroptosis-mediated IL-33 release. METs subsequently process IL-33 into highly bioactive isoforms through METs-derived proteases (including MMP-12), thereby initiating ST2 receptor-mediated type-2 immune responses. Clinical validation revealed elevated serum METs marker and IL-33 levels in SAP patients. Therapeutic interventions with DNase I and Cl-amidine significantly attenuated IL-33 release, Th2 cell activation, and disease severity in experimental models. Our findings establish METs as critical regulators of SAP-associated CARS and propose METs inhibition as a promising therapeutic strategy for SAP management.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a4010b4f963c42ca69e0ca886cf84014a1c3bf0b" target='_blank'>
              Macrophage Extracellular Traps Modulate the Compensatory Anti-inflammatory Response Syndrome through IL-33/ST2 Signaling in Severe Acute Pancreatitis
              </a>
            </td>
          <td>
            Quan Zhou, Zhao Shi, Xuan Wang, Lingxi Meng, Kun Liu, Siqi Zhou, Yihang Jiang, S. Nie, Yuanyuan Yu, Hao Zhu, Mingdong Liu, Bo Kong, H. Friess, Lei Wang, Hongzhen Li, Shanshan Shen, Xiaoping Zou
          </td>
          <td>2025-09-22</td>
          <td>International Journal of Biological Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Macrophages are crucial for neuroinflammatory responses following traumatic brain injury (TBI), encompassing various subtypes, such as border-associated macrophages (BAMs) that contribute to both brain damage and repair. However, the pathophysiological relevance of subtype-specific molecular markers is poorly understood. This study investigated the role of the BAM marker mannose receptor C-type 1 (MRC1, also known as CD206) during the early phase of TBI using controlled cortical impact (CCI). MRC1 gene expression was up-regulated, peaking between 3 to 7 days post-injury (dpi), and MRC1 protein expression predominantly localized to BAMs. To assess pathophysiological relevance, MRC1-deficient (MRC1-KO) and wild-type littermates (MRC1-WT) were examined following CCI for early neurological deficits, brain structural damage, intracerebral hematoma, and neuroinflammatory marker expression. At 5 dpi, MRC1-KO mice showed increased brain lesion volume and hippocampal neuron loss, with minor differences in neurological deficits compared to MRC1-WT mice. Intracerebral hematoma size increased in male but remained unchanged in female MRC1-KO mice. Immunostaining revealed no genotype-specific effects on GFAP+ astrocytes, while the number of perilesional CD68+ macrophages/microglia were reduced in MRC1-KO mice. Analysis of neuroinflammatory gene markers revealed an overall reduction in MRC1-KO mice. Sex-specific regulation was observed for the M2-like macrophage/microglia marker Arg1, with decreased expression in male and increased expression in female MRC1-KO compared to MRC1-WT mice. In conclusion, lack of MRC1 exacerbated brain tissue damage following experimental TBI. Reduced CD68+ macrophages/microglia and neuroinflammatory marker expression suggests impaired neuroinflammatory response in MRC1-KO, indicating MRC1 expression on BAMs contributes to beneficial early neuroinflammatory response following TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ac5ec2bb9a4f897f1ee154ba78ff99b4c7b8daa" target='_blank'>
              The border-associated macrophage marker MRC1 contributes to an early neuroprotective inflammatory response to traumatic brain injury in mice
              </a>
            </td>
          <td>
            Jenny Strehle, Pawit Somnuke, Shuailong Li, Sudena Wang, Tobias Hirnet, Yong Wang, Michael K. E. Schäfer
          </td>
          <td>2025-10-30</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Abstract Background Survivors of COVID-19 frequently report psychiatric and cognitive sequelae. The origin of such sequelae has not been determined, as it has been a challenge to resolve whether these symptoms have a viral origin or are related to the contextual stressors associated with the pandemic. Using a mouse model of post-acute sequelae of SARS-CoV-2 infection (PASC), we examined neurobiological mechanisms underlying these effects without the confounding influence of contextual factors. Results SARS-CoV-2 infection induced cognitive, but not anxiety- or depression-like, behavioral deficits. Cognitive impairments correlated with severity of the acute disease. Infected mice showed significant alterations in brain cytokine levels, as well as in kynurenine pathway (KP) metabolites, both of which were associated with acute disease severity. Microbiome taxonomic profiling revealed group-specific differences, indicating that certain bacterial species may contribute to PASC development. Conclusions Our findings suggest that SARS-CoV-2 infection causes cognitive deficits in PASC, modulated by acute disease severity, while anxiety- and depression-like behaviors appear unrelated to the viral infection itself. This supports the idea that such psychiatric symptoms may stem from pandemic-related stressors rather than infection. Altered cytokine signaling and KP metabolism may play key roles in the pathophysiology of PASC, identifying potential biomarkers and therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fb3ed4fe779a93447277b5e14c32a1a056c5b57" target='_blank'>
              Neuropsychiatric- and cognitive post-acute sequelae of SARS-CoV-2 infection – evidence from K18-hACE C57BL/6 J mice
              </a>
            </td>
          <td>
            Marco Maria Santi, Eleonora Genovese, T. Schou, Matheus da Silva, Sophie Erhardt, L. Schwieler, Jacob Ahlberg Weidenfors, Giorgia Marino, S. R. Paludan, Sâmia Joca, G. Wegener, L. Reinert, C. Bay-Richter
          </td>
          <td>2025-09-30</td>
          <td>International Journal of Neuropsychopharmacology</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Abstract Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central nervous system (CNS) in which macrophages play a pivotal and multifaceted role. These highly plastic immune cells are key effectors in the immunopathology of MS, contributing to both inflammatory-driven demyelination and subsequent tissue repair. Historically, macrophage function was viewed through the binary lens of pro-inflammatory M1 and anti-inflammatory M2 polarization. However, recent research reveals a far more complex spectrum of activation states within the dynamic microenvironment of MS lesions. Understanding the intricate signals and molecular pathways that govern macrophage polarization in the CNS represents a critical frontier for therapeutic innovation. Interventions aimed at rebalancing macrophage phenotypes have yielded encouraging results in preclinical models, and some therapeutic agents are now advancing into clinical trials. Future investigations are focused on the diverse functions of macrophages in MS pathogenesis, including their involvement in oxidative stress, antigen presentation, and myelin debris clearance. A particularly innovative approach involves harnessing macrophages as cellular vehicles for targeted drug delivery across the blood-brain barrier, offering a potential solution to one of the most significant challenges in CNS therapeutics. The primary challenge now lies in the safe and effective clinical translation of these macrophage-centered therapies. Successfully navigating this transition from bench to bedside holds the potential to deliver transformative treatments that can halt disease progression and restore neurological function for individuals living with this debilitating disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aad33ff0adee236c1c773c1750932b0d5634824d" target='_blank'>
              Emerging Insights into the Role of Macrophages in Multiple Sclerosis: Pathogenesis and Potential Therapeutic Strategies
              </a>
            </td>
          <td>
            Jundong Yang, Ziyue Fu, Qiyuan Zou, Zhaoyinqian Li, Yuhan Xing
          </td>
          <td>2025-10-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aafe79bc1a3e7118116d1f3a06bf63a057763842" target='_blank'>
              Multivariate Host-Pathogen Interactions Driving Heterogeneous Viral Shedding and CD8+ T cell Control of Influenza Virus Infection
              </a>
            </td>
          <td>
            Nicole Bruce, J. J. Weaver, C. Jeynes-Smith, Fatemeh Beigmohammadi, Solene G. D. Hegarty-Cremer, Amanda P. Smith, Morgan Craig, Amber M. Smith
          </td>
          <td>2025-10-27</td>
          <td>None</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Activating immune receptors provides mechanisms for phagocytes to elicit important effector functions that promote the killing of microbes. Leukocyte immunoglobulin‐like receptor A5 (LILRA5), an orphan immune receptor expressed by human phagocytes and co‐localising with FcRγ, remains poorly characterised. To address this, we developed a highly specific anti‐LILRA5 monoclonal antibody that has agonistic properties. We show LILRA5 expression on naïve monocytes and neutrophils, and that ligation of LILRA5 stimulates ROS production. While increased LILRA5 transcripts have been associated with sepsis, we also observed increased levels in patients with systemic infection but without sepsis complications. Ex vivo bacterial infection of whole blood did not alter surface LILRA5 expression, but LPS stimulation changed expression levels, indicating that surface LILRA5 expression is dynamic and likely regulated post‐transcriptionally, changing responses to different stimuli or over time. Soluble (s)LILRA5 was enhanced in sera from sepsis patients and in supernatants of monocytes that were LPS‐stimulated, indicating that shedding of LILRA5 from cell surfaces or that expression of sLILRA5 isoforms provides a mechanism to regulate surface LILRA5 expression levels. Finally, we show that altered surface LILRA5 expression influences LILRA5‐induced ROS production capacity. Thus, LILRA5 is a dynamically regulated activating receptor expressed on phagocytes that stimulates ROS production.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e622c651c7e7739946e6713271f95711e4f0f55e" target='_blank'>
              LILRA5 Functions to Induce ROS Production on Innate Immune Cells
              </a>
            </td>
          <td>
            Zuyi Fu, Matevž Rumpret, Irina Kube-Golovin, M. Lyndin, Vera Solntceva, Yuxi Zhao, Anastasia Konieva, Na Liu, A. Press, Stefanie B Flohé, Michael Bauer, Gunther Wennemuth, Bernhard Singer, Alex J. McCarthy
          </td>
          <td>2025-10-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic, immune‐mediated autoimmune disease characterized by the infiltration of autoreactive T cells and other inflammatory immune cells from the periphery into the central nervous system. Currently, there is no cure for MS, and treatment consists of disease‐modifying therapies (DMTs), most of which modify or delete specific immune cell populations. These populations express crucial MS treatment‐associated receptors, which may be differentially expressed in each patient, and thus each drug may affect individuals differently. Here, we developed the first comprehensive 24‐parameter flow cytometry immunophenotyping panel to evaluate treatment‐associated receptor expression on the major MS‐associated immune cells in whole blood. Analyzing whole blood samples from treatment‐naïve individuals with MS using this panel, we demonstrated that expression levels of these receptors vary between individuals. Response to the chosen DMT treatment also differed across participants. When monitoring the receptor expression during the course of treatment, we detected an increased response to treatment when receptor expression was elevated at the start of treatment. This panel reliably detects these receptors in MS treatment‐naïve participants and enables monitoring of their expression throughout treatment. This tool will enable deep interrogation of the immune receptors targeted by MS therapies and highlights that treatment‐associated receptor expression levels might be used to predict or correlate with treatment response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/019f2dcb4e902228e625f81330b78afadd2958ea" target='_blank'>
              Monitoring Treatment‐Associated Receptor Expression in Multiple Sclerosis Using a Newly Developed Panel for Spectral Flow Cytometry
              </a>
            </td>
          <td>
            Katharina Robichon, Jennifer Taylor, Imogen Milner, Kathryn E Hally, A. L. La Flamme
          </td>
          <td>2025-09-23</td>
          <td>Cytometry Part A</td>
          <td>1</td>
          <td>27</td>
        </tr>

        <tr id="ABSTRACT The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in 2020 led to the immediate development of vaccines to combat SARS-CoV-2 infections and coronavirus disease 2019 (COVID-19). First-generation (2020–2021) COVID-19 vaccines demonstrated high immunogenicity and efficacy, successfully reducing hospitalization, disease severity and COVID-19 related deaths. However, the initial clinical trials for these vaccines focused on overall healthy individuals, and generally excluded high risk populations, such as people with cancer. The SARS-CoV-2 VaccinE Response, Immunological eFfects and safetY in patients with Cancer (VERIFY-C) study formed a unique cohort in early 2021, to capture the initial immune response to BNT162b2 mRNA (Pfizer) vaccination in people with cancer, with or without ongoing/recent exposure to systemic cancer treatment. Fifty-three participants diagnosed with cancer were enrolled. Majority were non-Hispanic, Caucasian females. Patients under cancer treatment had significantly lower antibody responses than those without treatment at pre-second dose and 1-month post-second dose. The levels at 6-months post-second dose were similar between both groups. Patients under treatment had a significantly lower immune response 1-month post-second dose, with an increased immune response at 6-months post-second dose, suggesting a delayed immune response. Further investigations are needed to understand antibody functionality post-vaccination in these individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e45420f0ba45dea4c651f1e55f885e82dbe1ff7e" target='_blank'>
              Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment
              </a>
            </td>
          <td>
            Christine M Dang, Troy J. Kemp, Nancy V. Roche, Katarzyna Haynesworth, Sarah A Loftus, Benjamin J Borski, Ziad El Bakouny, C. Labaki, Gwo-Shou Mary Lee, Rachel Trowbridge, Sarah Strauss, Melissa E Hughes, Nancy U Lin, T. Choueiri, Ligia A. Pinto
          </td>
          <td>2025-10-14</td>
          <td>Human Vaccines & Immunotherapeutics</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Leprosy is a chronic infectious disease that targets the peripheral nervous system, leading to peripheral neuropathy. Mycobacterium leprae primarily infects Schwann cells, adipocytes, and macrophages, altering their metabolism and gene expression. This study investigates the metabolic interaction between M. leprae and Schwann cells, with a focus on indoleamine 2,3-dioxygenase (IDO), a key enzyme in tryptophan catabolism via the kynurenine pathway. We found that M. leprae induces IDO expression in Schwann cells, suggesting a role in immune modulation and neuropathy. Inhibition of IDO with 1-methyl-L-tryptophan (1-MT) reduced Schwann cell viability and metabolic activity in response to M. leprae. After 24 h of infection, M. leprae impaired mitochondrial membrane potential, although no significant changes in autophagy or mitochondrial ultrastructure were observed by electron microscopy. Interestingly, IDO1 inhibition upregulated the expression of antioxidant genes, including GPX4, NFE2L2, and HMOX1. In conclusion, these findings highlight a central role for IDO in shaping the metabolic and immunological response of Schwann cells to M. leprae infection. IDO induction contributes to immune regulation and cellular stress, while its inhibition disrupts cell viability and promotes antioxidant gene expression. These results position IDO as a potential therapeutic target for modulating host–pathogen interactions and mitigating nerve damage in leprosy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/abb3610626dbc037a9c11480f7a7205f2b79ea22" target='_blank'>
              IDO-Mediated Immune and Metabolic Dysregulation in Schwann Cells Exposed to Mycobacterium leprae
              </a>
            </td>
          <td>
            Atta Ur Rahman, Raíssa Couto Santana, Mylena Masseno de Pinho Pereira, Claudia Luciana dos Santos Moura, Débora Santos da Silva, Otto Castro Araujo, Thyago Leal-Calvo, Isabela Espasandin, Tatiana Pereira da Silva, E. Sarno, Bruno J. de Andrade Silva, R. Menna-Barreto, M. M. Jardim, C. S. de Macedo, F. A. Lara, Roberta Olmo Pinheiro
          </td>
          <td>2025-10-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>53</td>
        </tr>

        <tr id="Introduction Tuberculosis (TB) remains a global health challenge, with active TB disease (ATB) and latent TB infection (LTBI) representing distinct immunological states. Understanding immune responses in these groups is critical for developing effective interventions. The complex nature of immune responses to Mycobacterium tuberculosis (M.tb) within and between different stages of TB, host evasion mechanisms of the bacterium, variable protection conferred by the BCG vaccine in adults, and lack of validated immune correlates of protection are among the key challenges to the successful control of TB. Methods In the present study, we conducted functional and phenotypic characterization of peripheral blood mononuclear cells (PBMCs) from a cohort in Southern Thailand. We compared immune responses in individuals with ATB, LTBI and healthy controls (HC) using flow cytometry (ATB n = 9, LTBI n = 11, HC n = 10) and the mycobacterial growth inhibition assay (MGIA) (ATB n = 13, LTBI n = 15, HC n = 15). Results MGIA revealed significantly enhanced control of BCG growth in the ATB group compared to LTBI and HC groups. Furthermore, NK cell frequency and TNF-α levels were significantly elevated in ATB compared to LTBI and HC groups, and CD4+ T cell TNF-α responses correlated with mycobacterial growth control. Discussion The findings from this study demonstrate differential immune responses across TB stages in this cohort, identify potential cellular markers for TB diagnosis and monitoring, and may guide vaccine strategies and host-directed therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/95c33572a14fddd060c679d30c84bcc77fc66109" target='_blank'>
              Functional and phenotypic characterization of peripheral blood mononuclear cells from tuberculosis patients in Southern Thailand
              </a>
            </td>
          <td>
            Pyae Sone Oo, Jomkwan Ongarj, Ratchanon Sophonmanee, Narisa Mohthong, Sahasawat Suksan, Natapohn Saowaphong, Rachel Tanner, Nawamin Pinpathomrat
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Abstract Macrophages are important sites of bacterial replication and host immune responses during Mycobacterium tuberculosis (Mtb) infection with distinct roles for alveolar macrophages (AMs) early in infection and monocyte-derived macrophages (MDMs) later in disease. Here, we leverage data from human and mouse models to perform a cross-species analysis of macrophage responses to Mtb. Overall, we find that both subsets of human and murine macrophages mount a strong interferon response to Mtb infection. However, AMs across both species do not generate as strong a pro-inflammatory response as human MDMs or murine bone marrow-derived macrophages (BMDMs), as characterized by TNFA signaling and inflammatory response pathways. Interestingly, AMs from mice that were previously vaccinated with BCG (scBCG) or from a model of contained TB (coMtb) had more similar responses to human AMs than control mice. We also identify species-specific pathways altered by infection differently in mouse and human macrophages, including cholesterol homeostasis. Lastly, to investigate downstream effects of the macrophage interferon responses, we examine expression of interleukin (IL)-10, an immunosuppressive cytokine induced by Type I Interferons, and c-Maf, a transcription factor required for myeloid IL-10 expression. We find that c-Maf and IL-10 have significantly lower expression in AMs compared to MDMs in both humans and mice, suggesting one possible mechanism by which AMs mount a stronger interferon response following Mtb infection. Overall, these results highlight the dynamics of innate myeloid responses throughout Mtb infection and the benefit of a combined analysis across species to reveal conserved and unique responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/194ddb392f765482c30469cec4ceddd1eb9d4221" target='_blank'>
              Shared and distinct responses of human and murine alveolar macrophages and monocyte-derived macrophages to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Kimberly A. Dill-McFarland, G. Peterson, Pamelia N. Lim, Shawn Skerrett, T. Hawn, A. Rothchild, Monica Campo
          </td>
          <td>2025-10-09</td>
          <td>ImmunoHorizons</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Extracellular vesicles (EVs) are rapidly gaining recognition as critical mediators of inter-cellular communication during viral infections. To contribute to fill the gap in knowledge regarding the role of EVs in adenovirus infection, we used human adenovirus type 4 of species Mastadenovirus exoticum (HAdV-E4), a prevalent respiratory and ocular pathogen, and characterized the cargo and biological properties of EVs released by HAdV-E4-infected A549 lung epithelial cells at a pre-lytic stage of infection. Using immunocapture-based isolation and multi-omics approaches, we found that infection profoundly alters the EV uploaded proteome and small non-coding RNA repertoire. Mass spectrometry identified 268 proteins unique to EVs purified from infected cells (AdV-EVs), with enrichment in pathways supporting vesicle trafficking and viral protein translation, and importantly also a few virus-encoded proteins. Small RNA transcriptome analysis showed differential uploading in AdV-EVs of various small non-coding RNAs, including snoRNAs, as well as the presence of virus associated RNAs I and II. Notably, AdV-EVs contained viral genomic DNA and were capable of initiating productive infection upon delivery to naïve cells in the absence of detectable viral particles. Our data suggest that EVs released during HAdV-E4 infection may serve as vehicles for non-lytic viral dissemination and highlight their possible role in intra-host dissemination.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2099efee27dc1f09a50509011e989cc86d99ff60" target='_blank'>
              Cargo and Biological Properties of Extracellular Vesicles Released from Human Adenovirus Type 4-Infected Lung Epithelial Cells
              </a>
            </td>
          <td>
            Alessio Noghero, Stephanie Byrum, C. Okeoma, A. Kajon
          </td>
          <td>2025-08-11</td>
          <td>Viruses</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Neuronal injury is a major pathological issue that cannot be ignored during viral infections. Mitochondria, the energy factories of the cell, play a unique role in this scenario and are severely impacted when viruses infect host cells. Viruses invade and infect cells via specific mechanisms, causing changes in cellular structure and function. These changes not only directly affect mitochondria but also disrupt their normal function through indirect pathways. This paper reviews the mechanisms of mitochondrial damage induced by infections with SARS‐CoV‐2, herpesviruses, human immunodeficiency virus (HIV), and hepatitis C virus (HCV), providing new insights and strategies for preventing and treating neuronal injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7d11a6515ce64c0aca63891acdc45f1bc68ba1f" target='_blank'>
              Mitochondrial Disruption in Viral‐Mediated Neuronal Injury: A Mechanistic Perspective
              </a>
            </td>
          <td>
            Shuqi Shi, Mingzhu Zhai, Benqing Wu, Wuping Sun
          </td>
          <td>2025-10-01</td>
          <td>Journal of Medical Virology</td>
          <td>1</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/01d23f6e4d0fadd94bb32dc65cae50f988969ac5" target='_blank'>
              Re-shaping the immune response to influenza vaccination in a host with immune memory from influenza
              </a>
            </td>
          <td>
            Chantelle L. White, Lara Mengu, Siva K. Gandhapudi, K. Richards, A. J. Sant
          </td>
          <td>2025-10-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="The SARS-CoV-2 pandemic presents a broad clinical spectrum from asymptomatic cases to severe respiratory failure with high mortality. Severe COVID-19 is characterized by immune dysregulation, including lymphopenia and alterations in the counts of T, B, and NK cells in peripheral blood. Due to the limited data on long-term outcomes related to immune dysregulation, we aimed to analyze immunologic features at baseline in severe and mild COVID-19 cases and assess follow-up characteristics associated with later mortality and long-COVID signs. We included adult patients consecutively hospitalized with COVID-19 between June and November 2020 at the University Hospital in Kraków, corresponding to the first and second waves of COVID-19 in Poland. We enrolled only those who had been thoroughly assessed in terms of clinic and laboratory data, including immunological workups, and survived the acute phase of the disease. In 2025, between February and April (median time of follow-up: 54 months), we conducted a telephone questionnaire on long-COVID symptoms among survivors who had given their consent. Statistical analyses were performed to compare groups with severe and mild disease in terms of dysregulation in lymphocyte subpopulations and the follow-up outcomes. The study included 103 COVID-19 patients, comprising 53 severe (based on the need for at least high-flow nasal oxygen therapy) and 50 mild cases, with no differences in age, sex, and body mass index. Severe COVID-19 patients compared to mild cases had lower CD3+ T cells (count and percentage), CD4+ T cells (count and percentage), CD8+ T cells (count), and NK cells (count), but higher CD19+ B cells (percentage) at baseline (p < 0.05, all). At the time of follow-up, we evaluated 80 patients (77.7% of the baseline participants), with 23 (22.3%) patients lost to follow-up. Among patients analyzed in the follow-up, 23 (28.8%) had died, and 29 of the 57 survivors (50.9%) reported persistent long-COVID symptoms. Patients who died had significantly lower baseline counts of CD3+ T cells (377 vs. 655 cells/µL), CD4+ T cells (224 vs. 372 cells/µL), CD8+ T cells (113 vs. 188 cells/µL), and NK cells (118 vs. 157 cells/µL) compared to survivors (p < 0.05, all). Notably, the percentage of CD19+ B cells was higher in deceased individuals (19.2% vs. 13.5%; p = 0.049). In contrast, we did not document differences in baseline immunological data among survivors with and without long-COVID signs. Our study suggests that dysregulation in lymphocyte subpopulations during the COVID-19 acute phase may be associated with increased late mortality, but not with the persistence of long-COVID symptoms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/de8b75924f0ad1abad27efe7fa8b5e02ab64f1f4" target='_blank'>
              Baseline Dysregulation in B, T, and NK Cells in COVID-19 Predicts Increased Late Mortality but Not Long-COVID Symptoms: Results from a Single-Center Observational Study
              </a>
            </td>
          <td>
            Aleksandra Matyja-Bednarczyk, Radosław Dziedzic, Anna Drynda, Ada Gradzikiewicz, Monika Bociąga-Jasik, Krzysztof Wójcik, Sabina Lichołai, K. Górka, N. Celejewska-Wójcik, Tomasz Stachura, K. Polok, L. Zarȩba, Teresa Iwaniec, Krzysztof Sładek, S. Bazan-Socha
          </td>
          <td>2025-10-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e2cd0bbb1e59a38e076fba7a9569f36e691a9aa" target='_blank'>
              SARS-CoV-2 infection induced alterations in ADAR editing patterns differ between patients who developed critical compared to non-critical COVID-19
              </a>
            </td>
          <td>
            A. M. Nair, H. Piontkivska
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3659e67328ffa6a7afc24383c34110e1246de0a3" target='_blank'>
              Single-Cell Atlas of CD4+ T-Helper 2 Cells Reveals Distinct Cytokine Functions Across Diseases
              </a>
            </td>
          <td>
            Son Vo, Maria Suprun, Han Do, My Ngo, Rajesh Rao, Saurabh Vishnu Laddha, Marta E Polak, Calixte Monast, Son Pham
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07b6cbe0eda40224684c97bf0f52bc79694f2cd8" target='_blank'>
              Third dose COVID-19 vaccination elicits immune memory in patients with inborn errors of immunity even in absence of neutralizing antibodies
              </a>
            </td>
          <td>
            E. S. J. Edwards, R. Gugasyan, N. Varese, S. Sun, J. E. Canning, E. G. Blight, P. Aui, I. Boo, S. Turville, A. Aggarwal, S. Ojaimi, J. J. Bosco, S. Stojanovic, P. M. Hogarth, H. E. Drummer, S. Bornheimer, R. O’Hehir, M. V. van Zelm
          </td>
          <td>2025-11-13</td>
          <td>None</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="Abstract Multiple sclerosis (MS) is characterized by immune-mediated demyelination and neurodegeneration. While cerebrospinal fluid (CSF) biomarkers can track tissue damage, the relationship between immune cell populations and tissue damage markers remains poorly understood. We performed comprehensive immunophenotyping of CSF samples from 63 participants [29 relapsing-remitting multiple sclerosis (RRMS), 7 primary progressive multiple sclerosis (PPMS), 27 patients with other suspected neurological diseases (OND)]. CSF levels of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) were measured using single-molecule array technology. Relationships between immune cell populations and biomarkers were assessed using partial correlation and multiple regression analyses, adjusting for age and sex. RRMS patients exhibited expanded lymphocyte populations compared with OND, with elevated CD3+ T cells (+5062 cells/mL, P < 0.0001) and CD19+ B cells (+180 cells/mL, P < 0.0001). Patients with multiple sclerosis showed an age-related shift in monocyte subsets, marked by increased CD14+CD16+ cells [rSP = 0.670, (95% CI: 0.44–0.81), P = 0.0029]. During active relapse, naive CD4+ T cells demonstrated the strongest association with NfL [cumulative geometric mean ratio = 2.892 (95% CI: 1.352–6.188), P < 0.0001], contrasting with non-relapse states [GMR = 0.689 (95% CI: 0.449–1.057), P = 0.101]. This study identifies distinct immunological signatures in multiple sclerosis and demonstrates disease activity-dependent associations between specific immune cell populations and tissue damage markers. The relationship between classical monocytes and GFAP in controls suggests a previously unrecognized role for myeloid cells in physiological CNS homeostasis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/46134946202a26ce86ebbd6da5499a6435fc3152" target='_blank'>
              Dynamic relationship between cerebrospinal fluid immune cells and tissue damage markers in multiple sclerosis
              </a>
            </td>
          <td>
            Sina Zaic, Theresa König, M. Ponleitner, Florian Gföllner, S. Silvaieh, N. Krajnc, T. Parvizi, S. Macher, B. Kornek, P. Rommer, Fritz Leutmezer, G. Bsteh, Elisabeth Stögmann, Thomas Berger, Tobias Zrzavy
          </td>
          <td>2025-11-05</td>
          <td>Brain Communications</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Recent studies suggest differential activation of immune cells and biochemical pathways during infection with distinct etiological agents of human malaria, Plasmodium falciparum or Plasmodium vivax. Rhesus monkeys infected with Plasmodium coatneyi develop pathology comparable to P. falciparum infection in humans, whereas P. vivax is modeled by infection with Plasmodium cynomolgi. To investigate host immune and metabolic responses, we analyzed and integrated public blood flow cytometry, transcriptomics, and untargeted metabolomics data from simian infection models and human malaria. We found conserved dynamics of blood dendritic cells, effector memory CD8+ T cells, and PD-1+ effector memory CD8+ T cells in simian infections; increased expression of HMOX1 and coagulation-related genes was conserved in simian infections, while the complement activation gene module was upregulated in rhesus and humans. Myeloid cell transcriptional responses were enriched in all infections, but gene modules reflecting chemokine responses and T cell differentiation were mostly associated with P. cynomolgi and P. vivax. Untargeted metabolomics analysis suggests conserved regulation of metabolites such as kynurenine and androgen- and estrogen-derived metabolites, and metabolic modules indicate tyrosine metabolism activity. Multimodal data integration from rhesus monkeys revealed distinct interacting network models. In conclusion, we identified conserved cellular, transcriptional, and metabolic responses between simian models and human malaria. Moreover, many significant variables were associated with one determined Plasmodium species, suggesting a significant impact of parasite biology on immune and metabolic host responses. However, systematic experimental comparisons are needed to distinguish species-specific host responses to Plasmodium from those that are caused by factors beyond the infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3ee554bc9cb54cbdfaa624b8d5a0a59e23dcd2be" target='_blank'>
              Systems Biological Analysis of Immune-Metabolic Host Responses to Distinct Malaria Parasites
              </a>
            </td>
          <td>
            Davi Vinícius Lima, Tiago Paiva Guimarães, Anne Cristine Gomes Almeida, Arthur Jesuz Teixeira, W. Monteiro, G. Melo, Luiz Gustavo Gardinassi
          </td>
          <td>2025-10-13</td>
          <td>ACS Omega</td>
          <td>0</td>
          <td>49</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5941ecec7872e6e7a4fe85dc2f11895a3625725" target='_blank'>
              PD-1 signaling is essential for the early accumulation of HBV-specific CD8+ T cells during HBV infection
              </a>
            </td>
          <td>
            Xiaoqing Zeng, Wen Pan, Ziwei Li, Zhaoli Liu, Hongming Huang, Xuecheng Yang, K. Sutter, Mengji Lu, Ulf Dittmer, Gennadiy Zelinskyy, Xin Zheng, Dongliang Yang, P. Kennedy, Yanqin Du, Jia Liu
          </td>
          <td>2025-09-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="INTRODUCTION
Cytokine storm can result from uncontrolled proinflammatory cytokines released in SARS-CoV-2 infection that cause damage to several organs. Il-6 is one of the major mediators of cytokine storm. IFN-α2 has been reported to have anti-viral potential and the pre-infection levels of proinflammatory cytokines have been suggested to drive the fate of the disease. There is a paucity of information on how anti-viral cytokines at the onset of infection affect the disease progression. This study aims to profile IL-2, IL-6, IL-10, and IFN-α2 expression levels for 44 days post-diagnosis and their effects on recovery.


METHODS
Peripheral venous blood was collected from 38 SARS-CoV-2 infected participants who came for diagnosis at the Center for Research on Emerging and Reemerging Diseases. IL-2, IL-6, IL-10, and IFN-α2 levels were measured using a Luminex panel.


RESULTS
Males had higher SARS-CoV-2 viral load than females, although the difference was not statistically significant (p=0.08). Age-related variation was also observed, with individuals aged 40-60 showing significantly higher viral load than those over 60 (p=0.045). Cytokines analysis revealed that males had significantly higher levels of IFNα-2, IL-2, and IL-6 (p=0.0031, p=0.009, and p=0.022 respectively) than females upon diagnosis, with cytokines levels decreasing over time in males but increasing in females. Cytokine levels trended higher in symptomatic individuals, although differences were not significant.


CONCLUSION
These findings highlight the influence of sex, clinical status, and viral load on cytokine dynamics in COVID-19, with potential implications for understanding disease severity and immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a96153529dbc58b976dae603414f6f5491296d91" target='_blank'>
              Cytokines dynamics and biological sex differences in SARS-CoV-2 infected people in Cameroon.
              </a>
            </td>
          <td>
            Hillary Tene, Romuald Ngamaleu, R. Djounda, Rachel Minomo, Sabine Ngale, Micheal Besong, Honore Awanakam, Krystelle Nganou Makamdop, Rene Essomba, Jude Bigoga, Daniel C. Douek, L. Esemu
          </td>
          <td>2025-09-22</td>
          <td>Clinical and experimental immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Inflammasomes and interferons are two critical defense mechanisms of innate immunity, and their imbalance is a key strategy employed by viruses to evade host immune surveillance. During porcine reproductive and respiratory syndrome virus (PRRSV) infection, an arteritis virus, a characteristic “high inflammation, low interferon” immune imbalance is observed. This study identifies PRRSV non-structural protein NSP5 as a central mediator of this immune imbalance. We demonstrate that NSP5 recruits NLRP3 to the endoplasmic reticulum (ER)-mitochondrial interface, triggering ER stress and Ca2+ leakage, which subsequently activates the NLR family pyrin domain containing 3 (NLRP3) inflammasome. Notably, a specific NSP5 mutation (G30A) abolishes its ability to activate NLRP3. PRRSV carrying this mutation exhibits suppressed NLRP3 activation and IL-1β release. Concurrently, NSP5 retains STING in the ER, preventing its trafficking and inhibiting type I interferon induction. This dual mechanism ultimately drives the high inflammation and low interferon phenotype observed during PRRSV infection. Importantly, our findings reveal that a single viral protein can orchestrate immune imbalance, suggesting a potentially widespread strategy for viral evasion of host immune surveillance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4e730d92266f5f6b0990407c8ac29dced1f7ed68" target='_blank'>
              PRRSV NSP5 orchestrates dual immune disruption by targeting NLRP3 and STING
              </a>
            </td>
          <td>
            Xiangyu Huang, Xuyan Xiang, Xiaohan Jiang, Weiyu Qu, Yufei Zhang, Zhenchao Zhao, Minjie Li, Haiwei Wang, Xin Li
          </td>
          <td>2025-10-16</td>
          <td>Veterinary Research</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Parrots, valued companion animals with a concerning conservation status, can act as reservoirs for zoonotic diseases. During various infections, systemic inflammation significantly impairs host health. However, the regulation of inflammatory responses in birds, particularly in cognitively advanced parrots, remains poorly understood. Here, we examine parrot systemic inflammation in response to virus-mimicking stimulation. In budgerigars (Melopsittacus undulatus), a novel model for neuroinflammation research, we induced sterile inflammation with synthetic poly(I:C) RNA and analysed dose-, time- and tissue-dependent gene expression patterns of key markers, including TLR3, NLRP3, CASP1, IL1B and IL6, during acute immune response. We report a significant relationship between cytokine expression (IL1B, IL6) in the intestine (local response) and brain (systemic response) that has not yet been described after viral stimulation in parrots. Peripheral IL6 expression was upregulated at 3–6 h after stimulation with poly(I:C). In the brain, multiple genes (TLR3, IL1B and IL6) showed activation early during the immune response. These findings highlight the susceptibility of parrots to neuroinflammation following viral infections, having specific relevance for basic research in neurobiology, immunology and behavioural science, and also veterinary research in psittacine birds. Our study provides a foundation for future comparative research on avian neuro-immune crosstalk and neuroinflammation-related behavioural disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b23dca0d96ff356c079d40ec7845a15398f0ccf4" target='_blank'>
              The neuro-immune crosstalk between periphery and central nervous system during acute immune response to virus-mimicking RNA in parrots
              </a>
            </td>
          <td>
            Balraj Melepat, Daniel Divín, Kateřina Marková, Tao Li, Nithya Kuttiyarthu Veetil, Eleni Voukali, Lucie Schmiedová, Martin Těšický, Michal Vinkler
          </td>
          <td>2025-10-01</td>
          <td>Royal Society Open Science</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Zika virus (ZIKV) can infect and replicate in the endoplasmic reticulum (ER) of different human cell types, including neural progenitor cells, radial glial cells, astrocytes, and microglia in the brain. ZIKV infection of microglia is expected to trigger both ER stress and the induction of an antiviral response through production of type-I interferons and pro-inflammatory cytokines, contributing to neuroinflammation during infection. Despite their critical role in ZIKV pathogenesis, the interplay between ER stress and the antiviral response during infection has not been fully characterized in human microglia. In this work, we show that infection of a human microglia cell line with ZIKV triggers the induction of an antiviral response and the activation of the endonuclease activity of the unfolded protein response sensor IRE1. Interestingly, we observed that both IRE1 and XBP1 were sequestered to the viral replication sites during infection. Moreover, pharmacological inhibition or hyperactivation of the endonuclease activity of IRE1 resulted in reduced viral titers. As such, while inhibition of IRE1 resulted in an increased type-I interferon response, hyperactivation led to a decrease in ZIKV RNA levels and the appearance of ER-derived cytoplasmic structures containing NS3, IRE1, and XBP1. Together, our data indicate that regulation of the endonuclease activity of IRE1 is critical for both ZIKV replication and immune activation, highlighting the potential of the ER stress sensor as a target for the development of antivirals to treat ZIKV infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c49266713c41489835395ed05f1e9648bda8bc34" target='_blank'>
              Activation of IRE1 Endonuclease Activity Regulates Zika Virus Replication and Antiviral Response During Infection in Human Microglia
              </a>
            </td>
          <td>
            Tomás Hernández-Díaz, A. Oyarzún-Arrau, Aracelly Gaete-Argel, Delia López-Palma, Javier López-Schettini, Dominique Fernández, F. Valiente-Echeverría, Fabiola Osorio, R. Soto-Rifo
          </td>
          <td>2025-09-24</td>
          <td>Viruses</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="T-cell exhaustion is a terminal state of immune dysfunction characterized by impaired proliferation and effector functions, diminished cytokine secretion, and sustained expression of inhibitory receptors. In coronavirus disease 2019 (COVID-19), increasing evidence links exhausted T-cell phenotypes with poor clinical outcomes, including severe disease, delayed viral clearance, and persistent symptoms associated with Long COVID. Exhaustion results from prolonged antigenic stimulation and inflammatory signals and is marked by transcriptional reprogramming, metabolic and epigenetic dysregulation, and co-expression of inhibitory receptors such as programmed cell death protein-1 (PD-1), T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Notably, exhausted phenotypes in COVID-19 frequently coexist with hyperactivation, raising the unresolved question of whether inhibitory receptor expression reflects transient activation or irreversible dysfunction. Emerging therapeutic strategies to reverse these dysfunctional states include immune checkpoint inhibitors, cytokine modulation, metabolic interventions, and epigenetic therapies, although their clinical translation remains at an early stage. Critical research gaps include the scarcity of longitudinal data, incomplete profiling of T-cell subsets across disease stages during COVID-19 and Long COVID-19, and contradictory evidence of vaccine-induced exhaustion with limited understanding of its consequences. This non-systematic literature review synthesizes current advances in COVID-19 immunopathology and therapeutic strategies, underscoring that understanding T-cell exhaustion is crucial to improving outcomes and shaping next-generation immunotherapies and vaccines.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fcda848fedb31d45bcaf7a6be07292887c93eed0" target='_blank'>
              T-cell exhaustion in COVID-19: what do we know?
              </a>
            </td>
          <td>
            Roderick Chen-Camaño, Rodrigo DeAntonio, S. López-Vergès
          </td>
          <td>2025-10-29</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Age is a critical factor in immune responses to infection. In malaria, severe disease risk increases with age in non-immune individuals. Malaria severity is in part driven by inflammation, but mechanisms contributing to age-dependent disease risk are incompletely understood. We assessed inflammatory cytokines during malaria in non-immune children and adults, and innate cell responses in vitro to malaria parasites in naive children and adults. We show during malaria age is associated with increased inflammatory chemokines CCL2, CCL3, CXCL8, CXCL9, along with CRP, and IDO, which associate with symptoms. In naive individuals, classical monocyte and Vδ2+ γδ T cells from adults have higher inflammatory cytokine production, and transcriptional activation following stimulation with parasites. Classical monocyte responses in adults are dominated by CCL2, while in children increased IL10 and enrichment of IL10 signaling pathways is detected. Findings identify age-dependent cellular mechanisms that play crucial roles in driving inflammatory responses in malaria. How age affect the immune response to malaria is not fully understood. Here, the authors characterise the transcriptome and serum inflammatory cytokines in children and adults in response to malaria, showing that there is an increase of inflammatory chemokine and cellular responses in adults compared to children.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/08d5c0c81051d13694cfc33dd1cf3b4215156753" target='_blank'>
              Age is an intrinsic driver of inflammatory responses to malaria
              </a>
            </td>
          <td>
            Jessica R. Loughland, Nicholas L Dooley, Zuleima Pava, Arya SheelaNair, D. Andrew, Peta E. Tipping, Peter Bourke, C. Engwerda, J. A. Lopez, Kim A. Piera, Timothy William, Bridget E. Barber, M. Grigg, N. Anstey, Gabriela Minigo, Michelle J. Boyle
          </td>
          <td>2025-09-30</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Pneumococcal infection of the leptomeninges triggers a strong inflammatory response, contributing to tissue damage and adverse outcome in meningitis. While border-associated macrophages (BAM) are thought to initiate immune responses against pathogens, their exact role in pneumococcal meningitis (PM) - especially at later stages - remains unclear. This study examined the impact of BAM depletion on disease progression. Mice received intracisternal injections of clodronate liposomes (CL) to deplete BAM, followed three days later by intracisternal infection with Streptococcus pneumoniae. At 18 h post-infection, CL-treated mice exhibited clinical signs similar to controls treated with phosphate-buffered saline liposomes (PBSL). However, CL-treated mice had lower cerebrospinal fluid leukocyte counts, increased expression of brain immune mediators, and elevated plasma levels of neuronal damage (NEFL) and astrocyte activation (S100B) markers. Over a 42-h observation period - during which ceftriaxone therapy was started 18 h post-infection - CL-treated mice showed significantly worse outcomes: 9 of 12 reached termination criteria versus 1 of 9 PBSL-treated mice. This correlated with more severe neuropathology, higher bacterial loads, and persistent inflammation. Notably, infection with a pneumolysin-deficient mutant conferred strong protection against disease aggravation caused by macrophage depletion, whereas caspase-1 inhibition - despite its known immunosuppressive effects in experimental PM - did not. These findings underscore a critical immunoregulatory role for BAM in PM, particularly in resolving rather than initiating inflammation. Their absence exacerbates disease severity, mainly due to increased bacterial proliferation and elevated levels of bacterial toxins.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6563837df86067b2d0826abdc0bf8ed3eb50df5b" target='_blank'>
              Pharmacologic depletion of border-associated macrophages worsens disease in a mouse model of meningitis
              </a>
            </td>
          <td>
            Susanne Dyckhoff-Shen, I. Masouris, H. Pfister, Stefanie Völk, Sven Hammerschmidt, Matthias Klein, U. Koedel
          </td>
          <td>2025-09-23</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="Emerging evidence suggests brain-resident myeloid cells, including perivascular macrophages and microglia, provide a reservoir for HIV infection in the central nervous system (CNS), and their inflammatory activation is a proposed pathogenic mechanism in HIV-associated neurocognitive disorders (HAND). We investigated whether cannabinoid receptor 2 (CB2), an immunomodulatory receptor expressed in myeloid cells, regulates viral replication and inflammation in HIV-infected macrophages and microglia. Using the synthetic CB2-specific agonist JWH-133, we found that CB2 activation reduced HIV replication in primary human monocyte-derived macrophages (MDMs) and human induced pluripotent stem cell-derived microglia (iMg) at differing doses, corresponding to the basal expression of CNR2, which encodes CB2, and related endocannabinoid transcripts in each cell type. JWH-133 broadly reduced release of cytokines from HIV-infected MDMs but not iMg. RNA-seq revealed that CB2 agonism primarily altered interferon and integrated stress response pathways in MDMs while altering homeostatic pathways, including synapse maintenance and phagocytosis, in iMg. Further analyses in iMg revealed that NLRP3 inflammasome activation, but not priming, was reduced by CB2 activation, which did not inhibit HIV-induced nuclear factor kB activation. This study identifies key differences in CB2 response between myeloid lineage cell types and implicates CB2-specific agonists as promising candidates for the regulation of HIV-associated neuroinflammation. Created in BioRender. Espinoza, C. (2025) https://BioRender.com/mxfla3i">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71c568f55c0cf3f5f771b5d05ce139396b2d6389" target='_blank'>
              Differential Effects of Cannabinoid Receptor 2 Agonists on HIV Replication and Inflammatory Activation in Monocyte-Derived Macrophages and Induced Pluripotent Stem Cell-Derived Microglia
              </a>
            </td>
          <td>
            Alexander Starr, Sara Rathore, Marzieh Daniali, P. J. Gaskill, Ç. Akay-Espinoza, Kelly L Jordan-Sciutto
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroimmune Pharmacology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Objective Thyroid hormones (TH) are well-known regulators of the immune system. However, the precise immunomodulatory mechanisms of TH action in immune cells remain elusive. In a previous study, an essential role of the TH receptor α (TRα) in regulatory T cell (Treg) immunity was demonstrated, affecting Treg activation at steady state. The present study therefore aimed to unravel the biological relevance of altered TRα action in protective immune responses during disease. Methods To assess the role of TRα action in immune responses, especially T cell responses, during disease, different TRα signaling mouse models (TRαKO, complete lack of TRα signaling; TRαGS, lack of canonical signaling) were challenged with influenza virus A/PR8/34, and in-depth immune phenotyping was performed. Results Upon influenza virus infection, TRαGS mice, which lack canonical TRα signaling, showed prolonged survival and reduced disease severity, correlating with enhanced anti-inflammatory Treg and decreased pro-inflammatory CD4 and CD8 T cell responses. The loss of TRα action in TRαKO mice was related to elevated viral titers upon influenza virus infection, which correlated with increased inflammatory monocyte responses early during infection. Conclusion The present study demonstrates a complex role of TRα signaling in protective immune responses during disease, with distinct effects on innate and adaptive immune cells. By exploring the understudied link between the endocrine and immune systems, this study provides novel evidence for the role of TH as modulators of immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a7d2ba259d2172edff4c6833e354709fd3242434" target='_blank'>
              Thyroid hormone receptor α signaling shapes innate and adaptive immune responses during viral infection
              </a>
            </td>
          <td>
            Christina Wenzek, T. Knuschke, G. S. Hönes, A. Boelen, R. Klopfleisch, Denise Zwanziger, Heike Heuer, A. Westendorf, L. C. Moeller, Dagmar Führer
          </td>
          <td>2025-10-27</td>
          <td>European Thyroid Journal</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="INTRODUCTION
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that emerged shortly after the coronavirus disease 2019 (COVID-19) pandemic began have altered epidemiological and clinical findings; and these variants changed the course of this health crisis.


METHODOLOGY
Whole-genome sequencing was performed on SARS-CoV-2 strains isolated from 21 patients with COVID-19. The frequency of structural changes in the virus and their effects on clinical findings of the disease were analyzed.


RESULTS
The spike Q493R mutation was detected more frequently in patients who had received four or more doses of a COVID-19 vaccine (p = 0.043). The clinical effect of the spike R346K and A263T mutations (reported in Türkiye for the first time) detected in a patient who had received four doses of the vaccine in the 3 months prior to being infected with COVID-19 could be related to escape from the antibody response. The spike R21T mutation may increase the virus's entry into intestinal cells; and, as a result it may be responsible for severe clinical course and gastrointestinal symptoms. The patient infected with the Omicron BA.2 subvariant with the spike L452M mutation exhibited a significant increase in inflammatory parameters; suggesting that this mutation may trigger an excessive immune response and hyperinflammation.


CONCLUSIONS
This is the first study based in Türkiye that evaluated the clinical impact of variations in the sequences of SARS-CoV-2 variants. There is a need for further investigation into the clinical impact of these results in a larger population spread over more centers, and more sequencing studies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f9038ab2f87898403bd45b31ad5eff4904f2f429" target='_blank'>
              Whole genome sequencing and analysis of the clinical implications of SARS-CoV-2 strains.
              </a>
            </td>
          <td>
            Firuze Soyak, Tugba Sari, O. Tokgun, Ahmet Çalışkan, Hüseyin Turgut
          </td>
          <td>2025-09-30</td>
          <td>Journal of infection in developing countries</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Abnormal lipid metabolism is observed in Alzheimer’s disease (AD), but its contribution to disease progression remains unclear. Genetic studies indicate that microglia, the brain’s resident immune cells, influence lipid processing during AD. Here, we show that microglia—the brain’s resident immune cells—selectively regulate lipid accumulation that associated with disease pathology in both AD mouse models and human postmortem brains. Using lipidomics and histological analysis, we identify a striking buildup of arachidonic acid–containing bis(monoacylglycero)phosphate in response to amyloid plaques, which depends on microglial activity and the AD risk gene GRN. In contrast, lysophosphatidylcholine and lysophosphatidylethanolamine accumulate independently of microglia, correlating instead with astrocyte activation and oxidative stress. These results connect dysregulated lipid metabolism in AD to distinct brain cell types and molecular pathways. Our findings highlight microglial lipid homeostasis as a potential therapeutic target for modifying disease progression in AD. Alzheimer’s disease disrupts brain lipid metabolism; while microglia are likely implicated, the relationship is unclear. Here, the authors show that microglia selectively regulate lysosomal and myelin lipids, but other lipid changes occur independently of microglia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dcf1904c66d1a89b63b357f3807774f51ef30d3a" target='_blank'>
              Microglia-specific regulation of lipid metabolism in Alzheimer’s disease revealed by microglial depletion in 5xFAD Mice
              </a>
            </td>
          <td>
            Ziying Xu, Sepideh Kiani Shabestari, Savannah Barannikov, Kevin F. Bieniek, Mathew Blurton-Jones, J. Palavicini, Xianlin Han
          </td>
          <td>2025-10-15</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Chronic active lesions are a manifestation of multiple sclerosis (MS) and have been associated with disease progression. While astrocytes are heavily implicated in MS, little is known about their role in lesions, particularly in the lesion core. Here, we sought to gain insight into the spatial relationship between astrocytes and defined regions of chronic active lesions, and to better understand the environment within the relatively understudied lesion core, an area primarily composed of astrocytes. We analyzed four defined protein panels, focusing on astrocytes, in postmortem fresh-frozen cortical white matter tissue using NanoString GeoMx spatial protein profiling to compare normal appearing white matter (NAWM), the chronic active perilesion, rim, and core. We then performed immunofluorescent microscopy to determine the localization patterns of identified proteins within astrocytes. The most significant differences were observed between the chronic active lesion core and both NAWM and the perilesion. Proteins upregulated in the core relative to NAWM or the perilesion included the MAPK signaling pathway, immune checkpoint proteins, and indicators of phagocytosis. Our data indicate that astrocytes in the lesion core are distinct and actively influence the microenvironment. We posit that the differentially upregulated astrocytic signaling pathways, namely MAPK, immune checkpoints, and debris engulfment, are indicative of reactive astrocytes providing support to demyelinated axons by tempering the inflammatory milieu and clearing debris within the lesion core.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c0a97d1382855a706882af091c7b1299092d9d4a" target='_blank'>
              Spatial protein profiling reveals active roles for astrocytes in the chronic active lesion core during multiple sclerosis
              </a>
            </td>
          <td>
            Brandon C. Smith, Anthony Chomyk, Maria L. Habean, Benjamin C. Shaw, Rachel A. Tinkey, Bruce D. Trapp, Jessica L. Williams
          </td>
          <td>2025-11-01</td>
          <td>Acta Neuropathologica</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Highlights What are the main findings? COVID-19 patients show a unique DNA methylation profile in the upper airway, with over 510,000 differentially methylated CpGs affecting antiviral, interferon, and immune response genes. Some methylation changes are temporary, normalizing after 6 weeks, while key immune regulators (e.g., IL17A, ERK1/2, OAS1, MX1) remain significantly involved. What is the implication of the main finding? SARS-CoV-2 may reprogram immune and repair pathways in the airways, influencing recovery and susceptibility to future respiratory infections. These findings provide potential targets for biomarkers and therapeutic strategies to modulate post-COVID-19 airway health. Abstract SARS-CoV-2 infection remains a global health concern, with its impact on host immune responses not fully understood. In a case–control study, we examined how COVID-19 affects DNA methylation patterns in the upper respiratory airway of hospitalized individuals. DNA methylation arrays were performed on nasopharyngeal samples at inclusion/hospitalization and 6 weeks post-inclusion. We found a distinct DNA methylation pattern in COVID-19 patients compared to healthy controls, identifying 510,099 differentially methylated CpGs. Within the transcription start sites (TSSs) and gene body, COVID-19 patients displayed a higher number of genes/CpGs with elevated methylation levels. Enrichment analysis of TSS-methylated genes revealed effects of SARS-CoV-2 on genes associated with type I interferons, anti-viral and inflammatory responses, and immune functions. Some CpG methylations were transient, and normalized at group level by 6 weeks post-inclusion. Several IFN-regulated genes, including OAS1, OAS3, IFIT3, and MX1, were identified. Among the top regulators were IL17A and ERK1/2, both involved in inflammatory processes. Networks nodes included IGF1 and EGF, associated with processes including tissue repair and activation of immune responses. Overall, our data suggests that COVID-19 can impact the upper airway by modifying gene methylation patterns. This could have implications for conditioning of the airways, how individuals respond to future airway infections, and therapeutic interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c17feb2000b785e79540fe240ded0e083db9f8dc" target='_blank'>
              Altered DNA Methylation Pattern Contributes to Differential Epigenetic Immune Signaling in the Upper Respiratory Airway of Unvaccinated COVID-19 Patients
              </a>
            </td>
          <td>
            Melissa Govender, Jyotirmoy Das, Francis R. Hopkins, Cecilia Svanberg, Johan Nordgren, M. Hagbom, Jonas Klingström, Åsa Nilsdotter-Augustinsson, Y. Yong, V. Velu, S. Raju, Johanna Sjöwall, Esaki M. Shankar, Sofi A Nyström, Marie Larsson
          </td>
          <td>2025-10-27</td>
          <td>Cells</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="

 Despite extensive research, the pathogenesis and predispositions underlying long COVID (long-term coronavirus disease 2019) remain poorly understood.



 To address this, we analyzed the immunological landscapes of 44 patients with long COVID and 44 matched convalescents using single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) and validated the findings with plasma cytokine measurements via Luminex technology.




 While the immune cell compositions showed minimal quantitative differences only among natural killer (NK) cells, the transcriptome analyses identified distinct gene expression patterns, particularly in classical monocytes: patients with long COVID exhibited downregulation of the inflammation-associated genes, including
 IL1B
 and
 CXCL2
 . Imputation of the transcription factor activity hinted at a reduced inflammasome activity (via
 SNAI1
 ) and an impaired monocyte differentiation (via
 ATF2
 ) in long COVID. The RNA velocity data supported the presence of immature classical monocytes in these patients.




 These findings show that monocytes might be dysregulated and/or exhausted in patients with long COVID.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3892a0439deb222191d646b042b2e39ae2bf0fef" target='_blank'>
              Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients
              </a>
            </td>
          <td>
            Florian Fricke, Franz Mai, Christine Wossidlo, Felix Steinbeck, Wendy Bergmann-Ewert, Marcel Kordt, Karin Kraft, Britta Müller, Emil C. Reisinger, Brigitte Müller-Hilke
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="BackgroundMicroglia are central mediators of neuroinflammation in Alzheimer's disease (AD), contributing significantly to disease pathogenesis. Understanding microglial heterogeneity and their regulatory mechanisms is critical for identifying potential therapeutic targets.ObjectiveThis study aimed to investigate the diversity of microglial subpopulations in AD and uncover key transcriptional regulators driving their pathogenic activity.MethodsWe integrated bulk RNA sequencing data from AD patients and 5×FAD mouse models with single-cell RNA sequencing (scRNA-seq) to profile microglial heterogeneity. Differential gene expression, pathway enrichment, pseudotime trajectory, and SCENIC analyses were used to identify functionally distinct subsets and regulatory networks. Experimental validation was conducted through in vivo assays in 5×FAD mice and in vitro inhibition studies targeting HIF-1α.ResultsA unique microglial subpopulation, termed microglia_2, was identified with an inflammatory-angiogenic transcriptional signature that was enriched during AD progression. This subset showed significant activation of inflammatory pathways. Pseudotime and SCENIC analyses revealed HIF-1α as a master regulator of microglia_2. In 5×FAD mice, cognitive decline was accompanied by increased expression of HIF-1α and Apoe, as well as microglial activation in the prefrontal cortex. In vitro inhibition of HIF-1α significantly reduced microglial inflammation.ConclusionsOur study demonstrates that a specific microglial subpopulation characterized by elevated HIF-1α expression may contribute to AD-associated neuroinflammation. By integrating transcriptomic analyses and experimental validation, we provide cell type-specific insights into disease mechanisms, offering potential insights for future mechanistic studies and therapeutic exploration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e93c7b3dbe189816e022a4a45715e584784e4e7e" target='_blank'>
              HIF-1α-induced microglia-mediated neuroinflammation is involved in Alzheimer's disease: Evidence from single-cell transcriptomic analysis.
              </a>
            </td>
          <td>
            Manyu Dong, Yilun Qian, Yao Geng, Ruiyu Wang, Yu Wang, Jili Cai, Xihui Wang, Ying Huang, Yan Liu, Wentao Liu, Qi Wu, Ying Shen
          </td>
          <td>2025-09-19</td>
          <td>Journal of Alzheimer's disease : JAD</td>
          <td>1</td>
          <td>3</td>
        </tr>

        <tr id="Introduction The transition from inflammation to proliferation is a critical but poorly understood phase in wound healing. To elucidate the cellular and molecular dynamics of this pivotal stage, we performed single-cell RNA sequencing (scRNA-seq) on mouse skin biopsies 4 days after injury. Methods By employing our newly developed R packages, OptiRes for optimized clustering and TidyGenePlot for annotation, we identified 21 distinct cell types. CellChat analysis was used to identify intercellular communication clusters. Findings on chemotactic signaling through CCR5, CCR1, and ACKR1 were validated in vivo, and the functional significance was confirmed by demonstrating that inhibition of CCR pathways reduced phagocyte infiltration. Results Our analysis revealed a dynamic shift in cellular composition, characterized by an influx of neutrophils, classical monocytes, and M1 macrophages. This recruitment of phagocytes was driven by enhanced chemotactic signaling through CCR5, CCR1, and ACKR1. Furthermore, CellChat analysis identified four distinct intercellular communication clusters, highlighting the early activation of VEGF and EGF signaling pathways, which are essential for angiogenesis and re-epithelialization. Discussion Together, these findings provide a high-resolution map of the cellular and molecular landscape during the transition from inflammation to proliferation, offering novel insights into the mechanisms that orchestrate tissue repair and identifying potential intervention manner to enhance wound healing.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dea50aded0034e870eae144612b4869eb621ef6d" target='_blank'>
              Bridging inflammation and proliferation: scRNA-seq analysis of chemotactic and growth factor signaling in mouse skin wound repair
              </a>
            </td>
          <td>
            Lingzhang Meng, Hongmian Li, Jian Song, Wenxian Lin, Xiuli Mao, Xiamin Zhang, Mingyu Yang, Kezhao Wu, Liu Lu, Feiteng Liang, Feng Long, Yueyong Li, Qiang Tang
          </td>
          <td>2025-09-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d1d21447178093351e803b8b614442677ca29c26" target='_blank'>
              The TEAIV model: Extending the standard TEIV model to account for viral budding ramp up
              </a>
            </td>
          <td>
            S. Gholami, C.S. Korosec, Q. Su, M.I. Betti, J. M. Conway, I. R. Moyles, J. Watmough, J. Heffernan
          </td>
          <td>2025-11-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Emerging evidence underscores the critical role of Toll-like receptor 7 (TLR7)-mediated interferon (IFN) signaling in host defense against viral infections including SARS-CoV-2, through the modulation of both innate and adaptive immunity. However, the specific mechanisms by which TLR7 activation shapes SARS-CoV-2-specific immune responses, particularly via IRF-IFN pathways, remain incompletely elucidated. This review synthesizes current findings on how intrinsic TLR7-driven IFN signaling influences viral clearance, modulates adaptive immunity, and contributes to autoantibody production in COVID-19. A deeper understanding of these processes is essential for developing targeted therapeutic interventions and improved vaccines aimed at mitigating severe COVID-19 and preventing post-acute sequelae of SARS-CoV-2 infection (PASC).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2bd6dead6a1a78751a4bbff0555654ffbab2b138" target='_blank'>
              Unraveled role of TLR7-mediated interferon signaling activation in COVID-19
              </a>
            </td>
          <td>
            Junjian Xue, Xiaoyin Wang, Hui Wang, Bin Qiao, Pengfei Gao, Bin Ren, Shushan Yan
          </td>
          <td>2025-10-08</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a25d1a5423c9c1eef83bca0be3e66901f651d912" target='_blank'>
              Pre-treatment naïve T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanoma
              </a>
            </td>
          <td>
            K. Marks, Alice Horisberger, M. Elahee, I. Adejoorin, Nilasha Ghosh, M. Postow, L. Donlin, Anne R Bass, Deepak A. Rao
          </td>
          <td>2025-10-31</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>93</td>
        </tr>

        <tr id="The intra-host diversity of SARS-CoV-2 in pediatric populations remains insufficiently studied. To address this significant knowledge gap, the present study investigates the intra-host variability of SARS-CoV-2 in both immunocompetent and immunodeficient children, including those with severe cases. The research encompasses both short-term and long-term infections, aiming to provide a comprehensive understanding of viral dynamics in these vulnerable groups. This study analyzed 47 pediatric COVID-19 patients: 37 with short-term infections and 10 with long-term infections including 3 immunodeficient cases. Viral RNA was extracted and detected using RT-qPCR, followed by whole-genome sequencing (WGS) using the Illumina COVIDSeq assay. Bioinformatics analysis was performed with the nextflow/viralrecon pipeline. The number of single nucleotide polymorphisms (SNPs) and the frequency of Major (M-SNPs) and minor (m-SNPs) missense SNPs were analyzed using the ggplot2 R package and GraphPad Prism software, respectively. A total of 96 SARS-CoV-2 sequences from 45 patients (35 short-term and 10 long-term shedders), were classified into four variants: Alpha, B.1.160, Delta, and Omicron. SNPs were common across SARS-CoV-2 variants (88.21%-100%), with frequent cytosine-to-thymidine (C > T) substitutions (44.05%-52.85%). Missense mutations were also prominent (57.52% to 80.32%). Variability in SNPs numbers was observed over time in Delta and Omicron variants, particularly in severe and immunodeficient cases. Missense m-SNPs exhibited variation in long-term shedders, especially among severe immunocompetent and immunodeficient patients. Our findings revealed significant intra-host variability in SARS-CoV-2 among severe and immunodeficient pediatric patients. These results underscore the critical importance of continuous surveillance of viral variants within pediatric populations to enhance our understanding of their impact on disease progression and clinical outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4e973c51fc8ed78f3afe6698d11bd2f8f55fefd4" target='_blank'>
              Intra-host diversity of SARS-CoV-2 in children with long-term and short-term excretion in nasopharyngeal samples
              </a>
            </td>
          <td>
            Haifa Khemiri, Alessio Lorusso, Kaouther Ayouni, N. Radomski, M. Khaled, I. Mangone, A. Di Pasquale, C. Cammà, Ilhem Ben Fraj, N. Mekki, Khawla Meftah, Oussama Souiai, Imene Ben Mustapha, Semia Rekaya, H. Touzi, A. Sadraoui, Z. Meddeb, Nahed Hogga, H. Smaoui, M. Barbouche, M. Ouederni, Mariem Gdoura, Henda Triki, S. Haddad-Boubaker
          </td>
          <td>2025-11-04</td>
          <td>BMC Infectious Diseases</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8351d90d1e76d2976355d93ad064503b2904e7b0" target='_blank'>
              Reconstructing EBV reactivation and DNA damage response kinetics in morphologic pseudotime
              </a>
            </td>
          <td>
            Dina G. Tekle, Jonathan Z. Sexton, E. SoRelle
          </td>
          <td>2025-10-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disorder of the central nervous system (CNS). Age is the strongest predictor of disease phenotype, with the majority of older adults transitioning to a progressive form marked by irreversible neurological decline. This clinical progression is associated with smoldering, CNS-compartmentalized inflammation and neurodegeneration, for which there are currently no effective disease-modifying therapies. Cellular senescence, characterized by the secretion of pro-inflammatory mediators collectively known as the senescence-associated secretory phenotype (SASP), increases with age and contributes to tissue injury. In MS, neuroinflammation can further promote cellular senescence, creating a self-reinforcing cycle of damage. Senescent microglia have been identified within MS lesions, where their SASP may impair remyelination and exacerbate neurodegeneration. Senolytic agents selectively target and eliminate senescent cells by disrupting anti-apoptotic pathways. In experimental autoimmune encephalomyelitis (EAE), a widely used model of MS, senolytic treatment reduces senescent microglia burden and attenuates disease severity in an age- and drug-dependent manner. Specifically, here we show that middle-aged mice (40–44 weeks) with EAE exhibit improved clinical outcomes and survival following treatment with either dasatinib plus quercetin (D+Q) or navitoclax. Early-phase clinical trials of senolytics in age-related diseases have demonstrated functional benefits, including improved gait speed in idiopathic pulmonary fibrosis and CNS penetrance in Alzheimer’s disease. Translating senolytic therapy to MS will require careful selection of CNS-penetrant and well-tolerated agents, identification of appropriate patient populations, and deployment of responsive biomarkers. Senolytic therapy represents a promising geroscience-based strategy to meet the urgent therapeutic need in progressive MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/833c0a2c74e7a7ab280e18c8d71dabfd9c454a2a" target='_blank'>
              Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach
              </a>
            </td>
          <td>
            Jeffrey Atkinson, Amy Dokiburra, Hayley Groover, Jonathan P. Godbout, B. Segal, Yinan Zhang
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Type 1 diabetes (T1D) risk has been associated with enteroviral infections, particularly coxsackieviruses B (CVB). Cellular host factors contributing to virus-induced islet autoimmunity remain unclear. We show that the Hippo pathway effector Yes-associated Protein (YAP) is markedly upregulated in the exocrine and endocrine pancreas of T1D and at-risk autoantibody-positive (AAb+) donors, along with its target CTGF. YAP expression correlates with CVB RNA presence, often in or near infected cells. YAP overexpression enhances CVB replication, islet inflammation, and β-cell apoptosis, whereas its inhibition halts viral replication in primary and immortalized pancreatic cells. In exocrine-islet co-cultures, CVB triggers YAP and target gene expression. In mice, chronic β-cell YAP expression impairs glucose tolerance, abolishes insulin secretion, and promotes β-cell dedifferentiation. Mechanistically, YAP, in complex with its transcription factor TEAD, induces its own negative regulator MST1. MST1 inhibition boosts viral replication and reduces β-cell apoptosis, constituting a negative feedback loop in which the reciprocal antagonism between YAP and MST1 balances viral replication and β-cell death during CVB infections. YAP is thus an important host factor for enteroviral amplification, offering a potential antiviral target in T1D. Viruses such as coxsackievirus B (CVB) have been associated with type I diabetes (T1D) and islet destruction. Here the authors show that Yes-associated protein (YAP) is upregulated in the whole pancreas in T1D and at-risk autoantibody (AAb + ) organ donors and that YAP over-expression enhances CVB replication, islet inflammation and β-cell apoptosis and suggest exocrine-islet-immune interactions as targeted interventions for T1D.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/46a8c22841dec45ad83eda3f4933a10a838e2d8e" target='_blank'>
              The Hippo terminal effector YAP boosts enterovirus replication in type 1 diabetes
              </a>
            </td>
          <td>
            Shirin Geravandi, Huan Liu, Heena Pahwa, Murali Krishna Madduri, Farah Atawneh, Adib Miraki Feriz, Sahar Rafizadeh, Annabelle Elisabeth Kruf, Mona Khazaei, Pouria Bahrami, David Gotti, Mohamed Elawour, R. Elgamal, Ausilia Maria Grasso, David Bund, Blaz Lupse, Zahra Azizi, Omar Zabad, Karim Bouzakri, Marc Horwitz, A. Pugliese, Kathrin Maedler, A. Ardestani
          </td>
          <td>2025-10-06</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="With the unprecedented surge of severe COVID-19 cases in early 2020, researchers and medical professionals worked actively to identify effective viral infection treatments based on a scientific understanding of viruses. Over the past few years, an enormous amount of research has investigated the viral infection and replication processes following the first SARS-CoV-2 case. With this knowledge, many drugs have been explicitly created to inhibit viral replication or decrease the severity of the immune response. Additionally, scientists have utilized decades of research and techniques to expedite SARS-CoV-2 vaccine development. SARS-CoV-2, a positive-strand RNA virus, belongs to the Sarbecovirus subgroup of Betacoronaviruses. Its emergence is not unique; previous outbreaks like SARS and MERS have shaped our understanding of coronavirus-related diseases. Molecular clock analysis suggests that the ancestor of all current coronaviruses existed over 10,000 years ago, with subsequent evolution occurring around 3300–2400 BC. Researchers have explored synthetic and natural treatments alongside other antiviral therapies, corticosteroids, and immunotherapies. Additionally, using artificial intelligence and nano-based technologies enriched SARS-CoV-2 diagnosis and management. In this comprehensive review, we provide recent literature on COVID-19, exploring its evolving etiology, pathogenicity, and pathophysiology, alongside developments in synthetic and natural therapeutic strategies, vaccines, artificial intelligence in diagnosis, and nano-based technologies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/87c8a723eadbbda2af3f16a95b70dc7eb21c41db" target='_blank'>
              Comprehensive review on COVID-19: etiology, pathogenicity, and treatment
              </a>
            </td>
          <td>
            Amr El Zawily, Sarah Eckert, Reed Adajar, Nardin Wagih, Abeer H. Elmaidomy, Abdelrahman M. Helmy, Mazen Mustafa, Mazhar Elshorbagi, Erin Ghali, Rehab G. Fadl, Jochen Bodem, U. Abdelmohsen, Marco Y. W. Zaki
          </td>
          <td>2025-09-23</td>
          <td>Frontiers in Medicine</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0387bf223414d2cdfcd6b8258e94b4747d5384ae" target='_blank'>
              Age- and Sex- Driven Transcriptional and Metabolic Diversity in Myeloid-Derived Suppressor Cells After Mouse Sepsis
              </a>
            </td>
          <td>
            Christine Rodhouse, Dayuan Wang, Hongru Tang, Valerie E. Polcz, Miguel Hernandez-Rios, Xuanxuan Yu, Leandro Balzano-Nogueira, J. Rincon, Angel M. Charles, Seiichiro Fujishima, Quan Vo, M. Dirain, Ricardo F. Ungaro, Dina C. Nacionales, Leilani Zeumer-Spataro, Larissa Langhi Prata, Shawn D. Larson, Gemma Casadesus, Feifei Xiao, Shannon M. Wallet, Maigan A. Brusko, Tyler Loftus, Letitia E. Bible, Alicia M. Mohr, Paramita Chakrabarty, Michael P. Kladde, Clayton E. Mathews, L. Moldawer, Robert Maile, Guoshuai Cai, Philip A. Efron
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="COVID-19 research now provides a coherent picture of the virus's immunological impacts, highlighting immune-evasion mechanisms, the particular vulnerabilities of patients with inborn errors of immunity (IEI), and evolving therapeutics for severe disease. SARS-CoV-2 exploits ACE2 for cell entry and can utilise CD147 to infect immune cells, undermining antiviral defences; recent work details cytokine storm biology, NLRP3 inflammasome activation, and suppression of type I interferon responses. IEI patients are disproportionately affected, often with severe, prolonged courses and persistent PCR positivity. Therapeutic approaches such as convalescent plasma, anti-cytokine agents interferon alpha-2b, and plasma exchange show variable effectiveness, while vaccine performance is challenged by ongoing viral evolution. Together, these insights underscore the need for tailored treatment strategies for IEI populations, vigilant monitoring for immune-escape variants, and continuous adaptation of therapeutic and preventive measures. The aim of this review is to synthesise these findings, evaluate their implications for clinical management, and highlight future directions for research and patient care.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f582b3a29cce6c91c09a0b1c7c85ccffbfc52a0" target='_blank'>
              Lessons From COVID-19 on Inborn Errors of Immunity: A Five-Year Narrative Review.
              </a>
            </td>
          <td>
            Gamze Sonmez, Gizem Gunduz, S. Esenboğa, D. Çağdaş
          </td>
          <td>2025-10-28</td>
          <td>Scandinavian journal of immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Objective The prevalence of diabetes mellitus (DM) is escalating globally, presenting a significant public health challenge. The immune system, particularly T cells, plays a crucial role in the pathogenesis of diabetes. This study aims to elucidate the characteristics of T cell receptors (TCRs) and immune dysregulation within peripheral blood mononuclear cells (PBMCs) of diabetic patients, with exploratory analysis of microbial profiles. Methods We employed high-throughput RNA-seq to analyze the protein-coding genes expression, and function enrichment with different expression, BCR/TCR repertoires and microbial communities in PBMC samples collected from both diabetic patients and healthy controls. Comparative analysis was conducted to identify distinct TCR signatures associated with diabetes. Microbial communities were secondarily assessed via unmapped RNA-seq reads. Results Overall, we found different patterns of gene expression, gene function, immune cell proportion, immune repertoire and microbiome between the different DM and control groups. 1145 upregulated 400 down-regulated genes were identified, and immune response function terms were enriched, such as, cell-cell adhesion via plasma-membrane adhesion molecules, and homophilic cell adhesion via plasma membrane adhesion molecules (BP); as well as in the T cell receptor complex, plasma membrane signaling receptor complex, alpha-beta T cell receptor complex (CC), and in antigen binding and immunoglobulin receptor binding (MF). Furthermore, reactome pathway enrichment analysis revealed enrichment of these DEGs in Viral mRNA Translation, Influenza Viral RNA Transcription and Replication, SARS-CoV-1 modulates host translation machinery, Interleukin-6 family signaling, etc. DM PBMC showed significantly lower chao1 index of TCR (including TCRA and TCRB) and reduced expression of TRAV/TRBV genes compared to controls. Enriched pathways included T cell receptor complex, antigen binding, and interleukin-6 signaling. Exploratory analysis of microbial reads revealed decreased alpha diversity (chao1/ACE) in DM and 123 altered taxa, though microbial abundance was low. Conclusion Our study provides novel insights into T cell receptor dysregulation in diabetes. The role of PBMC-associated microbiota requires further validation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/18546128081181301a5973a20aa453f9ab300ba4" target='_blank'>
              Immune repertoire profiling and T cell dysregulation in Peripheral Blood Mononuclear Cells of Type 2 diabetic patients
              </a>
            </td>
          <td>
            Zheng Bi, Fanjing Wang, Shengmao Wang, Zhaohui Fang
          </td>
          <td>2025-10-09</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>4</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2024', '2025'],
    y: [2, 13],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>